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Für meine Mädels.
The posttranscriptional regulation of gene expression determines the amount of a
protein produced from a specific mRNA. All stages of the mRNA life cycle are post-
transcriptionally regulated. The untranslated regions (UTRs) of mRNA play an im-
portant role in this process. UTRs encode cis-regulatory elements that interact with
trans-acting factors such as RNA binding proteins or non-coding RNAs. These interac-
tions are based on the specific recognition of sequence or structured motifs. Similar to
the conservation of linear sequences, the conservation of secondary structures can be an
indicative of a functional cis-regulatory element.
In the first part of my doctoral thesis, I identified structurally conserved regulatory
elements in 3’UTRs of mRNAs. For this, I performed reporter gene assays with bioin-
formatically predicted structurally conserved RNA elements and discovered a regulatory
element in the 3’UTR of the UCP3 (uncoupling protein 3) mRNA. UCP3 is a protein of
the inner mitochiondrial membrane and is associated with the development of diabetes
melitus type 2 (T2DM). Through sequence and structural analysis, I discovered that
the element has an active conformation that consists of two short RNA stem-loops. In
further experiments, I was able to confirm that the presence of both RNA stem-loops is
necessary for efficient regulation. Furthermore, I showed that the reduction of reporter
gene expression is caused by a reduction of the mRNA half-life. The prediction of con-
served RNA structures thus provides a powerful tool for the de novo identification of
cis-regulatory elements.
In the second part of my doctoral thesis, I characterized the regulatory element from
the 3’UTR of UCP3 in detail. First, I performed RNA affinity purification to identify
proteins specifically associated with the UCP3 element by mass spectrometry. This
allowed me to show that the proteins Roquin-1 and Roquin-2 bind to the RNA stem
loops of the UCP3 element. Furthermore, I showed that endogenous UCP3 is regulated
by Roquin. Roquin proteins bind to constitutive (CDEs) and alternative (ADEs) decay
elements and induce the rapid degradation of mRNAs of genes that play an important
role in the immune response. Binding studies with the Roquin-1 ROQ domain showed
that Roquin binds with significantly higher affinity to the UCP3 element, when both
CDEs are present. Both CDEs in the UCP3 element do not correspond to the previously
suggested CDE consensus. Performing a detailed mutational analysis, I revised the CDE
consensus. With my data >160 new CDE- and 19 new ADE-coding mRNAs could
be identified. Furthermore, I confirmed new CDE/ADE-containing mRNAs as targets
of Roquin. Interestingly, I was able to show that not only the expression of CDE-
encoding mRNAs, but also regulation by Roquin is cell type dependent. In conclusion,
I have extended Roquin’s role in the posttranscriptional regulation of gene expression
and suggest that its role is not limited to the regulation of the immune response.
Die posttranskriptionelle Regulation der Genexpression bestimmt maßgeblich die Men-
ge eines Proteins, welches von einer bestimmten mRNA hergestellt wird. Alle Prozesse im
Lebenszyklus einer mRNA werden posttranskriptionell reguliert. Eine besondere Rolle
spielen dabei die nicht translatierten Bereiche (UTRs) der mRNA. UTRs kodieren cis-
regulatorische Elemente welche mit trans-agierende Faktoren wie RNA Bindeproteinen
oder nicht-kodierenden RNAs interagieren. Diese Interaktionen basieren auf der spezi-
fischen Erkennung von Sequenz- oder Strukturmotifen. Ähnlich wie die Konservierung
von Sequenzen, kann auch die Konservierung von Sekundärstrukturen Hinweis auf ein
funktionales cis-regulatorisches Element sein.
Im ersten Teil meiner Doktorarbeit identifizierte ich strukturkonservierte, regulatori-
sche Elemente in 3’UTRs der mRNA. Dazu führte ich Reportergenanalysen mit bioin-
formatisch vorhergesagten strukturkonservierten RNA Elementen durch und entdeckte
ein regulatorisches Element im 3’UTR der UCP3 (uncoupling protein 3) mRNA. UCP3
ist ein mitochondriales Membranprotein und mit der Entstehung von Diabetes Melitus
Typ 2 assoziiert. Durch Sequenz- und Strukturanalyse fand ich heraus, dass das Element
eine aktive Konformation mit zwei kurzen RNA Stammschleifen einnimmt. In weiteren
Experimenten konnte ich bestätigen, dass die Anwesenheit beider RNA Stammschlei-
fen notwendig für die Regulation ist. Darüber hinaus zeigte ich, dass die Reduktion der
Reportergenexpression durch eine drastische Verringerung der mRNA Halbwertszeit ver-
ursacht wird. Die Vorhersage konservierter RNA Strukturen, stellt somit ein effizientes
Werkzeug zur de novo Identifikation cis-regulatorischer Elemente dar.
Im zweiten Teil meiner Doktorarbeit untersuchte ich das regulatorische Element aus
dem 3’UTR von UCP3 im Detail. Zunächst führte ich RNA Affinitätsaufreinigung durch
um Proteine, die speziefisch mit dem UCP3 Element interagieren, mittels Massenspek-
tromentrie zu identifizieren. Dadurch konnte ich zeigen, dass die Proteine Roquin-1 und
Roquin-2 an die RNA Stammschleifen des UCP3 Elements binden. Darüber hinaus zeig-
te ich, dass endogenes UCP3 durch Roquin reguliert wird. Roquin Proteine binden an
konstitutive (CDEs) und alternative (ADEs) Abbauelemente und induzieren eine schnel-
len Abbau der mRNA von Genen die eine wichtige Rolle bei der Immunantwort spielen.
Bindungstudien mit der Roquin-1 ROQ Domäne zeigten, dass Roquin mit deutlich hö-
herer Affinität an das UCP3 Element bindet, wenn beide CDEs vohanden sind. Beide
CDEs im UCP3 Element entspechen nicht dem bisherigen Consesus für CDEs. Mit Hil-
fe einer Mutationsstudie revidierte ich den CDE Konsesus. Mit meinen Daten konnten
>160 neue CDE- und 19 neue ADE-kodierende mRNAs identifiziert werden. Drüber
hinaus bestätigte ich neue CDE/ADE-kodierende mRNAs als Ziele von Roquin. Inter-
essanterweise konnte ich zeigen, dass nicht nur die Expression CDE-kodierender mRNAs,
sondern auch die Regulation durch Roquin, Zelltyp abhängig ist. Durch meine Arbeit
konnte die Rolle von Roquin in der posttranskriptionellen Regulation der Genexpression
erweitert werden und und gezeigt werden, dass die Regulation durch Roquin nicht auf
Gene der Immunantwort beschränkt ist.
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1 Introduction
The regulation of gene expression in eukaryotes is complex and tightly controlled, and
is commonly described as the process by which the genetic code is used to direct protein
synthesis. The abundance of a protein is not only regulated at transcriptional level,
but also at several post-transcriptional levels. Post-transcriptional regulation (PTR) is
achieved at all steps in the complex life of a messenger RNA (mRNA), from its birth over
pre-mRNA splicing, through mRNA export to translation. An ensemble of RNA-binding
proteins (RPB) as well as non-coding RNAs (ncRNA) can interact with a given mRNA,
forming a dynamic messenger ribonucleoprotein particle (mRNP) and thereby determine
the fate of an mRNA from synthesis to decay [1]. The untranslated regions (UTRs) of
an mRNA play a particularly important role, as they encode cis-regulatory elements
that interact with trans-acting factors, i.e. RBPs and ncRNAs. While the 5’UTR
of an mRNA generally regulates translation, the function of 3’UTRs is more divers.
Regulatory elements in 3’UTRs determine protein abundance by the regulation of mRNA
stability, mRNA localization and translation efficiency. Next generation sequencing
methods provided us not only with a landscape of 3’UTRs, but also with the discovery
of a plethora of RBP and ncRNA binding sites that directly contribute to the regulation
of the respective mRNA.
This doctoral thesis focuses on an important part in understanding RNA-based regula-
tion that intends to understand how regulatory mRNA structures contribute to PTR. A
variety of concepts emerged in this field to understand cis-regulatory elements and their
interplay with trans-acting factors. But, while manifold methods were developed for the
prediction and identification of linear sequence motifs over the last decade, structured
RNA elements and their contribution to PTR are more difficult to assess and therefore
less studied.
1.1 Post-transcriptional Regulation
The regulation of gene expression can be divided into two broad categories: transcrip-
tional and post-transcriptional events. Transcriptional control concerns all processes
that determine the amount of transcript produced from a given gene. PTR on the other
hand, includes all regulatory events that directly influence mRNA and thereby determine
protein abundance.
In the process of transcription, RNA polymerases synthesize pre-mRNA molecules
based on DNA matrices. This process predominantly relies on the accessibility of a
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given genomic locus by the transcription machinery. Accessibility is achieved by dy-
namic remodeling of higher order genome structures. The primary structure of eu-
karyotic chromosomes consist of nucleosomes, a stable complex that constitutes of the
double-stranded DNA and histone proteins. Contiguous nucleosomes are separated by
short sections of linker DNA and yield the classic bead-on-a-string structure. These nu-
cleosomes are then organized in a higher order structure the chromatin, which involves
folding of the beads-on-a-string motif into a ∼30 nm thick fiber [2]. In order to provide
access to the DNA, the chromatin structure can be altered by modifying the strength of
the DNA-histone interaction. This is achieved by a number of post-translational modifi-
cations, i.e. acetylation, methylation, phosphorylation, ubiquitylation and sumoylation,
of specific amino acid residues of the histones, resulting in open or closed chromatin [3]
[4]. Additionally, ATP-dependent chromatin remodellers are involved in sliding, evict-
ing and restructuring of nucleosomes [3]. Most protein-coding genes in eukaryotes are
transcribed by RNA polymerase II. This process is dependent on regulatory proteins,
transcription factors, which are mandatory for the correct recruitment and binding of
the polymerase to the DNA. These factors recognize the core promoter of a gene, but
also nearby regulatory elements and distal elements in cis, which can be enhancers, si-
lencers, insulators or locus control regions, which function either to enhance or repress
transcription [5]. Therefore transcription factors significantly contribute to selective gene
expression in cells.
In contrast to prokaryotes where transcription is directly coupled to translation, those
two processes are spatially separated in eukaryotes as result of compartmentalization:
transcription takes place in the nucleus, whereas translation takes place in the cyto-
plasm. The uncoupling of transcription and translation provides the cell with extensive
opportunities to regulate the amount of protein that is synthesized, at the mRNA level.
PTR is evident throughout the different stages of an mRNA’s life [6] [7]. A schematic
representation of the eukaryotic mRNA life cycle is depicted in Fig. 1.1.
As soon as mRNA precursors are transcribed, the nascent pre-mRNA associates with
proteins that are necessary for further processing. Initially, the nascent pre-mRNA is
modified at its 5’ end by addition of a 7-methylguanosine in a co-transcriptional man-
ner. The 5’ end associates with specific protein factors, i.e the cap-binding complex
(CBC) that also facilitates splicing, 3’ end formation and even export as it diffuses with
bound mRNAs to nuclear pores [9]. After the export into the cytoplasm the CBC is
exchanged for the translation initiation factor EIF4E [8]. During transcription the non-
coding intronic sequences of an mRNA are removed by the process of splicing. This
is facilitated by a multi-protein complex, the spliceosome. Alternative splicing vastly
increases protein diversity of eukaryotic genomes. Alternative splicing can also label an
mRNA for specific degradation in the cytoplasm [10]. The 3’ end of the transcript en-
codes a polyadenylation signal sequence -AAUAAA- that is recognized by cleavage and
polyadenylation specificity factor 6 (CPSF6), which mediates cleavage of the nascent
pre-mRNA and addition of a 150-200 nt polyadenine (A) tail to the transcript. The
poly(A) tail of the mRNA associates with poly(A) binding proteins (PABPs) and me-
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Figure 1.1: The complex life of mRNA. Illustration of the mRNA life cycle from transcription
to translation to decay. Important RBPs that are crucial at various steps are shown.
Most RPBs that associate with the mRNA are replaced during transcription. For de-
tails refer to the main text. CBC, cap-binding complex; m7G, 7-methylguanosine cap;
EIF4E, eukaryotic initiation factor 4E; CPSF6, cleavage and polyadenylation specificity
factor 6; EJC, exon junction complex; hnRNPC, heterogeneous nuclear ribonucleopro-
tein C; NXF1, nuclear export factor 1; PABPC1, cytoplasmic poly(A) binding protein
1; PABPN1, nuclear poly(A)-binding protein 1; Pol II, RNA polymerase II; TREX1,
transcription export complex 1; XRN1, 5’-3’ exoribonuclease 1. Adopted from [8].
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diates circularization of the mRNA by interaction with 5’ end interacting proteins and
thereby forms the mRNP. mRNA circularization increases mRNA stability in the cyto-
plasm as well as the translation efficiency. The dynamic composition of an mRNP in
the cytoplasm dictates the subsequent fate of an mRNA by regulating its localization,
stability and translation efficiency [6] [8]. However, at the end of the mRNA life cycle
lies always the degradation by nucleases. The degradation of an mRNA can be either
dependent on the removal of 5’ cap or the 3’ poly(A) tail and is extensively regulated
by cis-regulatory element within the UTRs of an mRNA.
1.1.1 Pre-mRNA Splicing
In eukaryotic genes, the protein-coding sequence is interrupted by intervening sequences
(introns), which must be removed by splicing. This process is catalyzed by a dynamic ri-
bonucleoprotein complex, the spliceosome, mostly in a co-transcriptional manner, but it
can also occur post-transcriptionally [11] [12]. Co-transcriptional splicing allows for the
regulation by diverse transcription-dependent mechanisms, whereas post-transcriptional
splicing could create additional layers of regulation by coupling splicing with downstream
events like mRNA export [13]. Nuclear pre-mRNA splicing contains two simple transes-
terification reactions that involve reactive groups from three regions in the pre-mRNA.
Self-splicing group II introns fold into a complex secondary and tertiary structure, which
juxtaposes the reactive groups in an intron and thereby forms an active site. In contrast,
bringing reactive groups in a pre-mRNA intron into close proximity is dependent on the
trans-acting factors comprising the spliceosome [14]. The major spliceosome consists of
five small nucleolar ribonucleoproteins (snRNP) that dynamically interact with three
specific regions to exert pre-mRNA splicing. These important features are: the 5’ splice
site (SS), the 3’SS and the branch point (BP) with its adjacent poly(Y)-tract. Usually
introns encode a 5’SS that starts with a GU dinucleotide and a 3’SS that ends with
an AG dinucleotide. The third important feature is the BP, which is located 18-40 nt
upstream of the 3’SS and characteristically displays a -YNYURAY- motif.
In the first step of the splicing reaction the 2’-OH of the BP adenosine performs
a nucleophilic attack on the phosphodiester backbone at the 5’SS resulting in a free
5’ exon and an intron-3’ exon lariat. In the second step, the 5’ exon 3’-OH attacks
the phosphodiester backbone at the 3’SS, leading to exon ligation and lariat intron
excision. In order to bring all relevant protein and RNA components together at the
pre-mRNA the spliceosome comprises a large number of subunits, to accommodate for
all relevant reaction steps and their regulation. The assembly of the spliceosome on
the pre-mRNA is orchestrated by subsequent interactions of the spliceosomal snRNPs.
Initially, the U1 snRNP recognizes the 5’SS by base pairing interactions and the factors
SF1/mBBP and U2AF interact with the BP and poly(Y)-tract. Then, the U2 snRNP
forms a stable complex with the BP and thereby forms the pre-spliceosome (also A-
complex). A pre-assembled complex of the snRNP U4/U6 and U5 than is recruited to
the A-complex resulting in a pre-catalytic B-complex, which is subsequently rearranged,
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leading to release of U1 and U4 and results in the activated spliceosome. After catalytic
activation by auxiliary factors the first transesterification can be catalyzed, which yields
the complex required for the second step of the splicing reaction [15]. In an energy
consuming step the spliceosome is than resolved and its components reused in subsequent
rounds of splicing reactions.
There are different pathways for early stage spliceosome assembly in metazoans. As
most mammalian pre-mRNAs are composed of ∼120 nt long exons and introns which
vary in length from hundreds to thousands of nucleotides, splicing complexes initially
define the exons. In this process, the U1 snRNP binding to the 5’SS downstream of an
exon promotes U2AF association to the 3’ upstream poly(Y)-tract which leads to the
recruitment of the U2 snRNP to the upstream BP. This exon defined complex is stabilized
by interaction of serin/argine-rich (SR) proteins with splicing enhancer sequences, that
establish an exon-spanning network of protein-protein interactions [15].
1.1.2 Alternative pre-mRNA Splicing
Alternative splicing (AS) is an essential and ubiquitous mechanism that plays an im-
portant role in almost every biological process over the entire life span of an organism
from its birth to its death [16]. AS post-transcriptionally regulates gene expression be-
yond turning genes "on" and "off". In general, AS refers to any form of splicing that
variably includes or excludes exon, introns or fractions thereof, in a set of transcripts
from a given gene [17]. Thereby, AS contributes by large margins to eukaryotic protein
diversity. About 95% of human genes undergo AS, making it the most prominent RNA
processing mechanism that generates mRNA complexity. The variable inclusion or ex-
clusion of sequences in the protein-coding region of a gene, typically leads to different
protein isoforms that contain specific peptide domains or yields mRNAs harboring pre-
mature stop codons (PTCs), which trigger mRNA degradation by nonsense-mediated
decay (NMD). In contrast, AS of 5’ or 3’UTRs can alter the presence of cis-regulatory
elements within those regions and thereby influences mRNA localization, stability and
translation efficiency. Taken together, this highlights the fundamental role of AS as a
mechanism that is critical for the proper function of cells [18] [16]. The importance of
AS is further highlighted by the fact that corruption of the process is associated with
numerous pathologies like cancer and improper immune responses.
There are four major AS events. Almost 40% of AS events in higher eukaryotes
are exon skipping events, followed by alternative 5’SS and 3’SS selection accounting
for 7.9% and 18.4% of AS events, respectively. The rarest type of AS event is intron
retention which, only accounts for less than 5% of events in vertebrates and invertebrates
and is most prevalent in UTRs. In addition to that, less frequent events occur that
lead to transcripts with mutually exclusive exons, alternative promoters and alternative
polyadenylation. All of the four main splicing events can occur in the protein coding
sequence as well as in UTRs [19].
Alternative SS usage by the spliceosome is determined by the interaction of addi-
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tional proteins with specific pre-mRNA sequences, so-called intronic and exonic splicing
enhancer or silencer sequences, under particular cellular conditions. SR proteins are
splicing regulators that are best known to recognize exonic splicing enhancers and pro-
mote exon inclusion. On the other hand, heterogeneous ribonucleoproteins (hnRNPs)
often mediate exon skipping by interaction with exonic splicing silencers. AS there-
fore reflects the occupancy and interaction of these regulatory elements with different
proteins that are present in a specific cellular scenario [20].
1.1.3 mRNA Surveillance
In order to ensure cell function and viability, gene expression must maintain a high level
of fidelity. Errors during transcription or RNA processing can lead to non-functional
transcripts, encoding truncated proteins that are potentially deleterious for a cell. At the
mRNA level, several quality control mechanisms evolved that operate during translation
in order to protect the cell from aberrant mRNAs: non-stop decay (NSD), no-go decay
(NGD) and NMD. NSD targets transcripts for degradation that do not contain a stop
codon. NGD targets mRNAs with ribosomes stalled during elongation. NMD promotes
degradation of mRNAs that undergo premature translation termination by encoding a
premature stop codon [21] [22].
The best described RNA surveillance mechanism in eukaryotes is NMD, which pro-
vides a powerful means of not only controlling mRNA quality, but regulation of gene
expression as well. The fact, that 30% of all mutations involved in human diseases lead
to a PTC, highlight the biological importance of NMD [22]. NMD targets at least two
different sets of mRNAs. The first important group of NMD targets are mRNA tran-
scripts that harbor a PTC that truncates their open reading frame. In general, a stop
codon located ∼55 nt upstream of an exon-junction complex triggers NMD [23]. These
transcripts arise from different origins. Mutation at the DNA level can introduce PTCs
by direct nonsense mutation or by frame-shift inducing deletions or insertions. More
importantly, PTC containing mRNAs can be produced by AS. Computational predic-
tions propose, that one third of alternatively spliced mRNAs harbor a PTC, highlighting
the coupling of NMD to AS. Various studies revealed how AS events exploit NMD as a
means to regulate the abundance of transcripts under certain cellular conditions. This
type of regulation therefore has been termed AS-NMD or RUST (regulated unproductive
splicing and translation) and is found in the regulation of many splicing regulators, like
SR proteins and hnRNPs, indicating its role as important feedback regulator of splicing.
Because NMD sensitive mRNA isoforms are not translated into a protein, AS-NMD al-
lows for the control of overall protein abundance by switching between transcripts that
are translated or degraded. Approximately 10-15% of all human genes are regulated by
the AS-NMD mechanism [24].
The second group comprises physiological transcripts that encode full-length proteins.
The role of NMD as regulator of physiological mRNAs was highlighted in transcriptome
profiling studies that revealed, that NMD controls the abundance of 3-10% of cellular
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genes. Features that render physiological mRNAs sensitive for NMD include introns lo-
cated in the 3’UTR, upstream open reading frames (uORFs), programmed frame-shifts
and long 3’UTRs. An interesting case for NMD substrates are UGA codon bearing tran-
scripts, which can encode the amino acid selenocystein. When selenium concentration
is high UGA encodes selenocystein, if selenium concentration is low UGA is interpreted
as PTC [24].
1.1.4 mRNA Decay
In general, eukaryotic mRNAs have 5’ cap structures and 3’ poly(A)-tails. These features
are essential for the formation of the mRNP, which protects the mRNA from decay by
exonucleases and is necessary for efficient translation. However, this state is dynamic and
transient. The rate limiting steps of mRNA decay are the shortening of the poly(A)-tail
of an mRNA and removal of the 5’ cap structure. In eukaryotes, two distinct pathways
for mRNA decay exist. After deadenylation mRNAs can be degraded in either 3’→5’
direction by the exosome or in 5’→3’ by the nuclease Xrn1 [25].
Initially, the the main deadenylation machinery, a complex consisting of Ccr4–Not in
yeast or PARN (poly(A)-specific ribonuclease) and PAN2/PAN3 (polyA-specific ribonu-
clease subunit) in metazoans, facilitates the loss of PABP by shortening of the poly(A)-
tail which leads to the disruption of the circular mRNP structure. mRNA linearization
enables the association of additional factors to both ends of an mRNA molecule. One
mechanism for cytoplasmatic mRNA turnover is the deadenylation-dependent 5’→3’
degradation. This process is limited by the rate of decapping. Decapping of the acces-
sible 5’ end is executed by the Dcp1p/Dcp2p decapping complex in conjunction with
the activity of several accessory factors. These include the heptameric Lsm1-7p com-
plex, the Dhh1p RNA helicase (also known as RCK/p54 or Me31B), and Pat1p, which
are proposed to facilitate the association of the decapping complex. This process is
further modulated by enhancing factors, the Edc1, Edc2, and Edc3 (Lsm16) proteins.
Interestingly Dhh1p and Pat1p which stimulate the decapping complex, also serve as
translational repressors. After decapping, the mRNA is subsequently degraded by the
exonuclease Xrn1 [25] [21].
The alternative post-deadenylation mRNA decay pathway is the 3’→5’ degradation
by the multi-subunit exosome complex. A nine subunit containing catalytic inactive
core exosome complex is present in both the nucleus and the cytoplasm. For catalytic
activity different additional factors associate with the exosome in each compartment.
In addition to the nine core exosome subunits, catalytically active exosomes need the
nuclease factor Dis3p/Rrp44p and the 3’→5’ exonuclease Rrp6p/Ski7p in the nuclear or
cytoplasmic exosome, respectively [26].
mRNAs that undergo degradation have been observed in two distinct translational
states. On the one hand, translationally inactive mRNAs localize to P-bodies, distinct
cytoplasmatic foci that are enriched in components of the mRNA degradation machinery,
where they undergo degradation. On the other hand, actively translated mRNAs present
7
1.1 Post-transcriptional Regulation
in polyribosome fractions can be degraded. Deletion of the key P-body genes Edc3 and
Lsm4 did not impair mRNA decay of individual mRNAs suggesting that localization
to P-bodies is not obligatory for mRNA degradation. This is further highlighted by
experiments that showed that polysome fractions contain deadenylated, decapped, and
partially exonucleolytically degraded mRNAs, and the finding that mRNA decay factors
cofractionate with ribosomes [21].
1.1.5 Non-coding RNAs in Gene Regulation
High-throughput transcriptome studies revealed that ∼90% of the human genome is
transcribed. Yet, only 1-2% of the genome encodes for proteins. Thus, the vast ma-
jority of transcripts are non-coding (nc) RNAs, which have regulatory functions [27].
Evidence supports that ncRNAs play a role in the response to stress and environmental
stimuli as well as in developmental processes. NcRNAs can be divided into two main
groups: infrastructural ncRNAs and regulatory ncRNAs. The first group comprises ri-
bosomal, transfer, small nuclear and nucleolar RNAs. These RNAs function as scaffolds
in dynamic RNA-protein complexes that are involved in every step of an mRNA’s life.
The second group of ncRNAs comprises regulatory ncRNAs: microRNAs (miRs), Piwi-
interacting RNAs (piRNAs), small interfering RNAs (siRNAs), and long non-coding
RNAs (lncRNAs). PiRNAs are a group of 24–31 nt long ncRNAs that form complexes
with Piwi proteins of the Argonaute protein family and thereby suppress transposon
activity during germline development. SiRNAs are linear, perfectly base-paired dsRNA,
which is processed to a 21-24 nt long siRNA by Dicer and mediates post-transcriptional
silencing when loaded onto Argonaute proteins. The siRNA mode of action is similar to
that of miRs (see below). LncRNAs represent the largest group of non-coding transcripts
and are generally >200 nt long. The majority of lncRNAs are transcribed as complex
networks of sense and antisense transcripts regarding their respective genomic locus.
Antisense transcripts have been shown to modulate mRNA stability, e. g. of hypoxia
inducible factor alpha (HIF-1a), nitric-oxide synthase (eNOS) and tyrosine kinase with
immunoglobulin-like and EGF-like domains 1 (tie-1), which highlights their importance
in PTR [27].
Probably the most elaborately studied group of regulatory ncRNAs are miRs. They
comprise a large family of ∼21 nt long ncRNAs that are present in most eukaryotic or-
ganisms and are key-regulators of gene expression [28]. The first the miRs, lin-4 and
let-7, were identified in C. elegans screenings for genes that control larva development
[29]. Typically, miRs are associated with the repression of protein-coding genes, but
rare examples were miRs may lead to the induction of a specific gene under certain
conditions also exist [30] [31]. The widespread involvement of miRs in PTR is substan-
tiated by >2,500 miRs that have already been discovered in humans (collected in the
miRBase 20.0 database) [32], of which >600 have been experimentally confirmed [33].
Approximately 50-60% of all protein-coding genes are regulated by miRs [34] [35]. MiRs
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regulate gene expression by modulation of mRNA stability or translation efficiency of
their target gene. They often interact with the 3’UTRs of target transcripts [36]. MiRs
mature by a complex biogenesis, which itself is highly regulated [37] [38] [39]. MiR genes
are generally encoded in intergenic regions or introns. They are typically transcribed
by RNA polymerase II to produce the primary (pri)-miR transcript that harbors an
RNA hairpin structure that co-transcriptionally associates with the multi-protein Mi-
croprocessor complex. The Microprocessor contains the RNase III Drosha and the RBP
DGCR8 and crops the pri-miR to a ∼60 nt hairpin-structured pre-miR. Alternatively,
pre-miRNA-like introns, called mirtrons can produce pre-miRs by splicing, independent
of the Drosha processing. Next, the pre-miR is actively transported from the nucleus
to the cytoplasm by Exportin-5 (Exp5), where the proteins Dicer, TRBP and PACT
assemble on the pre-miR and cleave it into a ∼21 nt miR duplex. This duplex is loaded
onto an RNP complex called RISC (RNA-induced silencing complex), which facilitates
degradation of the passenger strand. The miR-RISC complex then associates with par-
tially complementary sequences in an mRNA, depending on the accessibility of the miR
binding site and the occurrence of the minimal perfect Watson–Crick base pairing nu-
cleotides of the seed region between miR and target mRNA [28].
1.1.6 RNA-binding Proteins
Along with miRs, PTR of gene expression is achieved by the dynamic interactions of
RNAs with RBPs that assemble into an RNP. Generally RBPs contain one or multiple
RNA-binding domains [40], by which they recognize their targets and orchestrate all as-
pects of the mRNA life cycle from production over processing to mRNA function. Key
components of mRNPs, like the cytoplasmic cap–binding proteins, PABP and hnRNPs
were initially identified in the 1970s [41]. More than 1500 RBPs were identified since,
most of them by RNA interactome studies over the last decade [33] [42] [43]. Deregulation
or dysfunction of RBPs is often associated with disease, highlighting the importance of
RBPs in cellular homeostasis [44] [43]. RBPs change the fate of an mRNA upon binding
by modulating RNA processing, modification, stability, translation and localization. In-
versely, RBP fate can be changed by RNA binding by altering RBP function, facilitating
protein-protein interaction or modulation of stability and spatio-temporal distribution
(Fig. 1.2) [45] [46]. Approximately 3-11% of eukaryotic genomes encode RBPs. Most
RBPs contain a set of well defined RNA binding domains (RBD) such as the RNA
recognition motif (RRM), K-homology domain (KH), CCCH zinc finger domain (ZnF)
and double-stranded RNA binding motifs, like the DEAD box helicase domain (DHX)
[47]. By the modular combination of RBDs and their cooperative function, RBPs build
up affinity and specificity for their respective RNA targets [44]. In addition, an increas-
ing number of RBPs lack classical RBDs at all and contain protein domains with dual
functions that can perform enzymatic activities and RNA binding or contain protein
folds of unknown function or lacking any defined tertiary structure in the unbound state
[44]. Binding affinity and specificity is also influenced by composite RNA motifs that
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Figure 1.2: The functional relationship between RNA and RBPs. RBPs interact with RNAs by
binding to specific cis-regulatory elements in a sequence or shape dependent manner,
thereby modulating RNA fate. Inversely, interaction with RNA can also alternate RBP
fate. Adopted from [45].
are differentially targeted by the respective RBP (Fig. 1.3). Recently, high-throughput
SELEX (systematic evolution of ligands by exponential enrichment) studies with RBPs
revealed that ∼70% of RBPs recognize short single stranded RNA sequences whereas
∼30% have a binding preference for structured RNA motifs. Interestingly, many RBPs
can bind to multiple different motifs [48].
Figure 1.3: Composite RNA-binding domains and RBP binding sites guide RNA/RBP in-
teraction. RBPs bind to RNA through a limited number of RBDs. Binding specificity
is accomplished by RBD composition. Discrimination of similar RNA motifs is achieved
through distinct affinities of an RBP to an RNA motif. The affinity is modulated by
composite motifs, flanking sequence composition and RNA structure. Adopted and
modified from [42].
The combination of canonical and non-canonical RBPs allows for a plethora of RBP-
RNA interactions with a wide range of binding efficiencies and specificity, but not all
of these can be assumed as relevant. A variety of RBP-RNA interactions is depicted
in Fig. 1.4. One of the most common RNA-protein interactions in PTR is the high-
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affinity binding of an RBP to a certain sequence or structure element in the target RNA.
RBPs that recognize such signals often serve as adaptors for the recruitment effector
proteins that modulate target mRNA stability or translation efficiency. In addition,
numerous steps in RNA metabolism depend on indiscriminate RNA binding by RBPs.
This is exemplified by various proteins involved in mRNA translation and degradation
that need to bind non-selectively to RNAs to function. In a similar manner the exon-
junction complex is non-selectively deposited at a fixed upstream position on the nascent
mRNA. Approximately 50% of all RBP binding sites mapped in the RBDmap [49] map
to intrinsically disordered domains (IDD) and ∼170 RBPs apparently rely exclusively
on IDDs for RNA binding. This mode of binding is exemplified by the fragile X mental
retardation protein 1 (FMRP). NMR studies revealed that glycine and arginine amino
acid residues in the FMRP IDD guide the interaction of positively charged amino acids
with Watson–Crick base pairs, which stack on two adjacent RNA G-quadruplexes that
form as a result of protein–RNA co-folding. In addition to that, many shape-based
Figure 1.4: Different modes of RNA recognition by RBPs. RBPs harboring canonical RBDs
interact with RNA in a sequence or shape dependent manner. EIF4E associates un-
specifically with capped mRNAs in order to induce translation. The exon-junction
complex is unspecifically deposited at exon junctions by interaction with splicing fac-
tor CWC22. The FRMP IDD cofolds with it target mRNA. The HCV IRES directly
interacts with the 40 S ribosomal subunit by extended shape complementarity. The
moonlighting RBP IRP1 binds with high affinity to conserved RNA stem-loop struc-
tures in iron-deprived cells. Adopted and modified from [45].
RNA-protein interactions are achieved through large RNA-protein interfaces without
any defined protein regions. This is exemplified by the spliceosome, where snRNAs
fold into complex structures that interact with protein partners that are complementary
in structure and biochemical properties. Another example is the interaction of the
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hepatitis C virus (HCV) internal ribosome entry site (IRES) with the ribosome, which
again does not depend on a defined RNA-binding domain but rather on a strong shape
complementarity between the IRES and the 40 S subunit of the ribosome. Over the
last decade, mRNA interactome studies identified a number of metabolic enzymes with
intrinsic RNA-binding activity. Iron regulatory protein (IRP) 1 (also aconitase, ACO1)
requires an iron-sulfur cluster for its enzymatic activity, which however precludes RNA
binding activity. In addition, to its role in the citric acid cycle, IRP1 regulates the
expression of genes involved in the iron uptake and storage by binding to iron responsive
elements in the UTRs of iron metabolism related genes (see section 1.2.1)[45].
1.1.7 The Roquin Protein Family
The Roquin protein family contains the two RBPs, Roquin-1 and Roquin-2, which are
key regulators of immune homeostasis. They repress the expression of immune relevant
targets and thereby control gene expression and cell fate decisions. They are named by
their unique RBD, the ROQ domain, that recognizes specific RNA stem-loop structures.
Roquin localizes to P-bodies and stress-granules were it promotes target mRNA decay by
the recruitment of the CCR4-CAF1-NOT deadenylase complex. Initially, Roquin-1 was
identified by an N-ethyl-N-nitrosourea (ENU) mouse mutagenesis screen for regulators
of autoimmunity. Homozygous mice with a point mutation in the Roquin-1 encoding
RC3H1 gene, resulting in a methionine 199 to arginine amino acid exchange (so-called
sanroque mutation), developed a T follicular helper cell-driven lupus-like autoimmunity.
This phenotype is induced by the activation of T cells and the resulting accumulation
of T follicular helper (Tfh) cells and the production of autoantibodies [50] [51]. This is
achieved by the induction of the Roquin target ICOS (inducible T-cell costimulator) in
RC3H1san/san mice. Further immune relevant targets, like CTLA4 and Ox40, cytokines
TNF and IL6, transcription factors IRF4 and c-Rel, and modulators of transcription
NFKBID and NFKBIZ, have been subsequently identified as Roquin targets [52] [53]
[54]. Roquin’s role as a surpressor of immune relevant target genes is depicted in Fig.
1.5A. Interestingly, deletion of either Roquin-1 or Roquin-2 lead to perinatal lethality
in mice. This suggests additional functions for Roquin proteins outside the immune
response [53] [55].
Roquin-1 and -2 are highly similar and have ∼80% sequence identity in their N-
terminal region. It was shown that Roquin proteins bind to the 3’UTR of their targets
through their N-terminal half, encoding for a RING domain (really interesting new gene),
which functions as an E3 ubiquitin ligase, and two RBDs: the ROQ domain and a CCCH
ZnF domain. The effector functions of Roquin are harbored in the C-terminal region,
which recruits the deadenylation machinery for subsequent target mRNA degradation
[56] [52]. This part of the protein seems to be intrinsically disordered and contains
a proline-rich stretch that might severe as surface for protein-protein interactions. In
addition to this, a coiled-coil domain, which could mediate protein-protein interactions
as well, has been predicted Fig. 1.5B.
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Figure 1.5: Roquins function in the immune response. (A) Roquin inhibits the expression of
costimulatory T cell receptors, cytokines, and transcription factors. Roquin binds to
cis-regulatory elements in the 3’UTR of target mRNAs and subsequently recruits the
CCR4–CAF1–NOT deadenylation machinery. (B) Roquin-1 consist of an N-terminal
RING domain, a ROQ domain and a ZnF. The C-terminal part of the protein contains
a proline-rich sequence (PRS) and a short coiled-coil domain. Adopted from [57].
In contrast to many other RBPs that recognize single-stranded RNA motifs, Roquin
proteins distinctively bind to an RNA motif that folds into a stem-loop structure, the
so-called constitutive decay element (CDE) [56] [52]. Roquin’s ROQ domain contains
two RNA binding sites. The A-site specifically binds CDEs, whereas the B-site un-
specifically recognizes dsRNA (Fig. 1.6A. The most extensively studied CDE is the
initially discovered TNF CDE. This cis-regulatory element resides in the 3’UTR of the
TNF mRNA and consist of a triloop hairpin structure. The structure of the TNF CDE
bound by Roquin’s ROQ domain is depicted in Fig. 1.6B). Detailed mutational anal-
ysis of the TNF CDE revealed Roquin’s preference for a pyrimidine-purine-pyrimidine
tri-nucleotide motif in the loop, along with two Y-P base pairs in the apical part of
the stem, which also allows it to a purine stack of five consecutive purines at the 3’
side of the stem [56]. However, this CDE consensus has been continuously revised as it
does not match CDE-like hairpins found in other Roquin targets [58] [59]. A number of
subsequent in vitro studies proposed that active CDEs form a 5-8 nt long stem capped
by a U-rich tri-nucleotide loop [56] [60] [57]. The shape dependency of Roquin binding
is further supported by structural analysis of Roquin-1 and Roquin-2 in complex with
different CDEs. These in vitro studies propose a mainly shape-specific recognition of
CDEs by Roquin that is independent of sequence [59] [61] [62] [63]. Moreover, SELEX
experiments showed that Roquin binds to hairpins with U-rich hexaloops with high affin-
ity. Such an alternative decay element (ADE) was identified in the 3’UTR of the Roquin
target Ox40 [64]. In addition to that, a recent publication suggests that Roquin might
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bind linear sequence motifs as well [65].
Figure 1.6: RNA recognition of Roquins ROQ domain. (A) Schematic representation of the
ROQ domain RNA interaction. The A-site specifically recognizes CDEs, whereas the
B-site unspecifically recognizes dsRNA.(B) Structure of the TNF CDE bound by the
ROQ domain. Adopted and modified from [57].
To date it is still unclear what defines a potent cis-regulatory element for Roquin-
mediated regulation. However, it seems that Roquin binding is much more versatile as
the in vitro and in vivo studies on the TNF CDE suggested. Therefore, a much wider
range of mRNAs than currently assumed could be functional Roquin targets.
1.2 The Role of UTRs in Gene Regulation
Post-transcriptional control of eukaryotic gene expression is an elaborate and extensive
process. Essentially every step of the mRNA metabolism is regulated in an mRNA-
dependent manner. The precise regulation of gene expression is a necessity for the
correct temporal and spatial expression of genes. This regulation is primarily based on
cis-regulatory elements residing in the UTRs of mRNAs, that are recognized by trans-
acting factors in a sequence- or shape-dependent manner. This allows for complex PTR
networks that enable cells to adapt to in- and extrinsic stimuli and thereby control
the onset, duration or magnitude of specific beneficial or pathological activities. The
structure of an generic mRNA encoding important cis-regulatory elements is depicted in
Fig. 1.7. Altering of UTRs by alternative promoter usage or alternative polyadenylation
can lead to serious pathologies [66]. The scientific field concerning the discovery of cis-
regulatory RNA elements is divers and rapidly growing. The attempt to present all
aspects of this field can only be incomplete. Therefore, I will concentrate on the core
aspects that are involved in PTR which, in combination, make mRNA-based regulation
an integral part of gene regulation.
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Figure 1.7: Structure of an eukarytic mRNA. Schematic representation of an mRNA molecule.
The UTRs contain variable cis-regulatory elements that affect gene expression. m7G,
7-methyl-guanosine cap; IRE, iron responsive element; uORF, upstream open reading
frame; IRES, internal ribosome entry site; CDS, coding sequence; SECIS, selenocystein
insertion element; ARE, AU-rich element; GRE, GU-rich element; miR, microRNA
binding site; zip code, RNA localization signal; CDE, constitutive decay element; PAS,
polyadenylation signal. Adopted and modified from [67].
1.2.1 Regulation by 5’UTRs
The 5’UTR of a human mRNA has an average length of 100-200 nt and can harbor
different functional elements that determine the translation of the downstream open
reading frame. 5’UTRs of mRNAs that encode transcription factors, proto-oncoproteins,
growth factors and proteins that are poorly translated under normal conditions, tend
to be longer in vertebrates compared to other eukaryotes. An additional, conserved
feature of vertebrate 5’UTRs is an increased GC-content of up to 60%, compared to
45% in 3’UTRs. The GC-content of RNA secondary structures can also affect translation
efficiency independent of its thermodynamic properties [68] [69]. By means of alternative
promoter usage, approximately 60% of all gene express alternative 5’UTRs and thereby
contribute to transcriptome diversity [70].
Secondary structure
Secondary structures in 5’UTRs, such as stable stem-loop structures can be an important
means of regulating translation. 90% of genes that encode for transcription factors,
proto-oncogenes and growth factors have stable structured elements in their 5’UTR.
60% of these are located in close proximity to the 5’ cap structure and are able to
inhibit translation initiation. Stable hairpin structures near the 5’ cap with a ∆G of -30
kcal/mol are sufficient to prevent binding of the pre-initiation complex to the mRNA. In
addition, stable secondary structures can resist unwinding by the helicase EIF4A [69].
Upstream open reading frames
Upstream open reading frames (uORFs) are major regulators of gene expression. Com-
putational predictions assume that approximately 50% of the human mRNAs contain
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uORFs. uORF-mediated regulation of translation was verified for ∼100 transcripts, 30
of them in human. UORFs are characterized by an initiation codon in frame with a
termination codon, located upstream or downstream of the main AUG. Consequentially
translation initiates before the main ORF and a small peptide is formed. The 40S
subunit of the ribosome can then either reinitiate and translate the encoded protein
or dissociate without translating the main ORF. Thus, uORFs are generally associated
with a reduction of protein expression. In addition to the translation inhibition of the
main ORF, uORFs can also induce rapid mRNA degradation by the NMD mechanism
as the uORF stop codon is recognized as premature. Interestingly, it was shown that in
cellular stress response, the presence of uORFs favours the expression of certain mRNAs
in the cell and thereby allows the respective mRNA to evade from global translation
inhibition [71].
Internal ribosome entry sites
Internal ribosome entry sites (IRESs) occur in 5’UTRs of mRNA [71] and comprise a
diverse group of cis-regulatory elements than can consist of a sequence of only 9 nt up
to a strongly structured element of more than 600 nt in length [72][73]. Under stress
conditions cap-dependent translation decreases. In order to maintain the translation of
specific mRNAs under conditions of global translation inhibition, specific IRESs facili-
tate translation [74]. This process depends on RBPs that specifically interact with the
IRES (ITAFs, IRES trans-activating factors) for the cap-independent recruitment of the
ribosome. Initially, IRESs were identified in picornavirus RNA [75]. Since then, IRES
elements were identified in a variety of human mRNAs encoding for proteins contributing
to cell survival [76], proliferation [77], and angiogenesis [78].
Iron responsive elements
Iron responsive elements (IREs) comprise another important class or regulatory RNA
elements that are located in the 5’ and 3’UTRs of genes, important for cellular iron
homeostasis. These ∼30 nt RNA stem-loop structures were initially discover in the
5’UTR of ferritin H- and L-chain mRNAs were they inhibit ferritin mRNA translation in
iron-deprived cells [79]. Subsequently, IREs were discovered in the mRNAs of transferrin
receptor, erythroid 5-aminolevulinic-acid synthase, aconitase, ferroportin, and divalent
metal transporter 1. IREs are highly conserved for any given gene and are very similar
between genes [80]. IREs interact with specific trans-acting RBPs, IRP1 and IRP2 with
high specificity and thereby control translation efficiency and mRNA stability of the
respective transcripts. If an IRE is located ≤40 nt downstream of the 5’ cap, binding of
the 43 S preinitiation complex is inhibited upon binding of IRP1 or IRP2. The 3’UTR of
TFRC encodes five IREs that regulate mRNA stability. In iron-deprived cells IRPs bind
to these stem-loops and thereby protect TFRC mRNA from endonucleolytic cleavage
and subsequent degradation [80]. Binding activity of IRPs is directly regulated by the
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iron concentration in the cytosol. If iron levels are high, IRP1 stores iron by binding
to a [4Fe-4S] cluster, which also inhibits binding to IREs. IRP2 on the other hand is
stabilized by the association with the [4Fe-4S] cluster under low iron concentrations [81].
Interestingly, IRP1 does not contain a canonical RBD and acts as a moonlighting RBP.
In association with the [4Fe-4S] cluster it catalyzes an enzymatic reaction in the citric
acid cycle.
1.2.2 Regulation by 3’UTRs
3’UTRs control protein levels by altering mRNA stability and translation efficiency.
This regulation is most commonly achieved by cis-elements. In addition, 3’UTRs can
facilitate local translation by the regulation of mRNA localization. mRNA fate can
further be modulated by the specific inclusion or exclusion of cis-regulatory elements in
3’UTRs by alternative polyadenylation as well as the observation that 3’UTR cleavage
products can act as ncRNA.
In human genes the median 3’UTR length is approximately 1200 nt. Although 3’UTRs
are less conserved than the protein-coding regions of an mRNA, they still show a high
degree of sequence conservation across vertebrates. Similar to the protein-coding region
3’UTRs contain island of sequence conservation, and these island often represent RBP
and miR binding sites [46]. In humans, 51–79% of genes express alternative 3’UTRs.
Alternative 3’UTRs can increase the accessibility of regulatory elements, that would
otherwise be structurally constrained within a long UTR. An important aspect of the
mRNA life cycle is the correct mRNA localization which is usually mediated by local-
ization signals (zip codes) in 3’UTRs. These elements are recognized by RBPs that
interact with motor proteins that move mRNAs along the filament of the cytoskeleton.
This is exemplified by the ASH1 mRNA which contains four cis-elements including one
located in the 3’UTR, important for proper localization. These elements are bound by
RBPs that recruit a myosin motor protein, which facilitates the movement along actin
microfilaments. Similar mechanisms have been described for the majority of localized
mRNAs [46].
1.2.3 AU-rich Elements
AREs are cis-regulatory elements that modulate mRNA stability and translation and are
predominantly encoded in the 3’UTRs of early-response genes and transiently expressed
mRNAs [82]. These mRNAs typically encode proteins that regulate cell proliferation,
RNA metabolism, transcriptional regulation, signaling, and response to stress and mi-
crobes. Such genes require a very precise control to be able to instantly react to such
stimuli. Therefore, in addition to transcriptional control, regulation of translation and
stability of the mRNA is a necessity. The importance of ARE-mediated repression is
highlighted by the observation that aberrant expression of ARE-containing mRNAs is
associated with a plethora of pathological states, i.e. cancer, chronic inflammations and
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autoimmune pathologies [83]. Initially, AREs were identified in the 3’UTRs of unsta-
ble mRNAs encoding cytokines and lymphokines [84]. To date, >4000 ARE-containing
mRNAs have been identified in the human genome, but only few of them have been
experimentally verified [85] [86]. This makes AREs the most common cis-regulatory
element. The canonical sites for AREs are 3’UTRs, but recent studies showed they are
also abundant in introns were their sequence is much more complex compared to 3’UTR
AREs [85]. AREs are classified into distinct families, which presumably are recognized
by specific sets of RBPs that act in trans for differential regulation. AREs are 50-150 nt
long and contain the core -AUUUA- motif embedded in an AU-rich sequence context
[85]. Based on the occurrence of the pentamer motif and overall sequence, AREs are de-
vided into three classes. Class I AREs contain several scattered copies of the -AUUUA-
pentamer in a U-rich environment. Class II AREs contain at least two overlapping
UUAUUUA(U/A)(U/A) nonamers. Class III AREs are less well defined U-rich ele-
ments without the core pentamer motif. An example for a class III ARE can be found
in the c-jun mRNA [83].
AREs are recognized by a variety of RBPs, so called ARE-BPs. Among these HuR, a
protein from the embryonic lethal abnormal vision-like protein family, is a ubiquitously
expressed ARE-BP. It is a universal RNA stability factor. It is known to bind to AREs
in 3’UTRs and introns, and to stabilize transcripts and enhance translation. Another
group of important ARE-BPs are proteins from the CCCH ZFP36 family, which contains
tristetraprolin (TTP). Because of its strong anti-inflammatory role and its role as tumor
suppressor, it is the most widely studied ARE-BP. TTP only binds to class II AREs and
promotes mRNA decay. The first ARE-BP that was discovered, AU-rich-binding factor
1 (AUF1, also hnRNP D) and its isoforms, bind to AREs and modulate mRNA stability.
In addition, AUF1 can interact with HuR and TTP. T cell intracellular antigen-1 (TIA-1)
and TIA-related (TIAR) proteins cause translational inhibition by binding to AREs.
Specific binding of an RBP to an ARE is determined by the type of ARE, its length
and context. Specificity is further regulated by ARE-BP modifications and interaction
between ARE-BPs. In this context competitive binding, as in the case of TTP and HuR,
and cooperative binding, e.g. TTP and KSRP, significantly contributes to target mRNA
fate [85].
In addition to AREs, other classes of U-rich regulatory elements that are associated
with rapid mRNA decay, exist. Computational analyses estimate that 5% of human
mRNA contain GU-rich elements in their 3’UTRs [87]. These elements are highly
conserved among mammals. These cis-regulatory elements contain 2-5 overlapping -
GUUUG- pentamer motifs. Members of the CELF protein family have been shown to
recognize GU-rich elements. GU-rich-elements are functionally linked to mRNA decay,
polyadenylation and pre-mRNA translation [88] [89].
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1.2.4 Structured Regulatory RNA Elements
A plethora of single stranded RNA elements is known and accessible in a variety of
databases. There are databases for annotated binding sites of RBPs [90], miRs [91] as
well as AREs [92] and splicing regulators [93]. In contrast, only a small number of struc-
tured regulatory RNA elements, that regulate mRNA stability or translation efficiency,
is known. In addition to the few individual examples that exist, effort is put into the
computational prediction of structured regulatory RNA elements [94].
RNA can adopt abstract shapes by folding into complex secondary structures by intricate
patterns of Watson-Crick or G-U base pairing. A number of non-canonical base pairing
events involving Hoogsteen base pairing and sugar-edge patterns and the formation of
triple base pairs contribute to the formation of extensive tertiary structures. Common
structural features of RNA molecules include RNA-RNA duplexes, single-stranded re-
gions, hairpins, bulges, internal loops and junctions. In addition, inter-base pairing,
such as loop-loop interactions and pseudoknots can form tertiary structures [95].
A important example for a structured RNA element that regulates mRNA stability
is the histone RNA stem-loop [96] [97]. In constrast to poly(A)-mRNA, histone mRNAs
contain a conserved 25-26 nt stem–loop structure at their 3’ end [98]. This structured
RNA feature is recognized by the stem-loop binding protein (SLBP), which induces rapid
mRNA decay of histone mRNAs at the end of S-phase or when DNA synthesis is inhib-
ited. Upon binding, SLBP recruits additional proteins, which faciliate the addition of an
oligo(U) tail to histone mRNA. This initiates the decapping of the histone RNA and the
subsequent 5’→3’ degradation, whereas the 3’→5’ degradation via the exosome stalls
[98]. Recent studies revealed, that exoRNase Eri1 binds to the histone stem-loop and
trims the mature histone mRNAs 3’ends. Subsequently the oligo(U)-tail is recognized
by Lsm1-7 which then interacts with Eri1, which is then able to degrade the stem-loop
[99].
The RBP Smaug recognizes RNA stem-loop elements in Drosophila maternal mRNAs.
Binding of Smaug induces the CCR4-CAF1-NOT-dependent mRNA degradation and
also regulates the translation of nanos mRNA in flies [100].
Another example for an RNA structure that targets mRNAs for degradation is the
Staufen binding site (SBS). Staufen-1 targets mRNA for degradation by binding to
long RNA-RNA duplex [101] in a process call Staufen-mediated decay (SMD). There-
fore, Staufen-1 interacts with the NMD factor UPF1 to elicit mRNA decay. ∼1% of
HeLa mRNAs are targets of Staufen-1 suggesting that SMD constitutes a significant
post-transcriptional regulatory pathway [102]. Staufen binds to its targets through four
dsRBDs. SMD requires an SBS that is situated sufficiently downstream of a termina-
tion codon, in the 3’UTR. SBSs are formed by intramolecular base pairing within an
mRNA 3’UTR or intermolecular base pairing between an Alu element and a partially
complementary Alu element within certain lncRNAs [102] which allows transactivation
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of SMD by lncRNAs [103].
Selenium is considered an essential trace element in human health and is incorporate in
∼25 human selenoproteins via the 21st essential amino acid, selenocysteine. This depends
on the translational recoding of an in-frame UGA codon. 3’UTRs of selenoprotein
mRNAs always harbor a selenocysteine insertion sequence (SECIS) downstream of the
UGA codon. SECIS elements are not conserved at sequence level, but their secondary
structures can be represented as a consensus stem-loop motif. SECIS elements are
recognized by SECIS binding protein 2 (SBP2) and ribosomal protein L30, but little is
known about the exact mechanisms of UGA recoding [104].
In addition to this CDEs and IREs are conserved RNA hairpin structures that desta-
bilize their target mRNAs or inhibit their translation and have been described in sections
1.2.1 and 1.1.6.
1.2.5 Prediction of Regulatory RNA Elements
To understand how certain expression patterns emerge, it is necessary to know the exact
number and composition of regulatory elements in a particular mRNA. This knowledge
is also the key to understanding how these expression patterns change in response to
a variety of stimuli. A number of methods are available for the prediction and high-
throughput identification of linear sequence motifs [105] [106] [107]. As basically all
functions of RNA are controlled by its ability to fold into complex secondary and tertiary
structures the limited explanatory power of these methods can be easily appreciated. In
contrast to linear sequence motifs, the identification of structured RNA elements that
function in gene regulation is challenging and therefore less studied. To overcome this
drawback, methods for the in vivo probing of global RNA structure have been developed
recently. These methods are based on cell permeable chemicals that covalently modify
the RNA with different reactivity for single- and double-stranded regions and lead to
the displacement of the reverse transcriptase (RT) during cDNA synthesis. These RT-
stop sites are than analyzed by high-throughput sequencing and yield a high resolution
map of RNA structure based on the relative reactivity of the modifying chemical to-
wards individual nucleotides [108] [109] [110] [111]. However, these averaged reactivity
profiles fail to capture the complexity of RNA structures that include long-range struc-
tures, pseudoknots, and alternative conformations and no assumptions can be made
whether regions with low reactivity are actually double-stranded or not accessible for
the chemical because the RNA is bound by a protein. Recent approaches circumvent
this caveat by the direct detection of double-stranded regions by proximity ligation af-
ter cross-linking. In these methods, unbound double-stranded regions are detected by
psoralen-induced cross-linking [112]. In contrast, protein-bound regions can be detected
by UV-induced cross-linking in combination with immunoprecipitation of the desired
protein [101]. While these methods are promising tools for the comprehensive elucida-
tion of the in vivo genome-wide structural landscape of RNA, they have some inherent
limitations. The major disadvantage of all these methods is that they only provide a
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snapshot of RNA structures present in the moment of the experiment. However, many
RNAs with crucial roles in cell fate decisions are only expressed in certain cellular states.
Therefore, cell-type specific, cell-cycle specific or stress-induced RNAs are usually not
detected with the above mentioned methods [113].
An alternative approach to detect specific RNA structures, that is independent of the
expression level of RNAs, is the computational prediction of RNA secondary structures
[114] [115]. By means of RNA structure prediction it is possible to query simultaneously
the whole genome or certain features thereof, like UTRs, for potential RNA secondary
structure formation. In addition, base pairing probabilities can highlight base pairs
and structures that are more likely to be formed compared to base pairs with lower
probability of pairing [116] [117].
Conserved elements in the UTRs generally serve as an indicator of functional im-
portance. This can be conserved binding sites for miRs and RBPs or conserved struc-
tured RNA elements, like IREs. Therefore, the evolutionary conservation of structure is
equally indicative of functional importance [118]. Assessing structural conservation in
UTRs therefore improves the de novo discovery of RNA structures that function in gene
regulation.
Nucleotide mutation patterns that do not disrupt RNA structure formation are called
covariations. A structurally conserved RNA tends to show a pattern of compensatory
mutations consistent with some base-paired secondary structures [119]. Compensatory
evolution, as mediated by RNA secondary structure, can result in detectable patterns of
nucleotide substitutions in the phylogenetic alignment of homologous RNA sequences
and is indicative for functional structures. Based on this phylogenetic-comparative
method, consensus structures for tRNAs, rRNAs, and ribozymes have been generated[120].
This principal was first used by the program QRNA. QRNA uses mutational patterns
in phylogenetic alignments to identify conserved structures [119]. Based on covaria-
tion, computational identification of functional, structured RNA elements in bacterial
mRNA yielded >100 candidate structured RNAs [121]. The large number and variety
of available bacterial genomes together with their lower sequence content is a decisive
advantage for the utilization of covariation to identify conserved RNA structures. In
contrast, covariation is less useful for the de novo discovery of conserved RNA struc-
tures in mammals, because of the smaller number of available genomes, which are less
diverse as mammals have a closer evolutionary relationship. An alternative method for
the de novo discovery of conserved RNA structures is folding stability. This principal
was initially used by RNAz to find conserved RNA structures by combining a measure
for thermodynamic stability with a measure for structure conservation. In contrast to
previous methods, this approach is independent from mutational patterns [122] [123].
One drawback of RNAz is that it relies on a fixed input alignment and therefore fa-
vors sequences with high nucleotide identity over sequences that are difficult to align.
To solve this problem, the programs Dynalign and Foldalign were extended to discover
conserved structures [124] [125]. Both programs are based on the Sankoff algorithm
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and use dynamic programming. They take two unaligned sequences as input which are
simultaneously folded and aligned to identify the lowest free energy conserved structure
[126] [127].
1.3 Aim of this Study
The aim of this thesis is the identification and characterization of novel, structurally
conserved RNA elements in the 3’UTRs of human genes. Compared to single stranded
RNA motifs that are involved in PTR, only few examples exist for structurally con-
served RNA motifs. Structured cis-regulatory RNA elements can specifically regulate
complex genetic circuits and thereby ensure cellular homeostasis in response to a variety
of stimuli [56] [80] [96]. By the de novo identification of structurally conserved RNA
elements, I want to expand the current knowledge of how extensively this important
type of cis-regulatory elements contribute to the regulation of gene expression.
Therfore, I analyzed computationally predicted, structurally conserved RNA elements
in 3’UTRs. I investigated the regulatory properties of predicted elements and performed
structure function analysis to identify crucial RNA moieties in one regulatory element
from the 3’UTR of the UCP3 mRNA. For the identification of trans-acting factors, I
enriched RNA specific interacting proteins and verified Roquin as regulator of UCP3
mRNA levels. The identified CDE-like elements were then used to predict and ver-
ify new targets of Roquin that strongly suggest additional functions for this important
regulator outside the immune response.
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The central hubs of RNA regulation are mRNAs. Basically every step of the complex
life of an mRNA is post-transcriptionally regulated. This regulation is based on cis-
regulatory elements located in the UTRs of the mRNA. These elements in turn are
recognized by so called trans-acting factors like non-coding RNAs, i.e. miRNAs, and
RNA binding proteins in an either sequence- or shape-dependent manner. In particular,
regulation of mRNA stability is an important means of a cell to quickly respond to certain
extrinsic or intrinsic stimuli and stress response. Prominent cis-regulatory elements in
mRNA stability regulation include linear sequence motifs like miR binding sites which,
by base pairing, lead to RISC assembly and subsequent RNA degradation [29] and AU-
rich elements, which are recognized by ARE-binding proteins that destabilize the RNA
by recruiting the CCR4-NOT deadenylase complex[46]. In contrast, small RNA hairpin
structures, like SBSs, CDEs and IREs are recognized by RNA-binding proteins STAU-1,
RCH3H1/2 or aconitase in a shaped-dependent manner.
Roquin binding elements, so-called CDEs, have been identified in the 3’UTRs of TNF,
ICOS, OX40 [64], HMGXB3, IL6, IER3, NFKBID, NFKBIZ, PPP1R10 and TNFRSF4
[62], with only the TNF CDE being extensively characterized so far [56]. In my doctoral
thesis I describe the characterization of a tandem CDE structure in the 3’UTR of the mi-
tochondrial anion carrier UCP3, which is associated with fatty acid metabolism, obesity
and insulin resistance [128][129]. I discovered the repressive element by a computational
analysis for structurally conserved elements in 3’UTRs. After in depth functional and
structural analysis of the element, I identified Roquin as the trans-acting factor. I could
show that both CDEs are targeted individually by Roquin, but the presence of both
CDEs is necessary for robust regulation. Both CDEs residing within the element devi-
ate from the TNF -derived consensus. Detailed mutational analysis in vivo allowed me
to redefine the binding preferences of Roquin. Using this data allowed me to accurately
predict a set of new high potential Roquin targets genes and confirm new targets in vivo.
Taken together, this allowed me to expand the established role of Roquin in immune
response and inflammation to additional, yet unstudied cellular functions of Roquin.
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2.1 Identification of Regulatory RNA Elements Based
on Structural Conservation
Structured RNA elements have been known to be involved in many RNA regulation
processes like pre-mRNA splicing [130], regulation of miR target site accessibility [131]
and mRNA stability [102]. In order to understand how complex expression patterns are
achieved, knowledge about type and number of regulatory elements in a UTR is neces-
sary. Yet, so far, only a small number of regulatory mRNA structures has been identified
compared to linear RPB binding sites or miR target sites. This can be explained by
the fact that it is more difficult to identify structured RNA elements than linear RNA
elements. In this part of my thesis, I show how structurally conserved RNA elements
can be identified with the algorithm Dynalign. Using Dynalign, I identified a repressive
element in the 3’UTR of the UCP3 mRNA. In depth functional and structural analysis
revealed a 64 nt minimal motif that folds into a tandem RNA hairpin structure that is
sufficient and necessary for the regulation of gene expression.
2.1.1 A Conserved Structure in the 3’UTR of UCP3 Reduces Gene
Expression
The initial purpose of my study was the de novo identification of regulatory RNA struc-
tures. In collaboration with the Mathews Lab (Rochester University, NY), we inves-
tigated the conservation of RNA structures on a genome-wide scale. Therefore, we
compared all UTRs of human and mouse. We selected the mouse genome for this com-
parison, because it is currently the best annotated genome besides the human genome.
In addition, the goal of our analysis was to exclusively rely on RNA secondary structure
conservation. Therefore, we performed a bioinformatic prediction of conserved RNA
structures using the RNA folding program Dynalign. Dynalign simultaneously folds
and aligns two input sequences and thereby significantly improves the accuracy of the
structural predictions [132] [133]. It predicts the conserved secondary structure with the
lowest total score, which is the sum of the folding free energies of the two structures
as estimated by nearest neighbor rules and a score for the alignment [113]. Impor-
tantly, this alignment is made to reflect the conserved structure, and does not consider
sequence identity. Therfore, the accuracy of structure prediction is not adversely af-
fected by sequences with low similarity [133] [125]. This is a strong advantage over
other RNA structure prediction programs that rely on fixed sequence alignments as in-
put. Accurate prediction by such programs very much depends on the quality of the
initial sequence alignment and therefore favors sequences with higher similarity [134].
In contrast, Dynalign includes the advantage of evolutionary conservation for structure
prediction, without the necessity for high sequence conservation. For the discovery of
structured RNA elements in genomes, machine learning was used to train a model to
classify Dynalign output [125] [135]. Two sequences are input to Dynalign, the best
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scoring common structure is predicted and features of the sequences (length and nu-
cleotide composition) and the estimated folding free energy change are used to estimate
the probability that the two sequences represent a conserved and stable RNA secondary
structure.
For the genome-wide search, all human UTRs were divided into 100 nt long windows,
with a step size of 50 nt and structurally compared to the corresponding mouse sequences.
100 nt long windows were chosen, to balance structure prediction accuracy and scanning
efficiency. Using this approach, ∼5900 genes were predicted to contain at least one
structurally conserved element in their 5’ or 3’ UTR, with >0.9 estimated probability
of being a conserved structure. Importantly, known iron responsive elements in the
3’UTR of the transferrin receptor (TFRC) have been correctly predicted. In order to
test the regulatory function of the predicted windows, the 100 nt long sequences were
fused to the 3’ end of a firefly luciferase. To quantify the influence on luciferase activity
dual luciferase assays were performed and the relative luciferase activity of the firefly
luciferase fusions compared to an empty vector control without a predicted window.
Figure 2.1: Structurally conserved regions predicted by Dynalign influence gene expression.
Luciferase activity of various 3’UTR fusion constructs. 100 nt long 3’UTR sequences
predicted to encode structurally conserved regions, were fused to firefly luciferase.
Firefly luciferase activity was normalized to Renilla luciferase as internal transfection
control. Values are normalized to an empty vector control. n = 3. (**) P-value <0.01.
(*) P-value < 0.05. Adopted and modified from [113].
For an initial testing, I selected 20 windows for regulation of gene expression based
on an estimated folding probability of >90% to be a conserved structure. Also the total
length of the UTR containing a predicted window should fall within the average UTR
length of 500 to 1500 nt of human 3’UTRs. In order to simplify functional analysis the
predicted windows were not allow to overlap with other windows. The selected 100 nt
long 3’UTR sequences were cloned downstream of the firefly luciferase reporter gene
into the pDLP plasmid. The pDLP plasmid also encodes a Renilla luciferase which is
expressed from a CMV promoter under control of the same enhancer element as the
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firefly luciferase and was used for internal normalization. The pDLP plasmid map is
depicted in Suppl. Fig.5.1. To investigate the influence of the elements on luciferase
activity, luciferase-3’UTR fusions were transiently transfected into HEK293 cells and
luciferase activity measured (Fig. 2.1).
Four of the 20 windows significantly reduced luciferase activity in HEK293 cells. The
predicted structurally conserved windows from the 3’UTRs of ADM, ELK3 and TFDP1
reduced luciferase activity to ∼ 60% compared to the empty vector control in HEK293
cells. The most efficient reduction was observed with the window from the 3’UTR
of UCP3 which reduced luciferase activity to ∼ 35% in HEK293 cells. The UCP3
gene codes for a mitochondrial membrane protein. The UCP3 protein is implicated in
fatty acid metabolism, obesity and insulin resistance (reviewed in [128] [129]), yet its
physiological function is still under debate [136] [137]. Interestingly elevated UCP3 levels
were observed in obesity-resistant mice and a decrease in UCP3 levels was associated
with insulin sensitivity, a condition that precedes diabetes. Thus, modulation of UCP3
levels is an interesting target for the development of novel therapeutics.
To further confirm the importance of this element in UCP3 gene expression the com-
plete 1131 nt long UCP3 3’UTR as well as a deletion mutant without the 100 nt long
window was cloned into the pDLP plasmid. In addition, the influence of the 100 nt
long element alone, duplication and randomization of the element were investigated. An
overview of the constructs is depicted in Fig. 2.2A. To investigate the influence of the
Figure 2.2: The 100 nt long, structurally conserved region in the 3’UTR of UCP3 codes
for a repressive element. (A) Overview of luciferase reporter constructs. Different
fragments of the UCP3 3’UTR were fused to the firefly luciferase. (B) Luciferase
activity of UCP3 3’UTR fusion constructs shown in (A). Firefly luciferase activity was
normalized to Renilla luciferase as internal transfection control. n = 3. (**) P-value
< 0.01. Adopted and modified from [113].
various 3’UTR constructs on luciferase activity, HEK293 cells were transiently trans-
fected with the corresponding pDLP reporter constructs. 24 h post transfection firefly
luciferase activity was measured. The results of the reporter gene assay are depicted in
Fig. 2.2B. The complete 3’UTR and the 100 nt window alone repress luciferase activity
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in HEK293 cells to the same extend. Duplication of the regulatory window further em-
phasizes the repressive effect on luciferase activity. Deletion of the 100 nt long window
significantly restores luciferase activity, as does randomization of the 100 nt window. In
conclusion this showed that the 100 nt long structurally conserved region predicted by
Dynalign is necessary and sufficient for effective post-transcriptional regulation by the
3’UTR3 of UCP3.
2.1.2 The reduction of gene expression is not induced by miR-152
MiRs are a class of short, ∼22 nt long, endogenous non-coding RNAs that post-transcript-
ionally control gene expression. In addition to RBPs, they represent the most important
group of regulatory molecules that have a decisive influence on gene expression. In higher
eukaryotes it is predicted that miRs control ∼ 60% of all protein-coding genes and have
been shown to participate in every cellular process investigated so far [36]. MiRs repress
their target genes by either target mRNA destabilization or by repression of their trans-
lation [39]. To exclude the possibility that the repressive effect was induced by miRs I
evaluated the structurally conserved region with the TargetScan algorithm [138]. This
algorithm predicts miR binding sites in a given sequence. The computational analysis
revealed two overlapping conserved target sites for the miR families miR-148a/b and
152 and miR-130a/b and 301a/b (Fig.2.3A and B).
Figure 2.3: The structurally conserved region of the UCP3 3’UTR encodes a functional miR
binding site. (A) Location of the miR binding site within the Dynalign window. The
window encodes two overlapping sites indicated by black and green lines, respectively.
(B) Predicted miR target sites by miRanda [139]. Shown are the target site alignment
as well as miRanda-SVR calculated miR-SVR scores and target site conservation by
PhastCons. Adopted and modified from [113].
To assess whether these miRs are expressed in HEK293 and HeLa cells, I performed a
quantitative stem-loop RT-qPCR. In this assay, a miR specific stem-loop oligonucleotide
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was hybridized to the miRNA of interest. The hybrid was then reverse transcribed to
cDNA [140]. In the next step, the product of reverse transcription was then quantified
by qPCR. The values were normalized to the small nucleolar RNA U48 as internal
control. All of these seven miRs were either undetectable or expressed at very low levels
in HEK293 and HeLa cells (Suppl. Tab. 5.3). Therefore, it was highly unlikely that
they were responsible for the observed reduction in luciferase activity. To further proof
that the repression by the UCP3 element is not triggered by these miRs, a luciferase
construct was cloned in which the miR binding site was deleted. Deletion of the target
site had no effect on luciferase activity (Fig. 2.4 A).
Figure 2.4: Influence if miR-152 on the repression by the UCP3 element. (A) Luciferase
activity of the UCP3 Dynalign element (1x window) and a construct in which both
miR binding sites are deleted (∆miR) with and without overexpression of miR-152.
Firefly luciferase activity was normalized to Renilla luciferase as internal transfection
control. Values are normalized to an empty vector control. n = 3. (B) RT-qPCR
quantification of miR-152 levels after overexpression. Values are normalized to the
snoRNA U48 as internal control. (**) P-value > 0.01. (*) P-value > 0.05. Adopted
and modified from [113].
To investigate whether the predicted miR binding sites are functional at all, I in-
vestigated whether overexpression of miR-152 has an influence on the UCP3 reporter
construct. Of all predicted miRs that can bind to the target site miR-152 has the highest
miRSVR score, which is a measure for the extent of their expected downregulation at
the mRNA or protein level [139]. Also miR-152 was chosen because of its association
with type 2 diabetes mellitus [141] and its ability to alter dynamics of the intracellular
ATP/ADP ratio [142], which is a principal function of UCP3. For miR-152 overexpres-
sion experiments, the genomic locus of miR-152 together with its endogenous sequence
context (200 nt up- and downstream of the mature miR) was cloned into the plasmid
pCMV-MS and expressed from a CMV promoter. To investigate the influence of miR-
152 on luciferase activity, HEK293 cells were cotransfected with either the complete
UCP3 window or the miR target site deleted window containing pDLP plasmid and
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pCMV-miR152. 24 h post transfection, luciferase activity was measured (Fig.2.4A).
Overexpression of miR-152 was verified by stem-loop RT-qPCR (Fig.2.4B). Overex-
pression of miR-152 reduced luciferase activity of the UCP3 wild type (wt) sequence
significantly, but not that of the deletion construct without miR target sites. From
those findings I concluded that the observed effect was not caused by miRs in HEK293
cells. However, UCP3 may be regulated by miRs in other cell types or under certain
stress conditions as the overexpression experiments showed that, in principal, miR-152
can repress gene expression of UCP3.
2.1.3 A 64 nt Minimal Motif is Sufficient for Gene Repression
Since I could now exclude that the repression of luciferase activity is caused by miRs, I
wanted to identify the features of the UCP3 window that are important for regulation.
Dynalign predicted a structure that consists of three RNA hairpin structures that are
separated by regions that are less conserved at both, structure and sequence level (Fig.
2.5). To asses the importance of the three hairpin structures in regulation of gene ex-
Figure 2.5: Secondary structure prediction by Dynalign. Secondary structure prediction by
Dynalign of the structurally conserved regions in the human and mouse UCP3 3’UTRs.
Geen: Hairpin 1, Blue: Hairpin 2; Red: Hairpin 3. Deviating nucleotides in the three
hairpins are highlighted in grey. Adopted and modified from [113].
pression, truncation studies of the 100 nt long UCP3 window were performed. Therefore,
the element was shortened step by step from the 5’ or 3’ end and the luciferase activity
was measured. An overview of the truncations is depiced in (Fig. 2.6A). Deletion of
hairpin 1 alone or together with the miR target sites had no effect on repression. How-
ever, truncation or deletion of hairpin 2 or 3 led to a significant increase in luciferase
activity to ∼ 70% (Fig.2.6B). The shortest version that still has the full regulatory
function (del2) consists of the 64 nt at the 3’ end of the UCP3 window and contains
RNA hairpins 1 and 3. This minimal motif is very AU-rich (73.4%) and harbors the
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core pentamer motif -AUUUA- typically found in AREs. AREs are important regulators
of gene expression. It has been shown that RBPs like HuR, TTP, TIA-1, KSRP and
AUF1 can bind to such elements and reduce gene expression either by reducing mRNA
half-life or translation efficiency [83]. To investigate this further a reporter construct
was cloned in which the -AUUUA- motif was mutated to -AGGGA-. Mutation of the
pentameter led to a significant increase in luciferase activity (see MUTII in Fig. 2.10B.
However, the mutation not only altered the sequence but also the secondary structure
of hairpin 3. Therefore, the effect could not be clearly attributed to the pentamer motif.
Furthermore, the mutation does not explain why the deletion of hairpin 2 also leads to a
loss of function. To exclude any unspecific luciferase reduction by the high AU-content,
we fused five different randomized sequences with the same nucleotide composition and
one randomized sequence with uniform nucleotide content (64 nt) to the luciferase re-
porter. All randomizations significantly restored luciferase activity (Suppl. Fig. 5.7).
This confirmed, that the 64 nt long del2 is the minimal motif that is necessary and
sufficient for regulation.
Figure 2.6: Truncation study of the 100 nt UCP3 window. (A) Overview of truncations
of the 100 nt long window. (B) Luciferase activity of UCP3 truncation constructs
shown in (A). Firefly luciferase activity was normalized to Renilla luciferase as internal
transfection control. Values are normalized to an empty vector control, without UCP3
UTR sequences. Luciferase activity of the 100 nt window is indicated as dashed line.
n = 3. (**) P-value <0.01. Adopted and modified from [113].
2.1.4 The Repressive Element is a Conserved Tandem Stem-Loop
Structure
In the next step, it should be investigated whether the observed effect is caused by
a linear sequence motif or by the RNA structure predicted by Dynalign. To address
the structure experimentally, I performed in-line probing analysis. In this RNA cleavage
assay, base-paired nucleotides are protected from spontaneous phosphodioester bond hy-
drolysis. Radiolabeled UCP3 del2 RNA was incubated in in-line probing buffer for 40 h
at RT. The reaction products were then separated by gel electrophoresis and visualized
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by phosphoimaging. The results are depicted in Fig. 2.7 A. In-line probing of the 64 nt
long minimal region confirmed the existence of the two hairpins predicted by Dynalign.
In vitro, both stem-loop structures form a 6 bp long stem with an A-U closing base pair
that is capped by a terminal UAU tri-nucleotide loop (Fig. 2.7B). Notably the stem
of hairpin 2 is only composed of A-U base pairs. The basal U-A base pair of hairpin 3
is not formed in vivo. Therefore, both hairpins have an identical stem length of 6 bp.
Furthermore, a small stem of 5 bp is formed by the surrounding sequences. Sequence
comparison of the 64 nt long UCP3 minimal motif with the corresponding sequences
from 46 other mammals annotated in the UCSC Genome Browser showed that both
RNA hairpins are highly conserved in primary sequence compared to the surrounding
sequences (Supp. Fig. 5.5), further underlining their importance in gene regula-
tion. To confirm the hypothesis that the two RNA hairpins are crucial for regulation,
a screening was performed to identify the exact areas necessary for post-transcriptional
gene regulation by the 64 nt long element. Therefore, the sequence was mutated in blocks
of seven nucleotides to balance the number of clones and sequence perturbation. To a
achieve maximum variation, A to C and G to U and vice versa were mutated in the
individual blocks. This not only changed the sequence but also all pyrimidine to purine
bases and vice versa. All mutations that prevented structure formation of the hairpins
led to a significant increase in luciferase activity. Even the mutant 8-14, which shortened
the stem of hairpin 2 by only 1 bp down to 5 bp, already showed a significantly higher
luciferase activity compared to the wt sequence (Fig. 2.7C). In contrast, mutants which
only changed the surrounding sequences had no significant effect on luciferase activity.
These results also fit perfectly to the conservation of the primary sequence. In summary,
I was able to show that the 64 nt long minimal motif folds into a tandem RNA hairpin
that largely corresponds to the structure predicted by Dynalign and that both hairpins
are essential for the regulatory function of the element in vivo.
2.1.5 The UCP3 Element Reduces mRNA Half-Life
Cis-regulatory elements can reduce gene expression by either reducing translation effi-
ciency or mRNA half-life. Regulation of mRNA turnover in the cytoplasm is important
for controlling the abundance of cellular transcripts and, in turn, protein abundance. To
investigate whether the UCP3 element reduces gene expression by reducing the RNA
half-life, I investigated the RNA half-life of RNAs encoding either the 64 nt wt motif or
a double mutant that prevented the formation of both hairpins (MUTI/II). Therefore,
a dual fluorescence reporter plasmid was cloned, containing an mCherry and a GFP
reporter under the control of a shared CMV promoter/enhancer element. The plasmid
also contained an FRT site for genomic integration into a FLPin host cell line. UCP3 wt
and MUTI/II were fused to the open reading frame of GFP and stably integrated into
the genome of HeLa cells. To show that the genomic integration was successful, both
GFP and mCherry levels were quantified by flow cytometry (Fig. 2.8A). Normalized
GFP levels showed a 7.7-fold reduction in GFP levels by the UCP3 wt element compared
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Figure 2.7: The UCP3 wt element folds into two hairpins. (A) In-line probing analysis of
UCP3 wt RNA. The RNA was loaded directly (NR, no reaction), subjected to cleavage
by RNase T1 or alkaline hydrolysis, or incubated for 40 h at room temperature and
pH 8.3 (in-line) prior to Urea PAGE. Paired regions are indicated by identically colored
lines. (B) Predicted lowest free energy secondary structure of the UCP3 wt element
by RNAstructure. Nucleotides detected by in-line probing shown in (A) are circled.
(C) Luciferase activity of UCP3 mutants for the identification of motifs essential
for gene regulation. Adenine was mutated to cytosine, guanine to uracil and vice
versa. Numbers indicate mutated nucleotide positions. Firefly luciferase activity was
normalized to Renilla luciferase as internal transfection control. Values are normalized
to an empty vector control, without UCP3 3’UTR sequences. Luciferase activity of the
UCP3 wt element is indicated as dashed line. n = 3. (**) P-value < 0.01. Adopted
and modified from [113].
32
2.1 Identification of Regulatory RNA Elements Based on Structural Conservation
to MUTI/II (2.8B). These values confirmed the results already obtained in luciferase
assays and underline the self-sufficiency of the repressive element. To determine whether
the reduction was a consequence of a decreased GFP mRNA abundance, the amount of
mRNA was quantified by RT-qPCR. A corresponding reduction could be observed at the
mRNA level (Fig. 2.9A). However, changes in mRNA abundance are not necessarily
Figure 2.8: Genomic integration of GFP-UCP3 wt element fusion mRNAs. (A) GFP and
mCherry fluorescence of UCP3 wt and double mutant (MUTI/II). GFP-UCP3 -fusion
constructs were stably integrated into the genome of HeLa cells. GFP and mCherry
fluorescence were measured by flow cytometry. n = 3. (B) GFP fluorescence of UCP3
wt and double mutant (MUTI/II). GFP fluorescence was measured by flow cytometry
and was normalized to mCherry values. n = 3. Adopted and modified from [113].
caused by alterations in mRNA stability. For example, mRNA biogenesis in the nucleus
such as transcription, RNA processing, and/or mRNA export may be altered by the
introduction of the UCP3 wt element into the 3’UTR of an mRNA. Thus, alterations in
the steady-state level of mRNA may not reflect changes in mRNA stability [143]. A rel-
atively simple way of analyzing mRNA kinetics involves blocking cellular transcription
with inhibitors like actinomycin D. This antibiotic interferes with transcription by in-
tercalating into the DNA. The amount of a particular mRNA remaining at various time
points after the treatment is then used to calculate the mRNA decay rate. Determina-
tion of mRNA half-lives after treatment with actinomycin D showed that GFP mRNA
containing the UCP3 wt element in its 3’UTR is very unstable (half-life of ∼ 1.5 h)
compared to the double mutant, for which no reduction of mRNA levels was detectable
over the time course of the experiment (Fig. 2.9B). In summery, I could show, that the
repression of gene expression by the UCP3 3’UTR element is the result of a significant
reduction in mRNA half-life compared to the control mRNA. Summarizing this part
of my thesis, I successfully identified a structually conserved regulatory element in the
3’UTR of the UCP3 mRNA. This element was predicted by Dynalign to be structurally
conserved across among human and mouse. I identified a 64 nt minimal motif that is
sufficient and necessary for regulation. Structural probing revealed that the sequence
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Figure 2.9: mRNA half-life of UCP3 wt and MUTI/II-containing mRNAs. (A) RT-qPCR
quantification of GFP mRNAs containing the UCP3 wt element (wt) or double mutant
(MUTI/II). Total RNA from HeLa cells stably expressing one of the two constructs
was isolated and GFP mRNA levels quantified by RT-qPCR. (D) HeLa cells stably
expressing one of the two constructs were treated with 5 µg/µl actinomycin D (ActD).
Thereafter, total RNA was isolated at 2 h intervals and GFP mRNA levels quantified
by RT-qPCR. GFP values are normalized to the housekeeping gene RPLP0. n = 3.
(**) P-value < 0.01 (*) P-value < 0.05. Adopted and modified from [113].
adopts the tandem stem-loop structure predicted by Dynalign and that both hairpins are
necessary for robust regulation. Furthermore, I was able to show that repression of gene
expression by the UCP3 wt element is a direct consequence of a significant reduction in
mRNA stability.
2.2 Identification of Trans-acting Factors
RNA affinity purification is a powerful tool, which allows for the identification and char-
acterization of various proteins bound to a certain RNA. There are a variety of different
strategies that are based on either covalent or non-covalent immobilization of the target
RNA to an affinity matrix. The high affinity binding of biotin by avidin has made the
biotin-avidin association an extremely powerful tool for affinity chromatography and a
method of choice for many researchers. With this method ITAFs which modulate XIAP
and cIAP1 IRES activity were successfully identified and characterized [144]. In this part
of my thesis, I used RNA affinity to specifically enrich UCP3 wt RNA-binding proteins.
In depth mass spectrometry analysis identified the proteins Roquin-1 and Roquin-2 as
trans-acting factors that bind to the UCP3 wt element. Detailed in vivo and in vitro
analysis confirmed that Roquin binds to the UCP3 wt element, and thereby reduces
expression of UCP3 wt element encoding genes. RNA mobility shift assays revealed
that both RNA hairpins in the UCP3 wt element are bound individually by Roquin
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through its core ROQ domain. These stem-loops are similar to known Roquin binding
sites, so called CDEs, in that they code for a 6 bp long stem capped by a tri-nucleotide
loop. Both stem-loops are required for efficient regulation by the UCP3 wt element. In
addition, I could show that endogenous UCP3 mRNA is repressed by Roquin in murine
C2C12 cells.
2.2.1 RNA Affinity Purification of RNA-binding Proteins
One major goal of this project was the identification of UCP3 wt binding proteins since
functional interaction partners have not been previously described. To identify RBPs
that specifically bind to my RNA of interest, I performed an optimized mRNP purifi-
cation based on the high affinity biotin-avidin interaction. Thus, I transcribed UCP3
wt RNA as well as mutants preventing formation of the first or second hairpin (MUTI;
MUTII) or both (MUTI/II) in vitro. Additionally, a randomized sequence with equal
nucleotide composition was synthesized (Fig. 2.10A). Prior to RNA affinity purification
all RNAs constructs were tested for their regulatory properties in HEK293 cells (Fig.
2.10B). As expected individual mutation of either RNA hairpin led to a significant in-
Figure 2.10: UCP3 RNAs used for RNA affinity purification. (A) Overview of UCP3 con-
structs used for RNA affinity purification.(B) Luciferase activity of UCP3 constructs
and a randomized control with the same nucleotide composition (R1) used for RNA
affinity purification. Firefly luciferase activity was normalized to Renilla luciferase as
internal transfection control. Values are normalized to an empty vector control. n =
3. (**) P-value < 0.01. (*) P-value < 0.05. Adopted and modified from [113].
crease of luciferase activity compared to the UCP3 wt element. Interestingly mutation
of both hairpins led to a further significant increase in luciferase activity compared to
the single mutants, whereas randomization of the element (R1 ) lead to a similar increase
in luciferase activity as the single mutants. Next, the in vitro transcribed RNAs were
5’-biotinylated and coupled to steptavidin-conjugated magnetic beads for affinity purifi-
cation of proteins from HEK293 cells. After stringent washing, RNA-bound proteins
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were eluted and separated by SDS-PAGE (Suppl. Fig. 5.8). While the majority of
proteins bound to all five RNAs, I was able to identify differentially enriched proteins by
mass spectrometry analysis based on unique peptide counts. 229 proteins were detected
by mass spectrometry using a cut-off of at least five unique peptides detected in at least
one of the samples. While most purified proteins associated with all five RNAs, ten of
these proteins were not detected in the two controls, i.e. the double mutant and the ran-
domized sequence (Tab. 2.1). Among these ten, the paralogs Roquin-1 and Roquin-2
Table 2.1: Proteins enriched by RNA affinity purification. Adopted and modified from [113].
No. of peptides
Description Gene Symbol MW [kDa] wt MUT1 MUTII MUTI/II R1
Roquin-2 RC3H2 132 30 20 23 0 0
Zinc finger CCCH domain-containing protein 7A ZC3H7A 111 19 0 29 0 0
Spermatid perinuclear RNA-binding protein STRBP 72 14 10 11 0 0
Roquin-1 RC3H1 126 7 1 6 0 0
Gem-associated protein 5 GEMIN5 168 5 26 0 0 0
ATP-dependent RNA helicase DDX1 DDX1 74 5 12 15 0 0
RNA-binding protein MEX3A MEX3A 54 3 0 5 0 0
tRNA-splicing ligase RtcB homolog RTCB 55 4 4 8 0 0
RNA-binding protein 47 RBM47 64 2 0 8 0 0
RNA-binding protein Raly RALY 32 3 5 0 0 0
were highly enriched. Roquin-1 has previously been described to destabilize its target
mRNA coding ICOS to prevent autoimmunity [145] [51]. It has since been found to
play an essential role in controlling the levels of mRNAs coding for various key proteins
involved in immune regulation [57]. In addition, Roquin destabilizes TNF mRNA by
binding to a small structured RNA motif, a so-called CDE, in the TNF 3’UTR [56].
Thus, Roquin proteins appeared to be promising candidates to regulate gene expression
by binding to the UCP3 wt element. The binding of Roquin proteins to the UCP3 wt
element was verified by western blot analysis after RNA affinity purification. Confirming
mass spectrometry results, I was able to detect Roquin association with UCP3 wt RNA
as well as the single mutants, where formation of one of the hairpins was prevented. In
contrast, no binding was detected with the double mutant (Fig. 2.11).
Figure 2.11: RNA affinity purification of Roquin-1/-2 with different UCP3 RNAs. For RNA
affinity purification HEK293 whole cell lysates were incubated with the different UCP3
RNAs 2.10(A). Roquin-1 and Roquin-2 were visualized by Western Blot using anti-
Roquin antibody. n = 2. Adopted and modified from [113].
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2.2.2 Roquin Proteins Mediate Repression by Binding the UCP3
wt Element
In the previously described experiments, I could show that the UCP3 wt element is
bound by Roquin in vitro. To determine whether Roquin leads to the repression of gene
expression by binding to the UCP3 wt element, I performed transient knockdown of
Roquin proteins and quantified the influence on luciferase activity. HEK293 cells were
transiently transfected with siRNAs targeting either Roquin-1, Roquin-2 or both. 24 h
post siRNA transfection the UCP3 wt element-encoding luciferase reporter plasmid was
transfected to investigate the influence of the Roquin knockdown on luciferase activity.
Successful knockdown of Roquin was verified by western blot analysis (Fig. 2.12A).
Knockdown of Roquin-1 led to a small, but significant increase in luciferase activity
Figure 2.12: Roquin regulates gene expression via the UCP3 tandem CDE. (A) Western
Blot of Roquin-1 and Roquin-2 after siRNA-mediated knockdown. Anti-Roquin was
used to verify the respective knockdown. Total lane protein is shown as loading
control. n = 3. (B) Luciferase activity of the UCP3 wt element after siRNA-
mediated knockdown of Roquin proteins. Firefly luciferase activity was normalized to
Renilla luciferase as internal transfection control. Values are normalized to an empty
vector control, without UCP3 3’UTR sequences. n = 3. (**) P-value <0.01. (*)
P-value <0.05. Adopted and modified from [113].
compared to the control. No influence on luciferase activity could be observed with
the knockdown of Roquin-2. Full restoration of luciferase activity was achieved only by
simultaneous knockdown of Roquin-1/-2 (Fig.2.12B). This finding is in line with the
previously reported redundant function of Roquin-1/-2 in repression of gene expression
[53]. In addition, transient knockdown of Roquin-1/-2 in HeLa cells stably expressing
UCP3 wt encoding GFP mRNA (see section 2.1.5) led to a significant increase in GFP
levels Suppl. Fig.5.9A and B.
So far, I only demonstrated repression by the UCP3 wt element in a reporter gene
context. To investigate whether endogenous UCP3 is a Roquin target, UCP3 mRNA
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was quantified via RT-qPCR. UCP3 is predominantly expressed in smooth skeletal mus-
cle and brown adipose tissue [146] [147] [148] and only detectable in trace amounts in
HEK293 cells. To assess changes in UCP3 mRNA abundance after Roquin knockdown, I
performed a transient knockdown of mouse Roquin-1/-2 in C2C12 murine myoblasts. Af-
ter siRNA transfection, cells were grown for 48 h to reach confluency and differentiation
induced by adding growth medium containing 2% horse serum. 24 h post induction, pro-
tein and RNA samples were prepared. Efficient knockdown 72 h post siRNA transfection
was verified by western blot analysis (Fig. 2.13A) and quantification of Roquin-1 and
Roquin-2 mRNA levels (Fig. 2.13B). The UCP3 mRNA level was significantly higher
(approx. 3-fold) in Roquin-1/-2 knockdown cells compared to the control (Fig. 2.13C).
Overall these results confirmed the role of Roquin in post-transcriptional regulation by
the UCP3 wt element.
Figure 2.13: Roquin knockdown reduces UCP3 mRNA levels in C2C12 cells. (A) Western
blot of Roquin-1 and Roquin-2 after siRNA-mediated knockdown in C2C12 cells.
AntiRoquin was used to verify the respective knockdown. Total lane protein is shown
as loading control. (B and C) RT-qPCR quantification of (B) RC3H1 and RC3H2
and (C) UCP3 mRNA levels after siRNA-mediated knockdown of Roquin-1 and
Roquin-2 in C2C12 cells. Values are normalized to the housekeeping gene GAPDH.
n = 3. (**) P-value < 0.01. Adopted and modified from [113].
2.3 Redefining Roquin Binding Preferences
In the previous chapter, I explained in detail how Roquin represses gene expression
by binding to the UCP3 wt element. In this chapter, I describe how I analyzed the
biochemical properties of the UCP3 wt-Roquin interaction. In RNA mobility shift
assays, I could show that Roquin binds to the UCP3 wt RNA with higher affinity
compared to the mutants, where formation of one of the two CDEs was prevented.
Mutation of the core ROQ domain results in a loss of binding activity. Roquin affinity
to the UCP3 wt RNA is comparable to known targets like TNF, ICOS and Ox40. Since
both CDEs in the UCP3 wt element deviate from the published CDE consensus, derived
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from the mutational analysis of the TNF CDE, I performed an extensive mutational
analysis of the UCP3 wt element. The results of these experiments substantiate in vitro
data, that the Roquin recognition is almost exclusively shape dependent and allowed me
to formulate a new CDE consensus that is more relaxed than the previously proposed
CDE consensus. This also suggests that many more genes could encode functional CDEs
and thus are regulated directly by Roquin.
2.3.1 The UCP3 Element Encodes Two Roquin Binding Sites
In the RNA affinity purification experiments, Roquin could be purified with UCP3
MUTI and MUTII RNA, but not the double mutant (see Tab. 2.1 and Fig. 2.11),
thus suggesting individual binding of Roquin to both CDEs in the UCP3 wt element.
However, mutation of one of the two CDEs was sufficient to significantly increase lu-
ciferase activity (see Fig. 2.10B). To investigate this discrepancy in more detail, I
performed RNA gel retardation assays with purified Roquin-1 protein and UCP3 wt
RNA as well as single or double mutants of both CDEs. To minimize the effect on
overall folding of the RNA molecules, only single nucleotide mutations were introduced.
The mutations only effected the closing base pair and prevented triloop formation (Fig.
2.14A). Overall folding was assessed by RNA secondary prediction by RNAstructure
Figure 2.14: Overview of UCP3 constructs used for binding experiments. (A) Schematic
overview of RNAs used in EMSA experiments. (B) Luciferase activity of UCP3
constructs shown in (A). Firefly luciferase activity was normalized to Renilla luciferase
as internal transfection control. Values are normalized to an empty vector control,
without UCP3 3’UTR sequences. n = 3. (**) P-value < 0.01. (*) P-value < 0.05.
Adopted and modified from [113].
(Suppl. Fig. 5.10). In accordance with my previous results, individual mutation of
CDEI or CDEII to a pentaloop increased luciferase activity to ∼ 67− 72% compared to
the empty vector control. Mutation of both CDEs led to a further small, but significant
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increase in luciferase activity to ∼ 89% of the control (Fig. 2.14B). These findings
suggested, that Roquin can bind to both CDEs individually, but that both CDEs are
necessary for robust regulation by the UCP3 wt element.
Roquin-1 is a multi-domain protein. The Roquin domain organization is depicted
in Fig. 2.15 (Roquin-1 fl). Roquin proteins share a highly similar N-terminus which
consists of a RING domain, that probably functions as an E3 ubiquitin ligase and two
RNA-binding domains: the ROQ domain, which is characteristic of Roquin proteins and
a CCCH zinc finger. The C-terminus of the protein is largely unstructured and contains
a proline-rich domain and a coiled-coil domain. Previous studies have shown that Roquin
binds the TNF CDE through its ROQ domain. Mutation of the ZnF as well as deletion
of the C-terminus had no effect on the association of Roquin with the TNF CDE [56].
Biochemical studies investigating the binding of Roquin to composite RNA elements in
Figure 2.15: Roquin-1 domain organization. Domain organization of mouse Roquin-1 and
overview of Roquin fragments used for binding experiments. fl: full length protein;
N-term: Roquin-1 N-terminus including the RING, ROQ and ZnF domain; ROQ:
Roquin-1 core ROQ domain. Figure adopted from [59]. Adopted and modified from
[113].
the 3’UTR of ICOS [58] and Ox40 [64] mRNA have previously been described. In these
examples ADEs and CDEs function in conjunction to achieve efficient Roquin binding.
In order to dissect Roquin binding to the UCP3 wt element, I performed EMSAs with
in vitro transcribed RNAs, equivalent to UCP3 mutants depicted in Fig. 2.14, and
purified Roquin-1 ROQ domain (Fig. 2.16A) and the complete Roquin N-terminus
(Fig. 2.16C). Therefore the RNA was radioactively labeled at its 5’ end and incubated
with increasing amounts of protein. The formed complexes were than separated by
native PAA electrophoresis in order to detect differences in RNA migration. The EMSA
experiments showed that both, the core ROQ domain as well as the complete N-terminus
bind with high affinity to the UCP3 wt element with respective apparent KD values
of 138 ± 2nM (ROQ) and 225 ± 1nM (N-term). Both Roquin-1 fragments showed a
significantly lower affinity to the two single mutants (Fig. 2.16B and D). For the
double mutant no binding could be observed. Interestingly in the binding reactions with
the Roquin N-terminus and UCP3 wt two complexes were detected in the gel which
is consistent with the fact that two Roquin entities can bind to the tandem CDE. In
contrast, only one band was detected upon binding of the ROQ domain with UCP3 wt.
However, the migration of this band was less retarded with the single mutation of the
CDEs compared to the UCP3 wt. This suggests individual binding of two core ROQ
domains to the UCP3 wt RNA.
40
2.3 Redefining Roquin Binding Preferences
Figure 2.16: Both UCP3 CDEs are required for efficient Roquin binding. Binding of recom-
binant Roquin-1 to the UCP3 constructs shown in Fig. 2.14. Radiolabeled RNAs
were incubated with increasing amounts of Roquin-1 ROQ domain (A) or N-terminus
(C). The apparent dissociation constant (KD) was calculated from 2-3 independent
experiments. (B and D) Representative quantification of EMSA experiments with
Roquin-1 ROQ domain (B) or N-terminus (D). n.d. = not determined. Adopted and
modified from [113].
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For further analysis of the reaction stoichiometry, I performed a stoichiometric bind-
ing experiment. In this EMSA experiment the protein is titrated to RNA of known
concentration with trace amount of radiolabeled RNA for detection. Total RNA con-
centration must be > 50-fold greater than the KD. By plotting the bound fraction of
RNA by the molar equivalent of protein a saturation curve is obtained. This curve
can than be compared to theoretical saturation curves and the binding stoichiometry
determined [149]. Stoichiometric binding experiments confirmed that UCP3 wt RNA
is bound by two core ROQ domains (Fig. 2.17A). This finding is in accordance with
the simultaneous detection of both CDEs by the core ROQ domain. Previous studies
showed that mutation of the core ROQ domain inhibits Roquin binding to the TNF
CDE. As demonstrated with the TNF CDE, no binding was observed in EMSAs with
triple mutant ROQ domain (K220A, K239A, R260A) and UCP3 wt RNA verifying that
Roquin binding to the UCP3 wt element is mediated by its core ROQ domain.
Figure 2.17: The core ROQ domain is essential for binding of Roquin-1 to the UCP3 wt
element. (A) Left: Increasing amounts of Roquin-1 ROQ domain were incubated
with 5 µM UCP3 wt RNA containing a trace of radioactively labeled RNA. Right:
Comparison of the observed binding saturation with theoretical saturation curves for
a 1:1; 1:2 and 1:4 binding stoichiometry. n = 2. (B) Radiolabeled UCP3 wt RNA
was incubated with increasing amounts of triple mutant (K220A, K239A, R260A)
Roquin-1 ROQ domain or N-terminus. n = 2. Adopted and modified from [113].
2.3.2 In vivo Mutational Analysis of the UCP3 Tandem CDE
Since the discovery of the CDE in the 3’UTR of TNF, a series of in vitro and in vivo mu-
tation studies have been performed with the aim to identify the structure and sequence
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requirements Roquin has for an effective binding to a CDE. Leppek et al. investigated
the influence of mutations that either altered the RNA hairpin structure or its sequence
on the mRNA half-life of a ß-globin reporter gene [56]. Based on their data, they con-
cluded a restrictive consensus structure that had specific sequence requirements for the
apical part of the stem (see Fig. 3.1A). Based on the findings of Leppek et al., a num-
ber of structural studies were performed to investigate the in vitro binding specificity of
Roquin to the TNF CDE. Schlundt et al. and Codutti et al. could show that the in
vitro binding of Roquin to the TNF CDE is almost exclusively shape dependent. Their
data showed only a very low sequence dependency and allowed to formulate a relaxed
consensus. This consensus also included the meanwhile published findings of Janowski et
al. which showed that Roquin is also able to bind U-rich RNA hexaloops, so-called alter-
native decay elements (ADE). The proposed consensus consists of an RNA hairpin with
a stem length of 6 bp, whereby the upper two base pairs must each be pyrimidine-purine
(Y-R) (Fig. 3.1B) [57]. However, the proposed CDE consensus was never subjected to
a detailed in vivo analysis.
Interestingly, both CDEs found in the 3’UTR of UCP3 deviate from the TNF CDE
derived consensus as well as from the more general proposed consensus which includes
the in vitro structural analysis. In order to clearify the binding preferences for Roquin
in vivo, I performed an in depth mutation screen to evaluate the contribution of the dif-
ferent features that have previously been described as being important to Roquin based
regulation. To assess the importance of different features in the UCP3 wt element I
introduced mutations into CDEI, CDEII or both and measured the effect on luciferase
activity. An overview of all mutations is depicted in (Fig. 2.18A). First of all I inves-
tigated the influence of the apical base pair of the stem which closes the tri-nucleotide
loop. In the published CDE consensus, the polarity of the closing pair is decisive for the
binding of Roquin. Mirroring the upper two Y-R base pairs of the TNF CDE results
in a significant increase of the β-globin reporter mRNA half-life [56]. In contrast to
the TNF CDE, both UCP3 CDEs feature an R-Y closing base pair. Mutation of the
closing base pair to any other Watson-Crick base pair in either CDEI, CDEII or both
did not influence luciferase activity (Fig. 2.18B). Mutation of the closing base pair
into a G◦U or U◦G wobble base pair however, led to a significant increase in luciferase
activity (Suppl. 5.11). However it did not increase the luciferase activity to the same
extend as the pentaloop mutations (Fig. 2.14B). This suggests that apical wobble base
pairs might occur in endogenous Roquin binding sites.
In the next step, I wanted to investigate whether the stability of the stem has an influ-
ence on Roquin binding in vivo. Therefore, I stabilized CDEI, which consists exclusively
of A-U base pairs, by introducing one (M10) or two G-C (M11) base pairs. Increasing
the ∆G of the CDEI stem did not influence luciferase activity (Fig. 2.18C). Smiliary,
destabilizing CDEII by exchanging the central G-C base pair to an A-U base pair (M13)
also had no effect on luciferase activity. In addition, I completely exchanged CDEI with
CDEII which had also no effect on luciferase activity in vivo compared to the UCP3 wt
element (Suppl. 5.11).
43
2.3 Redefining Roquin Binding Preferences
Figure 2.18: Mutational analysis of the UCP3 tandem CDE. (A) Overview of UCP3 mutants.
(B) Luciferase activity of closing base pair mutants. n = 3. (C) Luciferase activity
of stem mutants. n = 3. (D) Luciferase activity of triloop mutants. n = 3. (B-E)
Firefly luciferase activity was normalized to Renilla luciferase as internal transfection
control. Values are normalized to an empty vector control, without UCP3 3’UTR
sequences. Luciferase activity of the UCP3 wt element is indicated as dashed line.
(**) P-value < 0.01. (*) P-value < 0.05. n.s. = not significant. Adopted and
modified from [113].
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2.3 Redefining Roquin Binding Preferences
In the previously performed hepamerscreen (see Fig. 2.7C) mutation of nucleotides
8-14, which shortens the stem of CDEI by only one base pair down to 5 bp, already
significantly restored luciferase activity. To exclude the possibility that mutation of the
surrounding nucleotides contributed to this effect, I introduced point mutations (M30,
M31, M32) to shorten the stem of CDEI, CDEII or both. Shortening of the CDE
stem to 5 bp significantly increased luciferase activity, verifying that Roquin binding
is dependent on CDE stem length in vivo. Conversely, it has been shown in the TNF
CDE mutagenesis screen that extending the stem to 9 bp also inactivated CDE-mediated
mRNA decay [56].
The results of the TNF CDE mutagenesis also suggested that a purine stack of at
least three consecutive purines at the 3’ side of the stem is important for CDE mediated
mRNA decay. This assumption has already been questioned by subsequent studies in
vitro [57], but has never been thoroughly investigated in vivo. I could demonstrate
that neither the introduction of a purine stack into CDEI (M11) nor destruction of the
putative purine stack in CDEII (M12) had a significant influence on luciferase activity.
Taken together, this suggested that Roquin binding to both CDEs in the UCP3 wt
element is not dependent on stem stability or sequence nor is the polarity of the closing
base pair or the presence of a purine stack on the 3’ side of the stem a prerequisite for
Roquin binding in vivo.
Previous in vitro studies suggested Y-R-N as a possible motif for the tri-nucleotide
loop [60] [57]. However, this motif has not yet been comprehensively tested in vivo. To
investigate the influence of the loop nucleotides on Roquin binding in vivo, I mutated
nucleotides 1-3 of the loop to the corresponding other possible nucleotides and quantified
luciferase activity (Fig. 2.18D). The Mutation of U at position 1 to a C in CDEI, CDEII
or both had no significant influence on the luciferase activity. This finding is in line with
results from previous studies with the TNF CDE. On the other hand, the mutation
of A at position 2 to G led to a significant increase in luciferase activity compared to
the UCP3 wt element. The effect is most pronounced in the double mutant. This
result is in contradiction to the TNF CDE, which endogenously encodes for a G at
this position. Also mutation of G to A does not affect gene repression by the TNF
CDE [56]. The mutation of U in position 3 of the triloop to any other nucleotide
significantly increased luciferase activity. This was especially pronounced in the double
mutants. While luciferase activity in double mutants increases to ∼ 70 − 75%, it does
not reach the level of pentaloop mutants (90%) suggesting that though Roquin binding
is impaired, there is binding activity remaining. From the data shown, I concluded that
-YAU- triloops are most effective for the regulation of gene expression by Roquin. This
motif also corresponds to the conservation of the UCP3 wt sequence in mammals where
-YAU- occurs almost exclusively (Suppl. 5.5). However, it cannot be excluded that
endogenous Roquin targets code for a -YRN- motif, since these sequences still have a
certain regulatory activity. In summary, the presented in vivo data set let me formulate
a new CDE consensus (Fig. 2.19C). The UCP3 wt derived relaxed consensus consists
of a 6-8 bp long stem capped by a Y-R-N tri-nucleotide loop. The length of the stem
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Figure 2.19: Roquin recognizes a relaxed CDE consensus. A new general suggested, relaxed
CDE consensus based on the in vivo UCP3 wt mutational analysis presented in this
work.
is based on my results that shortening the stem to 5 bp already induced a significant
increase in luciferase activity and that extension of the TNF CDE to a 9 bp stem leads
to complete inactivation of CDE-mediated mRNA decay. Taken together, this suggests
that Roquin binding is mainly shape-dependent with only very few requirements for the
loop sequence. This supports previous structural studies that showed a strong shape
dependency of Roquin binding. Besides triloop nucleotide composition, stem length also
seems to be a very important feature of Roquin mediated gene repression. Further, the
above presented results suggest that many more genes may encode for functional Roquin
binding sites.
2.4 Identification of New High Affinity Targets of
Roquin
As described in the previous chapter, the detailed in vivo mutational analysis allowed
me to suggest a new relaxed CDE consensus. In this part of my thesis this data was
used to perform a computational analysis of the human genome for the identification of
new Roquin targets. Leppek et al. performed a descriptor search based on their initially
proposed TNF -derived CDE consensus. They identified 109 CDEs in 108 genes. 56
of the predicted CDEs were highly conserved among mammals. To verify that CDE-
containing mRNAs are targets of Roquin, they performed an immunoprecipitation (IP)
of Roquin-1 followed by RNA sequencing. The most enriched RNA they identified was
NFKBID which contains a tandem CDE in its 3’UTR. From that they concluded that
CDE-containing genes are primary targets of Roquin. However, it must be said that
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only 15 of all 95 mRNAs significantly enriched in the Roquin IP contained a conserved
CDE, corresponding to the TNF -derived descriptor, in their 3’UTR. This small overlap
suggests that their descriptor based computational prediction was not able to reliably
predict most binding site containing genes. With the help of the data generated in this
thesis and the general CDE motif derived from it, it should be possible to predict many
more genes that code for a functional CDE and therefore be primary targets of Roquin.
2.4.1 Computational Prediction of CDEs
In collaboration with the Mathews lab (Rochester University, NY), we predicted CDE-
containing genes on a genome wide scale. Therefore all human 3’UTRs were searched
for potential CDEs based on the UCP3 derived CDE consensus(Fig. 2.19). For this
search G◦U wobble base pairs were excluded, because this was the only mutation that
significantly increased luciferase activity. For the descriptor search, all human 3’UTR
sequences were obtained from the UCSC genome browser (hg19). The program RNAmo-
tif was run to identify CDE-containing genes. The program takes an RNA descriptor,
an RNA sequence file and outputs the positions where the RNA motif is found. Using
RNAmotif ∼ 2600 genes that contained at least one predicted CDE were identified. As
we have seen in the previous results that the correct folding of the CDE is decisive for
its correct function in gene repression, the estimate folding probability of the predicted
CDEs was calculated. In order to calculate the estimate folding probability a C++ pro-
gram called ProbStemloop was written, using RNAstructure. ProbStemloop takes three
input parameters: the sequence file, the starting position of a stem-loop and the length
of the stem-loop and outputs the folding probability of the the motif. The sequences
processed by ProbStemloop were truncated to 400 nt upstream and 400 nt downstream,
as has been demonstrated that this much sequence is a sufficient representation of the
local folding in mRNA [150]. In summary, this approach used an exact calculation of
the estimated thermodynamics and expanded on prior work from the Mathews lab that
calculated loop probabilities [151]. Among the predicted CDEs, known CDEs in the
3’UTR of TNF, Ox40 and ICOS were correctly identified. Estimate folding probabili-
ties of these known CDEs range between 15-98%. CDEII of UCP3 is in the middle with
55%, while CDEI, which consists entirely of A-U base pairs, is significantly lower with 6%
folding probability. Since UCP3 CDEI is the experimentally proven CDE with the low-
est folding probability [113], we used an estimate folding probability cutoff of 5%. CDEs
with an even lower folding probability (≤5%) may not be targeted by Roquin. About
a third of the predicted CDEs had a folding probability ≤5%. In addition, we analyzed
the evolutionary conservation of the predicted CDEs as an indicator for their functional
importance. We assessed conservation by querying the predicted human CDEs in Multiz
46-way multiple sequence alignments with chimpanzee, mouse, dog and cow. CDEs were
considered conserved if their nucleotide sequence was identical across all five species or
if only tolerated nucleotide changes which retained CDE structure and corresponded to
the initial descriptor (Fig. 2.19) were observed. Considered as tolerated were changes
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in the triloop that still fit the definition of the proposed consensus (5’ stem -YRN- stem
3’). It further included changes to the length of the stem, such that only 6 bp are re-
quired to be conserved and changes to the stem that can still form canonical base pairs,
like compensating base pair changes, or G◦U wobble base pairs.
About every eighth CDE predicted in humans was found also in the other four species
studied. Interestingly, the conserved CDEs had a significantly higher likelihood of folding
(≥5%) compared to the non-conserved CDEs (Fig. 2.21A). The stem of CDEI in the
UCP3 wt element solely consists of A-U base pairs. Therefore, I analyzed the AU-
content in the stems of all predicted CDEs. No significant enrichment for AU-rich
stems could be observed for the conserved CDEs compared to the non-conserved CDEs
(Fig. 2.21A). Strikingly, the conserved CDEs showed a significant enrichment of U
at position three of the triloop compared to the non-conserved CDEs. At position one
and two of the triloop, no significant change was observed between conserved vs. non-
conserved CDEs. These findings are in accordance with the in vivo mutagenesis data,
were triloops with a U at position three showed the best regulatory activity. Analysis
Figure 2.20: Nucleotide occurrence in the tri-nucleotide loop. Consensus used for bioinfor-
matic prediction of new CDE structures by RNAMotif. Nucleotide occurrences in the
triloop are shown for all and conserved elements. V = A, G, C. P-value < 0.0001
(Pearson’s chi-square test). n.s. = not significant. Adopted and modified from [113].
of the data set also allowed me to evaluate the occurrence of certain CDE features that
have previously been described as important for CDE based regulation. For example,
while the mutation study on the TNF CDE indicated the need for a purine stack on
the 3’ side of the stem, the mutation study on the UCP3 CDEs could not confirm this.
Analyzing the occurrence of purine stacks, it can be seen that they only show a slight
preference in the conserved CDEs compared to the non-conserved CDEs (Fig. 2.21A).
Thus, I conclude that while purine stacks do occur in CDEs, they a not required for
their activity in vivo. This confirms the results presented in this work. As described
in section 2.3.2 the mutational analysis of the UCP3 wt element showed that a G in
position two of the loop was sufficient to significantly increase luciferase activity. This
finding is in contrast to the TNF CDE were G and A are equally effective in regulating
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mRNA half-life. A distinctive difference between the two CDE elements is the polarity
of the closing base pair, which is R-Y (A-U) in both UCP3 CDEs as opposed to Y-R
(C-G) in the TNF CDE. Therefore, I analyzed if a G in position two in the loop occurs
preferably in conjunction with a Y-R closing pair in conserved CDEs. With an A at
position two in the loop no preference of the closing base pair was observed. In contrast,
there was a significant enrichment for Y-R closing base pairs among G containing triloops
in conserved CDEs compared to non-conserved CDEs (Fig. 2.21B). Taken together,
Figure 2.21: Statistically enriched CDE features. A) Probability of folding and composition of
the stem of conserved CDEs. Comparison of folding probability (> 5%), AU-content
(> 50%) and occurrences of purine (R) stacks at the 3’ side of the stem (at least
three consecutive purines) between conserved and non-conserved CDEs. p = p-value
(Pearson’s chi-square test). n.s. = not significant. B) Co-occurrence of A or G at
position 2 in the triloop with R-Y or Y-R closing base pairs. R = A, G and Y = C,
U. P-value < 0.0005 (Pearson’s chi-square test). Adopted and modified from [113].
I showed that CDEs that do not correspond to the initially proposed consensus (Fig.
3.1C) are conserved across human, mouse, cow, pig and dog. These conserved CDEs
are enriched for a higher estimate probability of folding and do show a strong preference
for U at position three of the triloop. In addition to this, mutational analysis and
bioinformatic prediction suggest that the purine in position two in conjunction with the
polarity of the closing base pair fine tunes the repressive strength of a CDE.
2.4.2 In vivo Verification of New Roquin Target Genes
With the information obtained, I was able to compile a set of 166 high potential target
genes that contained 1-2 CDEs in their 3’UTR. To be considered, the CDE had to
be evolutionarily conserved, a folding probability > 5% and a U at position three of
the triloop. A list of these high potential candidates can be found in Suppl. Tab.
5.4. To verify if the CDEs are functional, I chose three single and one tandem CDE to
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analyze their influence on gene expression. Therefore, I fused the single CDEs of CSF3
(also G-CSF), CYR61 (also CCN1) and ZC3H12A (also Regnase-1 or MCPIP-1) and
the tandem CDE of TM2D3 together with 40 nt upstream and downstream endogenous
sequences to the firefly luciferase. In order to attribute any effects directly to the CDEs,
additional constructs were cloned in which point mutations were inserted that prevented
triloop formation and thus no longer allow CDE-based regulation. An overview of the
CDEs and the corresponding mutations is depiced in Fig. 2.22. As positive control
for single CDEs the TNF CDE37 [56] and a corresponding loss of function mutant were
fused to the Firefly luciferase. The UCP3 wt element and UCP3 CDEI/IImut (Fig.
2.14) were used as control for the TM2D3 tandem CDE. In order to quantify the effect
Figure 2.22: Overview of conserved CDEs in the 3’UTRs of new Roquin targets. CDEs were
predicted by RNAmotif and selected based on their structural conservation, folding
probability and a U at position three of the triloop. Inactivation mutations preventing
triloop formation are shown next to the respective CDE. Adopted and modified from
[113].
of the new CDEs on reporter gene activity, I measured luciferase activity in HEK293
cells. The single CDE reporter constructs reduced luciferase activity to 67% (CSF3 )
- 82%(CYR61 ) compared to the empty vector control (Fig. 2.23). These values are
comparable to the individual CDEs from the UCP3 wt element, where CDEI reduces
luciferase activity to 73% and CDEII to 67% (Fig. 2.14B). In the luciferase reporter
system the TNF CDE reduce luciferase activity to 63% compared to the empty vector
control (Fig. 2.23). The tandem CDE from the 3’UTR of TM2D3 reduced luciferae
activity even further to 47% of the empty vector control which is comparable to the
repression by the UCP3 wt element. Most importantly, in all new CDEs studied, the
mutation of the triloop to a pentaloop resulted in a significant increase in luciferase
activity. This clearly demonstrated that the observed repression of luciferase activity is
directly related to the presence of the respective CDE. In addition this proofed, that the
new single and tandem CDEs were accurately detected by our computational approach.
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Figure 2.23: In vivo verification of new CDE-like elements. Influence of predicted CDE-
like elements and mutants on luciferase activity in HEK293 cells. Firefly luciferase
activity was normalized to Renilla luciferase as internal transfection control. Values
are normalized to an empty vector control n = 3. (**) P-value < 0.01. (*) P-value
< 0.05. Adopted and modified from [113].
2.4.3 Knockdown of Roquin Proteins Increases mRNA Abundance
of CDE-encoding mRNAs
Next, I wanted to verify these finding in an endogenous context. Therefore, I quanti-
fied mRNA levels of CDE-encoding genes after knockdown of Roquin proteins. For my
analysis, I used the four CDE-containing genes, from section 2.4.2. In addition to this, I
also chose eight other CDE-encoding genes from the high confidence set (Suppl. Tab.
5.4). Because some of the predicted targets are known to alter the function of endothe-
lial cells, I performed this analysis in HEK293 cells and HUVECs. For the knockdown of
Roquin proteins in HEK293 cells, I reverse transfected HEK293 cells with siRNAs tar-
geting human Roquin-1 and Roquin-2. 48 h post transfection RNA and protein samples
were prepared. HUVECs were forward transfected 24 h post seeding. Likewise protein
and RNA samples were prepared 48 h post transfection. Efficiency of the knockdown
was analyzed by western blot and quantification of Roquin-1 and Roquin-2 mRNA lev-
els (Fig. 2.24) to allow a direct comparison of relative protein levels and knockdown
efficiency in HEK293 cells and HUVECs.
All twelve genes that contain a predicted CDE in their 3’UTR could be verified as
Roquin target in HUVEC. mRNA levels of all genes significantly increased upon kock-
down of Roquin proteins. This is in accordance with an increase of mRNA half-live in
absence of Roquin proteins. The results substantiate that the bioinformatic prediction
is very precise in the prediction of CDE encoding genes and therefore genuine Roquin
targets. Of the selected genes, only ten were detectable in HEK293 cells. Interestingly,
only for seven out of the ten genes an increase in mRNA level could be detected (Fig.
2.25). This suggests that not only the expression of Roquin target is cell type specific,
the repression of target genes by Roquin proteins might be cell type specific as well.
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Figure 2.24: Knockdown of Roquin proteins in HEK293 cells and HUVECs. (A) Western
blot of Roquin-1 and Roquin-2 after siRNA-mediated knockdown in HEK293 cells
and HUVECs. Anti-Roquin was used to verify the respective knockdown. Total
lane protein is shown as loading control. n = 3. (B) siRNA efficiency in HEK293
cells and HUVECs. RT-qPCR quantification of RC3H1 and RC3H2 mRNA levels
after siRNA-mediated knockdown of Roquin-1 and Roquin-2 in HEK293 cells and
HUVECs. Values are normalized to the housekeeping gene RPLP0. n = 4. (**)
P-value <0.01. (*) P-value <0.05. n.d. = not detected. Adopted and modified
from [113].
Figure 2.25: Target gene mRNA levels after Roquin-1/-2 knockdown. RT-qPCR quantifica-
tion of new Roquin target genes encoding CDEs after siRNA-mediated knockdown
of Roquin-1 and Roquin-2 in HEK293 cells and HUVECs. Values are normalized to
the housekeeping gene RPLP0. n = 4. (**) P-value <0.01. (*) P-value <0.05. n.d.
= not detected. Adopted and modified from [113].
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2.4.4 Computational Prediction of ADEs
Recently, Janowski et al. discovered a new class of Roquin binding elements by SELEX.
This alternative decay element (ADE) constitutes a 7 bp long stem capped by a U-
rich hexaloop. In their study, they identified one endogenous ADE in the 3’UTR of
OX40, which also harbors a canonical CDE, and demonstrated that it is bound by
Roquin with high affinity [64]. No further ADEs have been identified since. Using our
established bioinformatic pipeline, we scanned all human 3’UTRs for additional ADEs
to gain insight how widespread this sort of Roquin binding site is on a genome-wide
scale. For the descriptor search we used an ADE consensus that consists of a 6-8 bp long
stem capped with a -GUUYUA- hexa-nucleotide loop (Fig. 2.26A). I chose the stem
in analogy to functional CDEs. Similar to Roquin binding to CDEs, the structure of the
Roquin-Ox40 ADE-complex showed no sequence specific binding within the stem region
[64]. By scanning all human 3’UTRs, 19 genes that encode for a potential ADE were
Figure 2.26: ADEs are independent Roquin binding sites. A) Consensus used for bioinfor-
matic prediction of new ADE structures by RNAMotif. B) RT-qPCR quantification
of new Roquin target genes encoding ADEs after siRNA-mediated knockdown of
Roquin-1 and Roquin-2 in HEK293 cells and HUVECs. Values are normalized to the
housekeeping gene RPLP0. n = 4. (**) P-value <0.01. Adopted and modified from
[113].
predicted. Of these 19 only one ADE had an estimate folding probability < 5%. Similar
to the CDEs, about 50% of the predicted ADEs had an AU-rich stem and a purine stack
on the 3’ side of the stem. In addition, no specific polarity for the closing base pair
was observed in the putative ADEs. Of the 19 genes that contained a predicted ADE,
three genes also encode for a canonical CDE. Interestingly, none of the three CDEs
is evolutionarily conserved, suggesting that ADEs function independently as Roquin
binding sites. Of the 19 predicted ADEs, six are conserved among chimpanzee, mouse,
dog and cow. As demonstrated before conservation is a strong indicator for functional
importance. In consequence, these six ADEs might be genuine Roquin targets. To
test whether the ADE containing genes are regulated by Roquin, I analyzed mRNA
abundance of four of the genes predicted to contain an ADE after knockdown of Roquin
proteins in HEK293 cells and HUVEC. All four genes tested for regulation by Roquin
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showed an significant increase in mRNA abundance upon Roquin knockdown in HEK293
cells as well as HUVECs (Fig. 2.26B). Most importantly, non of the selected genes
contained an additional CDE, which highlights the self-sufficiency of ADEs as Roquin
binding elements. In summary, our bioinformatic pipeline has enabled us to precisely
identify new ADE containing genes and these genes are directly regulated by Roquin
independent of the presence of a canonical CDE. This demonstrated that ADEs are
indeed self-sufficient cis-regulatory elements by themselves.
In summary, redefining the consensus CDE and accurate genome-wide prediction of
CDE containing genes as well as the genome-wide identification of ADE containing
genes, enabled me to identify and verify a variety of de novo Roquin target genes.
Many of the newly predicted and verified targets are not associated with the immune
response, the proposed primary function of Roquin. Therefore, the results presented
in this thesis suggest that Roquin proteins are involved in a much broader spectrum
of cellular processes. These new roles for Roquin proteins provide great potential for
deciphering post-transcriptional gene regulation and therefore need to be investigated
in the future.
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3 Discussion
In my doctoral thesis, I discovered a new tandem CDE and exploited it to discover
previously undetected Roquin binding sites on a genome-wide scale, which allowed me
to expand Roquins role in health and disease. For that, I first used a bioinformatic
prediction to screen for structurally conserved regulatory RNA elements. With this
method, I successfully identified regulatory RNA elements in 3’UTRs. The regulatory
element in the 3’UTR of UCP3 folds into a tandem CDE structure and is bound by
Roquin proteins with high affinity. CDEs have previously been identified in a variety
of immune response related mRNAs. In the context of this work, a Roquin target
that is not connected to the immune response is being analyzed in depth, for the first
time. Previously CDE-containing mRNAs were identified by a descriptor-based motif
search based on the TNF CDE consensus. In my thesis, I revised the CDE consensus
based on an in-depth mutational analysis of the UCP3 tandem CDE. This allowed the
prediction and identification of many novel decay elements in 3’UTRs of mRNAs that
are connected to a variety of physiological processes. It demonstrates the importance
of the Roquin-CDE interaction and its contribution to the regulation of critical cellular
processes by Roquin-mediated repression [113]. With my work, I hope to initiate the
further investigation of structurally conserved RNA elements in higher eukaryotes and
decipher their contribution to post-transcriptional regulation of gene expression.
3.1 Identification of Regulatory RNA Elements Based
on Structural Conservation
In the following, I will first present the starting point of my study to highlight the im-
portance of researching regulatory active RNA elements. RNAs are the central hubs for
regulating gene expression and protein synthesis [152] [153]. It is widely accepted, that
its functionality does not rely on sequence content only, but is also directly attributable
to its ability to fold into specific intricate secondary and tertiary structures [154] [131].
For the understanding of post-transcriptional gene regulation, it is therefore necessary
to have precise knowledge of structure and location of these RNA elements within an
mRNA of interest. There are many ways how RNA structure can be assessed experi-
mentally. High-resolution structures can be obtained by X-ray crystallography [155] or
nuclear magnetic resonance [156]. However, these methods have shortcomings like cost
or manual labor, rendering them slow and low-throughput [157]. In addition, these meth-
ods only provide structural insights into already known RNA elements. On the other
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hand structural profiling recently is emerging as an affordable and high-throughput ap-
proach to structure analysis as it provides snapshots of structural states at nucleotide
resolution in vivo or in vitro [158]. It can be utilized to analyze an RNA structurome
of a cell under different conditions and help to shed light on the role of structures in
governing biological functions. Since all in vivo structural probing methods are based on
cell permeable chemicals with different reactivity for single- and double-stranded regions
[159] [111], they all share the principal drawback that it is unclear whether an unde-
tected region, i.e. one that is not accessible to the chemical, is actually double-stranded
or bound by a protein. This is of critical importance since it is known that 3’UTRs
are extensively bound by a variety RBPs at the same time [160] [161]. Complemen-
tary methods circumvent this issue by detecting unbound double-stranded regions with
psoralen-induced cross-linking or protein-bound regions by UV-induced cross-linking in
combination with immunoprecipitation of the desired protein [112] [101]. Despite the
fact that all these methods are promising tools for a comprehensive elucidation of the
RNA structurome in the future, they share one significant disadvantage: they are lim-
ited to the transcripts present at the time of the experiment. Therefore these methods
are not applicable for the detection of transcripts that are induced by stress or show cell
type specific expression.
3.1.1 Prediction of Structurally Conserved RNA Elements
An alternative approach to detect specific RNA structures in cells is RNA secondary
structure prediction. The key benefit of this approach is the possibility of identifying a
regulatory element independent of the cellular level of the mRNA it is located in [114]
[162]. Similar to sequence conservation, evolutionary conservation of an RNA structure
can also be an indicator of functional importance [118]. A critical aspect for identifying
a conserved structure is to exclude sequence conservation bias. Programs like Dynalign
and Foldalign can identify conserved RNA structures by taking two unaligned sequences
and simultaneously folding and aligning them to identify the lowest free energy structure
both sequences can adopt [124] [125], whereas programs like RNAz [123] or Evofold [163]
rely on a fixed sequence alignment as input. Therefore, Dynalign includes the advantage
of phylogenetic conservation for structure prediction, without the disadvantage of relying
on high sequence conservation. A disadvantage of the Dynalign prediction, which must
be mentioned is that the algorithm is only able to compare two sequences with each
other. In this thesis, a prediction based on all human and mouse UTRs was used, since
at the time the analysis was performed those were the best annotated genomes. By
only comparing two species, which are very similar, it is not possible to asses whether
a structure really is conserved on a broader phylogenetic scale, which in turn increases
the possibility of false positive predictions. In general genome diversity is low among
mammals. The 3’UTRs of human and mouse genome have ∼73% sequence identity [164]
[165]. Due to the high sequence identity, it can be assumed that the RNA secondary
structure between both organisms will also be very similar, resulting in a large number
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of predicted conserved structures. Including more genomes into the analysis should
therefore increase the accuracy of the prediction of conserved regulatory structures.
In order to achieve this, the ∼6000 initially predicted elements could be re-evaluated
with the program Multilign. Multilign is based on multiple Dynalign calculations and
can predict structures common to three or more sequences [166]. Reinspection of the
windows with Multilign will considerably reduce the false positive rate, as it allows the
comparison of the structural conservation in a broader phylogenetic context.
3.1.2 Screening for Functional RNA Elements
The three dimensional structure of RNAs can be essential for their respective physi-
ological function. By predicting conserved structures in UTRs using Dynalign, I was
able to identify functional structured RNA elements. The identification of regulatory
RNA structures in higher eukaryotes remains a challenge, but is key to understand
complex patterns in RNA regulatory networks. Here, I present how I investigated the
regulatory properties of computationally predicted, structurally conserved, regulatory
RNA elements. In order to asses the regulatory properties of the predicted elements, I
performed a dual luciferase assay based screening to investigate the influence of 20 se-
lected 3’UTR elements on luciferase activity. While the majority of predicted elements
did not have an effect on reporter gene activity, four elements significantly reduced lu-
ciferase activity to ∼ 30-67% compared to the empty vector control (Fig. 2.1). For the
experiments cells were maintained in a steady state under optimal growth conditions.
However post-transcriptional gene regulation often occurs in response to stress signals
[167] [168]. Therefore, modification of culturing conditions, i.e. hypoxia, iron depletion
or serum starvation, could be applied to identify regulatory elements that exert their
function under certain conditions. Such an approach would take full advantage of the
unbiased predictive approach by Dynalign. Still, the use of a luciferase assay based
screening system limits the number of elements that can be analyzed, because it cannot
be up-scaled to a high-throughout methodology. In order to facilitate an efficient in vivo
interrogation of RNA elements for their function in post-transcriptional gene regulation
fluorescence-based screens have been used in a variety of contexts [169] [170]. These
studies utilize fluorescence-based reporter libraries, which are analyzed and sorted by
fluorescence activated cell sorting (FACS). In a study by Wissink et al. [107] they ex-
ploit chromosomally integrated dual-fluorophore reporter libraries, in combination with
FACS, in order to sort cells into different pools of reporter gene activity. In order to
recover the regulatory sequences, high-throughput sequencing is applied to the differ-
ent pools to attribute regulatory impact to discrete sequences [107]. A similar strategy
could be implemented with the plasmid pDF-FRT constructed in this thesis to query
all predicted structurally conserved elements. This encodes mCherry and GFP. Both
reporter genes are expressed from minimal promoters and share the same enhancer ele-
ment. A multiple cloning site downstream of the GFP ORF allows to insert sequences
of interest to investigate their influence on GFP expression. In addition, the plamid en-
57
3.1 Identification of Regulatory RNA Elements Based on Structural Conservation
codes an FRT site for genomic integration into a "Flip-In" host cell line. For maximum
applicability, a pDF-FRT plasmid library that contains all 100 nt long windows would
have to be cloned. Such a library could be easily integrated into different cell lines as
well as analyzed under diverse cultivation conditions and stimuli. Such an experimental
approach can also be combined with a knockdown of RBPs. In previous studies knock-
down of Dicer was applied to identify mRNAs that are targets of RNA silencing [171].
Performing a Dicer knockdown on an integrated dual-fluorophore reporter library would
therefore allow the identification of elements targeted by miRs. This approach can also
be applied to RBPs that affect mRNA stability or translation efficiency. Similar studies
were performed with the ARE binding proteins AUF1 [172] and TTP [173] or RBPs
that recognize specific RNA structures, like Roquin [52], but these studies are always
limited to one cell type and growth condition. Combining the presented computational
prediction with an integrated fluorophore reporter library, combined with RPB knock-
down and coupled to RNA sequencing may therefore be the most efficient approach for
the de novo identification of regulatory RNA structures.
3.1.3 A Repressive RNA Element in the 3’UTR of UCP3
I discovered a repressive element in the 3’UTR of the UCP3 gene. To proof the self suf-
ficiency of the element, I initially analyzed different variants of the 1131 nt long UCP3
3’UTR and their potential to regulate a luciferase reporter (Fig. 2.2). Only reporter
RNA encoding the predicted 100 nt structurally conserved RNA element reduced lu-
ciferase expression significantly. The residual 1031 nt long 3’UTR variant lacking the
predicted element only exhibited a slight reduction of reporter gene activity [113]. This
led me to the conclusion that the element, predicted by Dynalign, is responsible for the
observed reduction of luciferase activity. Further analysis showed, that duplication of
the element led to an increase in repression of the same magnitude. This supported my
conclusion that the element harbored a binding site for a trans-acting factor. UCP3 is
a member of a five mitochondrial membrane protein spanning subfamily (UCP1-5) of
the SLC25 family of mitochondrial anion carrier proteins [136]. In general UCPs are
important in regulating cellular energy metabolism and as attenuators of reactive oxy-
gen species [147]. UCP3 is encoded in the nucleus and imported into mitochondria after
translation of the entire protein in the cytoplasm and inserted into the inner membrane
by an import machinery specialized for membrane proteins [174]. The most prominent
member of the uncoupling protein family is UCP1 which is primarily expressed in brown
adipose tissue. Extensive studies highlighted its thermogenic function in the context of
oxidative phosphorylation [136]. There, its physiological function is to mediate a regu-
lated, thermogenic proton leak [129]. The inducible conductance of protons across the
mitochondrial inner membrane (MIM) represents a common property of all UCPs [175].
Importantly, the dissipation of protons across the MIM accounts for a substantial part
of the resting metabolic rate [129]. Therefore UCPs represent potential targets for the
treatment of metabolic diseases. While the involvement UCP3 in the pathogenesis of
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cardiovascular diseases is widely acknowledged, its physiological role is still under debate
[176] [128] [177]. Undoubted is its highly selective expression in skeletal muscle, brown
fat and diabetic heart. Previous studies showed that although UCP3 has uncoupling
properties, this does not seem to be its primary function. In a physiological context an
increase in UCP3 protein does not necessarily increase uncoupling. This is supported by
studies with UCP3-/- mice that did not show impaired thermoregulation, which suggests
other cellular functions for UCP3 [178] [179]. Three main hypothesis are currently under
debate: 1) UCP3 may play key regulatory roles in mitochondrial fatty acid oxidation; 2)
UCP3 may protect cells against oxidative damage by mitigating ROS emission from the
electron transport chain; 3) protect mitochondria from from oxidative damage by ex-
porting lipid hydroperoxide (LOOH). In physiological studies elevated UCP3 levels were
observed in obesity-resistant mice [180] and a decrease in UCP3 levels was associated
with insulin sensitivity, a condition that precedes diabetes [181]. Thus, modulation of
UCP3 levels is an interesting target for the development of novel therapeutics. Fasting,
acute exercise and high-fat intake all lead to increased UCP3 levels, which is in line with
the induction of UCP3 caused by PPAR transcription factors [147]. Interestingly, UCP3
mRNA levels are elevated in fasted mice and are quickly restored after refeeding [182].
This indicates that the UCP3 mRNA may be unstable. Thus, it can be concluded that
a rapid constitutive decay of UCP3 mRNA could be essential to trigger a rapid response
upon changing nutritional states.
3.1.4 The UCP3 Repressive Element is not a miR Binding Site
Almost 60% of all protein-coding genes contain conserved miR target sites, predomi-
nantly in their 3’UTR [183] [36]. I initially tested whether the element serves as a single
stranded miR binding site and thereby represses reporter gene activity. None of the
miRs identified by TargetScan analysis are expressed in significant amounts in HEK293
or HeLa cells. Therefore, I concluded that repression is most likely not caused by miRs.
In order to analyze if the element represents a miR target after all, I performed overex-
pression of miR-152 in the presence of luciferase reporters containing either the 100 nt
long element or a mutant without the binding region for miR-152. The UCP3 repressive
element contains a highly conserved miR-152 target site and miR-152 is known to desta-
bilize the mRNAs of many tumor related genes [184]. In addition, miR-152 serum levels
positively correlate with T2DM [141]. In this experimental set up, luciferase activity
was reduced to 70% in the wild type, but not in the miR binding site deletion mutant.
These findings strongly argue against the involvement of miR-152 in repression by the
UCP3 element because repression by miR-152 is independent of the observed repression
by the 100 nt element.
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To assess the features important for repression, I performed a truncation study. As
expected deletion of the 5’ end of the element, which contains the predicted miR target
sites did not influence reporter gene repression. Further truncation from either the
5’ or 3’ end resulted in a significant loss of function. The residual 64 nt minimal motif
contains two RNA hairpins that are similar in sequence and structure to CDEs. CDEs are
recognized by Roquin proteins in a specific shape-dependent manner and repress target
mRNAs by rapid mRNA decay [56]. To substantiate the assumption that the UCP3
element adopts a CDE-like structure, I verified the structure of the UCP3 element in
vitro by in-line probing and and performed a mutational analysis that connected reporter
gene repression to CDEI and CDEII. Interestingly, only CDEII could be observed by in-
line probing of the 100 nt window (Suppl. Fig. 5.6), whereas the remaining sequence
appeared single stranded. In comparison, probing of the 64 nt long minimal motif verified
the existence of both CDEs. This finding suggests that the tandem CDE my sample
different conformations in its natural sequence context. This was also observed with the
TNF CDE in a similar manner. In-line probing analysis of the TNF CDE in a 150 nt
sequence context resulted in diffuse cleavage patterns, compared to the TNF CDE37.
In addition, the stem-loop in CDE150 provided a much smaller decrease in free energy
compared to the CDE37, indicating that CDE150 may fluctuate between alternative or
unstructured conformations. [185].
Reporter gene repression by the UCP3 tandem CDE is caused by a rapid decrease
of mRNA half-life. Accelerated mRNA decay is known to be caused by recruitment of
the deadenylase machinery by Roquin to the CDE-encoding mRNA [56]. The observed
mRNA half-life of 1.5±0.4h for a GFP reporter gene encoding the UCP3 tandem CDE is
comparable to the mRNA half-lifes of other CDE-encoding genes like NFKBIZ 1.6±0.2 h,
LER 1.7 ± 0.4 h, PPP1R10 2.1 ± 0.3 h and HMGXB3 1.6 ± 0.1h [56]. RNA affinity
purification with the UCP3 tandem CDE and western blot analysis confirmed Roquin
binding to both CDEs present in the UCP3 element. EMSA experiments showed, that
Roquin binds to both UCP3 CDEs directly via its core ROQ domain which is consistent
with previous reports [145] [56] [59]. The core ROQ domain of Roquin-1 binds with an
apparent KD of 138 nM to the UCP3 tandem CDE [113]. This is consistent with other
high affinity Roquin binding sites that have been previously analyzed by EMSAs such
as the TNF CDE with a KD of ∼119 nM [56] [60] [59] and the ICOS CDE with a KD of
∼136 nM [186]. In contrast, to the TNF CDE, the UCP3 wt element needs two CDEs
in close proximity to achieve such high affinity as mutation of either CDEI or CDEII
significantly lowers affinity. Still the ROQ domain of Roquin-1 binds CDEmutII with
similar affinity as the Ox40 CDE with an apparent KD > 1000 nM [64]. For the ROQ
domain of Roquin-2 a KD of ∼360 nM to the Ier3 CDE has previously been reported [63],
which is comparable to the affinity determined for the Rquin-1 ROQ domain interaction
with CDEImut. In conclusion the apparent binding constants of the UCP3 wt RNA and
the single mutants are in the range of previously determined binding constants of Roquin
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to CDEs. Interestingly, both CDEs are necessary for efficient Roquin binding and robust
suppression of gene repression. Similar characteristics have recently been described for
a tandem element from the ICOS 3’UTR, encoding a CDE and an octaloop-containing
stem loop, by EMSAs [58]. Similar to my observations on the UCP3 tandem CDE,
efficient binding of Roquin N-terminus to the 88 nt long ICOS tandem element was only
observed if both stem loops were present.
The ICOS 3’UTR harbors a similar composite Roquin binding site. It also contains
two closely spaced Roquin binding sites. As in the UCP3 3’UTR the presence of both
CDEs is necessary for efficient Roquin binding and subsequent ICOS repression [58].
In addition to that Roquin mediated repression by the ICOS 3’UTR is supported by a
much further 5’ localized Roquin-bound CDE-like stem-loop that has previously been
identified [187] [53]. The data from the study by Rehage et al. indicate a cooperative
function between the different Roquin binding sites in the ICOS 3’UTR. Interestingly,
shortening the distance between the individual Roquin binding sites in the ICOS 3’UTR
leads to increased regulation by Roquin. It is therefore possible that several Roquin
binding sites lead to a positive cooperation and thus to a better regulation by Roquin.
This hypothesis is also supported by my findings that in vitro high affinity binding of
Roquin is only observed with the UCP3 wt RNA where both CDEs are present. However
to this end it is still unclear how such cooperativity is achieved at a molecular level. In
solution Roquin protein is a monomer, and direct interaction of Roquin proteins has not
been observed so far. However, interaction of Roquin proteins could be induced by RNA
binding or by auxiliary factors. Just recently NUFIP2 protein has been discovered to
enhance Roquin binding to ICOS mRNA in vitro and therefore enhance repression by
Roquin in vivo [58].
Conspicuously, although two CDEs are present in the UCP3 wt RNA only one RNA-
protein complex band was observed in EMSAs with the core ROQ domain and the UCP3
wt RNA. However, under equal running conditions, this band migrates significantly
slower than the single bands observed for the two mutants, which only contain one
CDE. Such underrepresentation of intermediates is a feature of cooperative binding.
Cooperative binding can also be deduced from the sigmoidal binding curve of the core
ROQ domain to the UCP3 wt RNA. To unequivocally confirm that more than one
core ROQ domain is bound to the UCP3 wt RNA, I performed stoichiometric binding
experiments. The analysis confirmed that at least two core ROQ domains are bound.
Interestingly, two bands with retarded migration were observed for binding of the N-
terminal Roquin fragment to the UCP3 wt RNA. With the CDEImut RNA only the
faster migrating band could be observed, which indicates only one bound N-terminal
fragment. For the CDEIImut RNA again a second, slower migrating band at higher
protein concentrations was observed, suggesting that the CDEII pentaloop mutation
does not completely inhibit the binding of a second N-terminal fragment. This could
have reasons that are independent of the binding of the core ROQ domain. First,
the N-terminal fragment also contains a CCCH ZnF domain not present in the core
ROQ domain. CCCH ZnF are known RNA binding domains that can recognize linear
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RNA sequence motifs [188] [189]. Second, binding of the stem region of CDEII by a
dsRNA-binding “b-site” found in extended ROQ domains [62] and also present in the
fragment I used. Importantly, this residual binding has no effect in vivo as the CDEII
pentaloop mutation is as effective as other more destructive mutations of CDEII. The
Hill coefficient for binding of the core ROQ domain to UCP3 wt RNA is 3, indicating
cooperative binding, while the Hill coefficient for the N-terminal fragment is 1, indicating
no cooperativity. Thus, these two isolated protein fragments show different behavior
in UCP3 wt RNA binding. Ongoing experiments by Dr. Andreas Schlundt (Johann
Wolfgang Goethe-Universität, Frankfurt) currently investigate this contradiction by a
structural analysis based approach.
3.2.1 Structure-Sequence-Function Analysis of the Tandem CDE
In 2013, Leppek et al. published that Roquin binds to a short stem-loop motif in the
3’UTR of TNF and induces mRNA decay [56]. Mutational analysis and a genome
wide descriptor search identified ∼50 CDE-encoding transcripts. CDEs in these target
transcripts were conserved among mammals. Contradictory, in the same study, a large
number of Roquin-1 targets were identified, which did not contain detectable CDEs.
Based on RNA-IPs [56], PAR-Clip [52] and SELEX [64] approaches Roquin-1 binding
to non CDE-like motifs and its contribution to mRNA destabilization was demonstrated
in various studies. Still, the TNF CDE remains the only CDE for which a compre-
hensive in vivo mutational analysis has been performed and its functional consequences
analyzed [56]. The findings of this initial study have been extended by several in vitro
binding studies as well as structural biology approaches to unravel the requirements for
a functional CDE. Based on these findings different CDE consensus have been described
(Fig. 3.1). Both CDEs in the UCP3 wt element do not correspond to the previously
proposed CDE consensus. A precise mutational analysis revealed that Roquin binding
is primarily shape-dependent. This is in accordance with previous structural analysis
[57], but has not been demonstrated in vivo yet, where at minimal pyrimidine-purine
base pairs in the apical part of the stem are required for Roquin binding activity. In this
regard, the data presented in this thesis contradict previous findings. In particular, the
necessity of pyrimidine-purine base pairs in the upper part of the stem was convincingly
refuted by the mutation study of the UCP3 tandem CDE. Even G◦U wobble base pairs
remain a certain regulatory capacity. This leads to the conclusion that the nucleotide
composition of the stem is not essential for in vivo activity. Mutational analysis of the
tri-nucleotide loops of CDEI and CDEII largely confirms the previously suggested -YRN-
motif. Contrary to TNF CDE, A in position two of the loop (instead of G) is required
for efficient in vivo activity. Also the previously proposed necessity of a purine stack at
the 3’ side of the stem [56] [60] could not be recapitulated in any of the UCP3 CDEs.
In addition, I was able to demonstrate for the first time that a minimum stem length of
6 bp is required for a fully active CDE [113]. This complements previous findings that
extending the stem to 9 bp inhibits CDE activity [56].
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Figure 3.1: Evolution of the CDE consensus. Roquin recognizes a relaxed RNA stem-loop in
vivo. (A) TNF CDE derived consensus by [56]. (B) In vivo CDE consensus based
on mRNA decay assays in 21,54 and suggested by Codutti et al. [60]. (C) A general
suggested CDE based on in vivo and in vitro studies proposed by Schlundt et al. [57].
(D) New, relaxed general CDE consensus based on the data presented in this study
[113].
Summarizing the collected data on the UCP3 tandem CDE allowed for the formulation
of a new consensus for active CDEs (Fig. 3.1D). Compared to previously proposed CDE
consensus (Fig. 3.1A-C), it is composed of a 6-8 bp long stem of variable sequence and
a -YRN- tri-nucleotide loop.
3.2.2 Identification of New Roquin Target Genes
With the new consensus, I was able to predict and verify a large number of new Roquin
targets and therefore expand Roquin’s role in regulation of gene expression. As expected
some of the identified target mRNAs are in line with the previously reported function
of Roquin in immune response and inflammation. The data presented in this thesis
clearly demonstrates that the mRNAs of the proinflammatory factors CSF3, CYR61
and TNFSF15 (also known as TL1A) are targets of Roquin mediated RNA decay. Most
interestingly, the majority of new targets is associated to other cellular functions and
therefore suggest a much broader involvement of Roquin in a variety of cellular processes.
This is also consistent with the observed perinatal lethality of Roquin-1 or Roquin-2
knockout mice, which cannot be explained based on Roquin’s function in the immune
system.
Among the newly confirmed Roquin target mRNAs, I identified Regnase-1 as Roquin
target. In addition, I successfully correlated the repression by Roquin with the predicted
CDE. Interestingly Regnase-1 has been reported to detect similar RNA stem-loop struc-
tures in 3’UTRs of its target mRNAs [190]. Regnase-1 is a ZnF-containing RBP that
also contains a PIN-like RNase domain and destabilizes its targets by endonucleolytic
cleavage. Remarkably, Roquin and Regnase-1 share an overlapping set of mRNA targets.
These target mRNAs can be suppressed in a cooperative manner [191] or by a spatiotem-
poral distinct mechanism [190]. One study demonstrated that both proteins function in
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distinct subcellular locations in HeLa cells. Roquin is associated with processing-bodies
and stress-granules, where it facilitates accelerated mRNA deadenylation and subsequent
RNA degradation. In contrasts, Regnase-1 has been demonstrated to localize to the en-
doplasmic reticulum and active translating ribosomes, where it degrades its targets in a
UPF1-dependent manner [190].
In accordance with the reported redundancy of Reganse-1 and Roquin in recognition
of stem-loop structures, I identified mRNAs as Roquin targets that have previously been
associated with Regnase-1, such as TM2D3, which contains a tandem CDE similar to
the UCP3 wt element, and TFRC. In a study by Mino et. al. TM2D3 mRNA was
significantly enriched by Regnase-1 immunoprecipitation [190]. Moreover, Yoshinaga et
al. demonstrated that TFRC levels are significantly elevated in Reg-/- mice compared to
control animals [192]. Additionally they performed luciferase based reporter assays that
demonstrated that repression by Regnase-1 is mediated by an RNA stem-loop structure
similar to CDEs independently of known iron responsive elements in the TFRC 3’UTR
[192].
Cui et al. recently investigated cross-regulation between Roquin and Regnase-1. In
contrast to the results of Jeltsch et al. in TH17 cells and my results in HEK293 cells
and HUVECs, they found that the double knockout of Roquin-1 and Roquin-2 did not
increase Regnase-1 mRNA levels in Jurkat cells [193]. Furthermore, overexpression of
Roquin had no effect on the activity of a luciferase-Regnase-1 3’UTR-reporter in HeLa
cells. Conversely, Regnase-1 knockout increased Roquin-1 and Roquin-2-mRNA levels
in Jurkat cells. Also, overexpression of Regnase-1 reduced the activity of luciferase
reporters with Roquin-1 and Roquin-2 3’UTRs in HeLa cells. Jeltsch et al. found
elevated Regnase-1 protein levels after acute deletion of Roquin-1 and Roquin-2 in TH17
cells, leading to the conclusion that Regnase itself is a Roqion target [191]. Additionally
and in accordance with our results, the 3’UTR of Regnase-1 encodes a functional CDE
[194] similar to the 3’UTR of Roquin-1 and Roquin-2 [56]. Taken together, this allows for
an extensive auto- and cross-regulation between all three proteins, but cross-regulation
seems to be cell type specific [193] [191]. In conclusion this means, that Regnase-1
targets can either be regulated by Regnase-1 or Roquin directly or indirectly by Roquin
mediated modulation of Regnase-1 mRNA abundance. From that, I propose that Roquin
will share cellular functions with Regnase-1, additional to their function in the immune
response, such as the regulation of the iron metabolism.
Interestingly, in vivo more CDEs seem to provide more efficient repression (Fig. 2.2B
and Fig. 2.23). This does not necessarily require cooperative binding, but could also
be due to Roquin’s increased avidity to the UTR and thus more efficient recruitment
of the mRNA decay machinery. Furthermore, this increased repressive activity of more
CDEs only applies in isolation, i.e with short 3’UTR fragments as it is not transferred
to the situation within a complete, endogenous 3’UTR. The highest induced mRNAs
after Roquin knockdown are ZC3H12A (Regnase-1) in HEK293 cells and CSF3 in HU-
VECs. Both encode only one CDE, while for example CASD1 mRNA, encoding two
CDEs, responds only slightly to Roquin knockdown (Fig.2.25). Thus, even if there is
64
3.2 The Tandem CDE in the UCP3 3’UTR
cooperative binding of Roquin to RNAs in vivo, the sensitivity of an mRNA target to
Roquin levels might depend much more on the overall composition of its 3’UTR (see
also section 3.2.4).
For effective binding of Roquin to the UCP3 tandem CDE both CDEs are necessary
as mutation of either CDE aggravates the affinity of Roquin to the UCP3 wt RNA,
which in turn reduces repression of gene expression in vivo. The 3’UTR of TM2D3 also
contains two CDEs in close proximity, similar to the UCP3 3’UTR. The two CDEs are
seperated by 84 nt compared to 18 nt in the UCP3 3’UTR. Both tandem CDEs reduce
luciferase reporter gene activity significantly stronger that any of the tested single CDEs.
In contrast to the reporter gene based findings, the induction of mRNA levels after
Roquin knockdown varies greatly between different target genes and also between cell
types [113]. This leads to the conclusion that the level of repression correlates with the
number of CDEs present in a UTR and therefore that two CDEs lead to a stronger
repression of gene expression than one CDE. However, this somewhat digital behavior
was only observable in isolation. This is nicely exemplified with the cytokine CSF3
mRNA. Among all verified target genes it shows the greatest induction upon knockdown
of Roquin proteins, yet the CSF3 CDE alone reduces luciferase activity comparable to
the other individual CDEs analyzed in this study.
In this context, it is must be mentioned that the CSF3 CDE was identified as a
repressive RNA element even before Roquin-mediated repression was discovered [195].
Putland et al. identified a stem-loop destabilizing element (SLDE) in the 3’UTR of
CSF3. Even without knowing that repression is mediated through Roquin binding they
found that the SLDE rapidly decreases mRNA half-life by increasing the rate of dead-
enylation [195]. Mutational analysis of the CSF3 CDE yielded the same preference for
a -YAU- tri-nucleotide loop motif. Additionally, they showed that triloop formation is
mandatory for the rapid degradation of a reporter gene by the CDE. Similar to both
UCP3 CDEs the closing base pair of the CSF3 CDE is A-U (R-Y) which further contra-
dicts previous assumptions based on the TNF CDE that Y-R closing pairs are required
for functional CDEs [56] [60] [59].
The mutational analysis data of the CSF3 [195], TNF [56] and UCP3 [113] CDEs
led me to the conclusion that although -YRN- tri-nucleotide loops combined with any
possible closing base pair are tolerated in active CDEs, some sequence combinations seem
to be better recognized by Roquin and therefore are more efficient in regulating gene
expression. The origin for such preferences is still unclear and has yet to be analyzed in
detail. Being based on the initial findings on the TNF CDE all available high-resolution
structures of Roquin-RNA complexes use a U-G-U tri-nucleotide loop with a C-G closing
base pair [59] [61] [62] [63]. In those examples the G at position 2 of the loop can stack
on top of the G of the C-G closing base pair and this interaction is locked by arginine
219 of Roquine-1 by a further stacking interaction [59]. The complex structure of the
TNF CDE and Roquin-1 is depicted in Fig. 3.2.
An A at the central position of the loop in conjunction with R-Y closing pairs could
allow for alternative interactions within the CDE or with the Roquin-1. These alternative
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Figure 3.2: Structure of the Roquin-1 TNF CDE complex. Close-up view of the contacts
between the ROQ domain and the G a position 2 of the TNF CDE tri-nucleotide loop.
G at position 2 in the loop (G12) stacks with the G (G14) of the closing C-G base pair
and is locked in that position by stacking interaction with Arg214. Figure adopted
and modified from [59].
interactions could possibly support the formation of the CDE Roquin-1 complex and thus
modulate in vivo CDE activity. Also, previous studies demonstrated that an incorrect
preformation of the TNF CDE mutant lead to an inhibition of Roquin binding [60].
Therefore it could be possible that specific combinations of closing base pairs and loop
nucleotides could impact preformation of the CDE and thereby facilitate or impede
conformational selection of a CDE by Roquin.
3.2.3 ADEs are Self-sufficient Roquin Binding Sites
In Adittion to CDEs, Roquin binding to ADEs has been shown [64]. Based on the ADE
from the Ox40 UTR, the only example of an ADE so far, we predicted ADEs on a genome
wide scale. Being constrained to the sequence of the hexaloop we only recovered a small
number of 19 ADEs. Nevertheless, all further analyzed mRNAs encoding an ADE were
induced upon Roquin knockdown. Strikingly, two of the verified targets, MAP35K5
(ASK1) and Itch were previously described as Roquin targets, but do not contain a
detectable CDE in their 3’UTR. MAP35K5 is a protein kinase involved in apoptosis
signal regulation and is known to activate its targets c-Jun N-terminal kinase and p38 in
diverse arrays of stresses [196]. Therefore the stability of MAP3K5 protein is regulated
through ubiquitination by Roquin-2 [197]. My findings suggest that in addition to the
regulation of proteolysis there exists an additional layer of MAP35K5 regulation by
targeting its mRNA stability. Essig et al. recently identified Itch as target of Roquin in
T-cells [65]. In their study they showed that the 3’ half of the Itch 3’UTR is sufficient for
the repression of a reporter gene by Roquin proteins. In this region of the Itch 3’UTR
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the predicted ADE is located. This further emphasizes that we accurately predicted
functional ADEs and that they can serve as self-sufficient cis-regulatory elements.
3.2.4 Determinants of Roquin-mediated Regulation
The induction of CDE- and ADE-encoding target mRNAs upon knockdown of Roquin-
1/-2 varies significantly between individual genes. In addition to that, some targets are
sensitive to Roquin depletion in HUVECs but not in HEK293 cells (Fig. 2.25). This
finding led me to the conclusion that in addition to the presence of a Roquin binding
element further determinants are necessary to modulate the response of target genes to
changes in Roquin levels. A prominent determinant of Roquin-mediated regulation is the
folding probability of a given CDE/ADE in its respective 3’UTR sequence environment.
High folding probability will facilitate recognition of the CDE/ADE by Roquin. This
is also supported by my findings that the predicted conserved CDEs have a significant
higher folding probability compared to the non-conserved CDEs. I addition to that,
lower folding probability could be compensated in composite Roquin binding sites that
harbor multiple CDE-like structures with sub-optimal properties that act cooperatively
to repress mRNA levels in vivo. This is also supported by Essig et al. who showed that
the minimal response element in the Nfkbid 3’UTR is composed of six stem–loop struc-
tures that cooperate to exert robust post-transcriptional regulation [54]. In addition,
recent findings highlight the role of auxiliary sequences, such as stem loop elements with
large U-rich loops, that are recognized by the ROQ domain [52] [58] [65], or AU-rich
sequences that are recognized by the ZnF [52] that positively influence Roquin binding.
Also, auxiliary proteins such as NUFIP2 have recently been described to support the
binding of the Roquin N-terminus to the ICOS and OX40 binding elements [58].
Furthermore competing factors that also bind to CDEs will modulate the regulation
by Roquin. As demonstrated by Cui et al. Regnase-1 could compensate diminished
quantities of Roquin by destabilizing shared target mRNAs [193]. This is of particular
importance as Regnase-1 itself is a target of Roquin and and therefore induced by low
Roquin protein levels [113] [193] [191]. On the other hand, ARID5A [198] and BAG3
[199] have recently been identified as Roquin antagonists which increase the stability of
target mRNAs.
In addition, the continuous destabilization of a target mRNA could be ensured by
backup systems that function independent of Roquin-mediated repression. Independent
mRNA destabilization could be achieved by AU-rich elements. A prominent example
of Roquin independent repression is TNF which, in addition to a CDE, harbors an
ARE in its 3’UTR that mediates mRNA destabilization by interaction with TTP [200].
It was also shown that Roquin can regulate target mRNAs in cooperation with miRs.
Srivastava et al. showed that Roquin enhances Dicer-mediated processing of pre-miR-
146a and directly interacts with Argonaute 2 and miR-146a, a miR that targets ICOS
[201]. In addition, a study by Essig et. al indicates that binding of Roquin to a stem-
loop structure precludes binding of miR-17∼92 and therefore stabilizes Pten mRNA [65].
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The UCP3 3’UTR contains miR binding sites 5’ to its tandem CDE [113]. I propose
that Roquin therefore could also support post-transcriptional regulation of UCP3 by
these miRs.
Taken together, these findings provide an insight into the magnitude of Roquin-
mediated regulation. A major challenge for the future will therefore be to fully un-
derstand how the regulation of individual target mRNAs by Roquin is achieved when
different trans-acting factors and different cis-regulatory elements cooperate or antago-
nize each other to modify cellular functions.
3.3 Summary and Outlook
In this thesis, I redefined the binding preferences of Roquin and thereby expanded the
role of CDE-mediated post-transcriptional regulation. My initial focus was the identifi-
cation of regulatory RNA structures in mammals. For that, I have successfully imple-
mented genome-wide bioinformatic predictions of conserved structured elements [132]
for the identification of repressive 3’UTR RNA elements. This included a luciferase re-
porter based screening, which identified several regulatory elements. The UCP3 3’UTR
element was most efficient in repression of reporter gene activity. I demonstrated that
the minimal element able to exert full regulation is a structured RNA motif that folds
into a tandem CDE structure. Structure formation of both CDEs is mandatory for func-
tion. RNA affinity purification enriched the paralogs Roquin-1 and Roquin-2. Roquin
mediates rapid mRNA decay of UCP3 mRNA. For efficient binding of Roquin to the
UCP3 3’UTR both CDEs are required. In-depth mutational analysis redefined the in
vivo requirements for Roquin binding. With the help of a descriptor based prediction
of CDE-encoding genes, I was able to discover Roquin targets on a genome-wide scale.
Combination of mutation analysis and bioinformatic prediction provided 160 vertebrate
mRNAs with highly conserved CDEs and 19 ADE- encoding mRNAs. I provided ev-
idence that mRNA stability of these transcripts is regulate by Roquin. Furthermore,
I discovered that not only the expression of Roquin targets is cell type specific, also
Roquin based regulation varies between different cells. Most importantly many of the
identified targets are not related to the previously described role of Roquin in inflamma-
tion and the immune response. Therefore my data highlights additional, yet unstudied
cellular functions of Roquin.
With the discovery of increasingly complex patterns of post-transcriptional gene reg-
ulation, it is becoming increasingly important to combine different genome-wide ap-
proaches with detailed mutational analysis in vivo and in vitro to understand the exact
binding preferences of individual RBPs. A genome-wide prediction of RNA structures
is therefore complementary as well as informative to in vivo experiments.
Future work should focus on improving the accuracy of the prediction of conserved
RNA structures. Key to accurate structure prediction will be the availability of a large
number of and better annotated mammalian genomes as well as increasing computational
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resources. In the meantime, UTRs should be reevaluated for structural conservation
with the algorithm Multilign. In addition, a high-throughput method for the analysis of
putative regulatory element has to be established. I suggest, a dual fluorescent reporter
gene library based on the pDF_FRT plasmid which could be integrated in the genome
of different cell lines and allows for FACS analysis coupled to sequencing.
In addition, the increasingly complex binding of Roquin to composite RNA elements
should be in the focus of future work. Therefore the question must be addressed, if
Roquin binds to the tandem CDEs in a cooperative manner. NMR titration studies
with the UCP3 tandem CDE and Roquin-1 protein may solve this question. Of par-
ticular importance will be the identification of auxiliary factors that modulate Roquin
binding. Therefore, further studies need to investigate what exactly defines in vivo
Roquin binding sites and identify the effect of auxiliary and competing proteins. Muta-
tional analysis of new Roquin binding sites should be performed to extend our currently
limited understanding of in vivo Roquin binding sites. For the dissection of Roquin-
mediated protein-protein interactions co immunoprecipitation analyzed by mass spec-
trometry should be applied. This could be complemented by in vivo interactome studies
of known Roquin targets. In total, this would allow the accurate prediction of target
gene response to fluctuating Roquin levels and thus advance our understanding of the
role of Roquin in health and disease.
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4 Material and Methods
4.1 Materials
All materials, chemicals and technical equipment used in this study are listed in detail
in the Appendix.
4.2 Methods
All commercially available kits have been used according to the manufacturer’s recom-
mendations unless otherwise stated.
4.2.1 Cell Culture and Transfection
Cell lines used in this study are listed in table 4.1
Table 4.1: Cell lines used in this study
Cell line Description and ATCC number
C2C12 mouse (Mus musculus) near-tetraploid myoblast cell line (ACC 565)
HeLa HF1-3 human (homo sapiens) epithelial cervix adenocancinoma "Flp-In"
Host Cell Line (ref)
HEK293 human near-triploid embryonic kidney cell line (ACC 305)
HUVEC human umbilical vein endothelial cells (Lonza, CC-2519)
HEK293 cells and HeLa "Flp-in" Host Cell Line HF1-3 were cultured in Dulbecco mod-
ified eagle medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal bovine serum
(FBS, Sigma-Aldrich), 1mM sodium pyruvate (Thermo Fischer Scientific) and penicillin-
streptomycine (Pen-Strep, Thermo Fisher Scientific). HeLa HF1-3 cells were additionally
supplemented with 100 µg/ml zeocine (Invivogen). HF1-3 cells stably expressing GFP-
UCP3 wt or -MUTI/II constructs were suplemented with 150µg/ml hygromycine B
(Invivogen). C2C12 murine myoblast cells were cultured as HEK293 cells but with 20%
FBS (Sigma-Aldrich). For differentiation of C2C12 cells, the cells were grown to 90-100%
confluency. Then cultivation medium was changed to Dulbecco modified eagle medium
(DMEM, Sigma-Aldrich) supplemented with 2% horse serum (Sigma-Aldrich), 1mM
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sodium pyruvate (Thermo Fischer Scientific) and Pen-Strep (Thermo Fisher Scientific).
HUVECs were cultured in EBM-Plus medium (Lonza) supplemented with EGM-Plus
SingleQuots (Lonza) and 10% FBS (Thermo Fisher Scientific). All cells were maintained
in T75 cell culture flasks at 37°C in a 5% CO2 humidified incubator. When cells reached
70-90% confluency the culture medium was removed and cells were rinsed with 5ml
phosphate buffered saline (PBS, Sigma-Aldrich).Then cells were detached by incubation
with Trypsin-EDTA (Invitrogen) for 5min at 37°C. Trypsine digestion was quenched by
adding 7ml culture medium. The number of viable cells was determined by Trypan blue
staining (Biorad) and counting the cells with a Biorad TC-10 automated cell counter.
0.5 − 1 × 106 HEK293 or HeLa cells or 2.5 × 104 C2C12 cells were transferred in a
new culture with 20ml culture medium. For the transient transfection of pDLP derived
plasmids bearing the different UCP3 variants Lipofectamine 2000 (Thermo Fischer Sci-
entific) was used as recommended by the manufacturer. Therefore 1×105 HEK293 cells
were seeded in 24-well cell culture dishes. A total amount of 100 ng of plasmid DNA per
well was used for transfection. For the transfection 1µl of Lipofectamine was diluted in
49 µl Opti-MEM (Sigma Aldrich) and incubated for 5min at room temperature (RT). In
the meantime the Plasmid DNA was diluted in 50 µl Opti-MEM. Both Dillutions were
mixed in a 1:1 ration and incubated for 20min at RT. The transfection mixture was than
added to the the cells. 24 h post transfection a dual luciferase assay was performed. For
miR-152 over expression, 400 ng pCMV-miR-152 or pCMV-MS and 100 ng pDLP-UCP3
reporter plasmid were cotransfected using Lipofectamine 2000 as described above. For
the generation of RNA and protein samples the complete procedure was scaled up (2x)
to 12-well cell culture dishes.
4.2.2 Plasmid Construction
Bacterial strains:
Table 4.2: Bacterial strains used for molecular cloning and plasmid production.
Strain Genotype Company
E. coli TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15
∆lacX74 recA1 araD139 ∆(araleu)7697 galU galK
rpsL (StrR) endA1 nupG
NEB
pDLP (luciferase reporter system):
To generate luciferase reporter plasmids encoding the 3’UTR of UCP3 (ENST000003140
32.8), the 1131 bp long 3’UTR plus 98 nt endogenous context were PCR amplified using
oligonucleotides UCP3_3UTR_fwd and UCP3_3UTR_rev and HEK293 genomic DNA
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as a template. The PCR product was purified (QIAquick PCR Purification Kit, Qia-
gen) and digested using the restriction endonucleases NotI-HF (NEB) and HindIII-HF
(NEB) as recommended by the manufacturer. After column purification (QIAquick PCR
purification kit, QIAgen) the insert was introduced downstream of the firefly luciferase
open reading frame into the multiple cloning site of pDLP [202] using NotI and HindIII
restriction sites using T4 DNA Ligase (NEB). A 20 µl ligation reactions contained 25 ng
linearized plasmid DNA and a 5-fold molecular excess of the insert DNA, 1mM ATP,
2 µl T4 DNA Ligase buffer (10x, NEB) and 1µl T4 DNA Ligase (NEB). Ligation was
performed at 4°C over night. The 3’UTR deletion mutant (DEL) without the predicted
structurally conserved window was generated by a two-step overlap extension PCR [203].
To generate the fragments for overlap PCR the oligonucleotide pairs UCP3_3UTR_fwd
and UCP3_DEL_rev as well as UCP3_3UTR_rev and UCP3_DEL_fwd were used.
Oligonucleotide sequences are listed in Suppl. Tab. 5.7. All 100 nt long variants of the
UCP3 repressive element, other conserved CDEs or other Dynalign-predicted windows
were generated by hybridization of complementary oligonucleotides and phosphorylation
of restriction sites. E. coli TOP10 (NEB) were transformed with 10µl of the ligation
reaction and plated on lysogeny broth plates (LB; 1% tryptone, 0.5% yeast extratct, 1%
NaCl, 2% agar) suplemented with ampicillin (100 µg/ml, Roth). Colony forming units
(CFU) were analyzed for correct insert size by colony PCR. Positive tested CFUs were
inoculated in 4 [ml LB medium with ampicillin and incubated az 37°C over night with
agitation. Plasmid DNA was isolate using the QIAprep Spin Miniprep Kit (QIAgen)
according to the manufacturers instructions. Mutations, cloning boundaries and coding
sequences were verified by Sanger sequencing (Seqlab). All sequences are summarized
in Suppl. Tab. 5.2 and Suppl. Tab5.5.
pHDV (in vitro transcription):
For RNA synthesis, UCP3 wt, MUTI, MUTII, MUTI/II, R1, CDEImut, CDEIImut,
CDEI/IImut sequences together with the T7 promoter (5’-TAATACGACTCACTAT
AGG-3’) at the 5’ end and the HDV cleavage site (5’-GCCGG-3’) at the 3’ end, were
generated by hybridization of complementary oligonucleotides and phosphorylation of
complementary overhangs. The generated inserts were introduced into the EcoRI and
NcoI sites the pHDV plamid [204] using T4 DNA ligase (NEB) as described above. In
order to prepare plasmid DNA for in vitro transcription the QIAprep Spin Maxiprep Kit
(QIAgen) was used according to the manufacturers instructions. RNAs were transcribed
as HDV ribozyme fusions to obtain uniform 3’ ends. Mutations, cloning boundaries
and coding sequences were verified by Sanger sequencing (Seqlab). All sequences are
summarized in Suppl. Tab. 5.2.
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pCMV (miRNA expression):
For the overexpression of hsa-miR-152-5p, the genomic locus with 200 bp up- and down-
stream endogenous context was amplified using the oligonucleotides miR152_fwd and
miR152_fwd (Suppl. Tab. 5.2). After purification the PCR product was digested
using the restriction endonucleases XbaI (NEB) and XmaI (NEB). After purification of
the digetsion reaction the insert was cloned in the XbaI and XmaI sites of the pCMV-MS
plasmid [202] using T4 DNA Ligase (NEB) as above.
pDF_FRT (stable integration):
For generation of the integration plasmid pDF_FRT, eGFP and mCherry expressed from
a shared CMV enhancer/promoter element were amplified using the oligonucleotides
pDF_fwd and pDF_rev with pBI-CMV1 (Clontech) as a template. FRT-site, the hy-
gromycin B resistance, a pUC origin and an ampicillin resistance were amplified using
oligonucleotides pFRT_fwd and pFRT_ref (Suppl. Tab. 5.2) with pcDNA5/FRT
plasmid (Invitrogen) as a template. Oligonucleotide sequences are listed in Suppl. Tab.
5.7. Both PCR products were digested using NotI-HF (NEB) and NheI-HF (NEB) and
ligated using T4 DNA ligase, resulting in the pDF-FRT plasmid. Pasmid sequence was
verified by Sanger sequencing (Seqlab).
pDF_FRT_UCP3_wt and _MUTI/II were generated by hybridization of comple-
mentary oligonucleotides and and phosphorylation of restriction sites. 3’UTR inserts
were introduced downstream of eGFP ORF into the NotI and HindIII restriction sites
of pDF_FRT using T4 DAN Ligase (NEB) as described.
4.2.3 Hybridization and Phosphorylation of Oligonucleotides
To generate inserts <120 nt, complementary oligonucleotides were annealed. The oligonu-
cleotides were designed to form complementary overhangs for the direct use in ligation
reactions with restricted plasmid DNA. Initially 50µl containing 10µM of each olionu-
cleotide wera incubated for 10min at 95°C and then cooled to room temperature. In
the next step 5’ overhanging ends were phosphorylated using T4 polynucleotide kinase
(PNK, NEB). A 50 µl reaction contained 5µl annealed oligonucleotide, 5µl T4 DNA
Kinase buffer (10x, NEB), 2mM ATP and 2 µl T4 PNK. The reaction was incubated at
37°C for 30min. 1µl of the reaction was used for subsequent ligation. A 20µl ligation
reactions contained 25 ng linearized plasmid DNA, 1µl of phosphorylated insert, 1mM
ATP, 2 µl T4 DNA Ligase buffer (10x, NEB) and 1 µl T4 DNA Ligase (NEB). Ligation
was performed at 4°C over night. A ligation reaction without insert DNA served as a
control. On the next day, E. coli Top10 cells were transformed with 10 µl of the ligation
reaction. Sequences used are summarized in Suppl. Tab5.2 and Suppl. Tab5.5.
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4.2.4 Polymerase Chain Reaction (PCR)
For plasmids containing insert longer that 120 nt, inserts were amplified by PCR. For
molecular cloning 100 µl reactions were performed using Q5 DNA polymerase (NEB).
The reaction mix and PCR program is depicted in Tab. 4.3. For the purification
of PCR reactions the Qiaquick PCR purification kit (Qiagen) was used, according to
the manufacturers instructions. If necessary, PCR products were gel purified using the
Qiaquick gel elution kit (Qiagen).
Table 4.3: Standard reaction mix and PCR program using Q5 DNA polymerase
Reation mix PCR program
1x Q5 reaction buffer (NEB)
30 pmol forward oligonucleotide
30 pmol reverse oligonucleotide
100 ng template DNA
20 nmol dNTPs (Sigma-Aldrich)
1 µl Q5 polymerase
ad. 100 µl
Temperature Time Cycle
98°C 3min
98°C 30 s
50°C 30 s 35x
72°C 15 s/kb
72°C 7min
8°C ∞
Screening of colonies upon E. coli transformation for plasmids bearing DNA inserts
of the correct size, colony PCR was performed. For pDLP-based plasmids the oligonu-
cleotides luc2_3UTR_seq_fwd and luc2_seq_rev2 were used. For pCMV-based plas-
mids the oligonucleotides CMV_prom_fwd and SV40__polyA_rev. For pHDV-based
plasmids the oligonucleotides pHDV_seq_fwd and AP1_pSP61 were used. Oligonu-
cleotide sequences are listed in Suppl. Tab. 5.7. For colony PCR, a single colony was
resuspended in 50 µl H2O and 1 µl of that suspension used as template. The reaction
mix and PCR program of a colony PCR is depicted in Tab. 4.4. In order to determine
fragment size the reaction products were separated on 1 or 3% agarose gels and analyzed
with a UV transilluminator.
4.2.5 Genomic Integration
For generation of stable cell lines, for the constitutive expression of mCherry and GFP
with the UCP3 wt repressive element and the double mutant MUTI/II, the Flp-In Sys-
tem (Thermo Fisher Scientific) was used. Therefore, HeLa HF1-3 cells were seeded to a
density of 90000 cells in 12-well cell culture dish in growth medium without antibiotics.
24 h post seeding the cells were cotransfected with the pOG44 plasmid and the respective
pFRT construct in a molar ratio of 9:1 using Lipofectamine 2000 (Thermo Fisher Scien-
tific). A plasmid without FRT-site was cotransfected as negative control. 48 h post trans-
fection growth medium was changed to selection medium supplemented with 15 µg/ml
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Table 4.4: Reaction mix and PCR program used for colony PCR
Reaction mix PCR programm
1x ThermoPol buffer
7.5 pmol forward oligonucleotide
7.5 pmol reverse oligonucleotide
1µl cell suspension
5 nmol dNTPs
1.25U Taq polymerase
ad. 25 µl
Temperature Time Cycle
96°C 4min
96°C 30 s
50°C 30 s 25x
72°C 60 s/kb
72°C 7min
8°C ∞
hygromycin B. During the selection process, the selection medium was exchanged every
second or third day. After 2 weeks of selection no cells could be detected in the neg-
ative control. Successful integration of pFRT_UCP3wt and pFRT_UCP3_MUTI/II
was analyzed by flow cytometry.
4.2.6 Flow Cytometry
For the analysis of the generated HeLa HF1-3 cells lines stably expressing GFP-UCP3 wt
or MUTI/II fusions as well as the red fluorescent protein mCherry cells were seeded to a
initial density of 200,000 cells in a 12-well cell culture dish. On the following day growth
medium was discarded and the cells rinsed with PBS once. Cells were detached by
adding 200µl Trypsin-EDTA and incubation for 5min at 37°C. After Trypsin treatment
cells were diluted 1:1 with PBS and fluorescence at 510 nm and 610 nm was measured
with a Beckman Coulter Cytoflex S. Analysis of flow cytometry data was performed
with FlowJo (Version 10) software.
4.2.7 Luciferase Reporter Assay
To investigate the influence of different 3’UTR variants on luciferase activity a dual
luciferase assay was performed. Dual luciferase assay of HEK293 cells was performed
24 h after transient transfection with pDLP-based reporter plasmids (see 4.2.1) with
the Dual-Glo® Luciferase Assay System (Promega) according to the manufacturer’s
instructions. First the cultivation medium was discarded and 100 µl growth medium
without phenol red added to each well. For cell lysis, 100µl of the Dual Glo® Luciferase
reagent was pipetted to each well and incubated for 10min at RT. After that the 200µl
cell lysate was transferred to a white 96-well Nunc™MicroWell™ plate. Firefy luciferase
activity was quantified by measuring the luminescence on an Infinite®M200 plate reader
with an integration time of 1 s. Thereafter, 100 µl Dual Glo® Stop&Glo® reagent was
added to each well. The reactions were incubated for 10min before Renilla luciferase
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activity was determined by measuring luminescence one more time. For the calculation
of relative light units (RLU) the firefly luciferase values were first normalized to the
Renilla luciferase values. After that mean and standard deviation were calculate from
triplicates and normalized to the empty vector control.
4.2.8 RNA Extraction and Reverse Transcription
For total RNA extraction cells were first rinsed with 500 µl PBS. Then 400µl Trizol
was added to each well and the mixture was incubated for 5min at RT. Cell lysis was
accelerated by pipetting up and down several times. The Lysate was then transferred
to a 1.5ml reaction tube. Genomic DNA was separated by adding 80µl chloroform. For
efficient extraction, lysates were vortexed for 15 sec and then incubated for 3min at RT
prior to centrifugation for 15min at 13,000 rpm and 4°C. The RNA containing aqueous
phase was transferred into a fresh 1.5ml reaction tube and 200µl chloroform was added.
After vortexing for 15 sec samples were again centrifuged for 15min at 13,000 rpm and
4°C. Once again the aqueous phase was transferred into a fresh 1.5ml reaction tube.
For RNA precipitation, 200µl ice cold isopropanol and 0.75 µl Glycoblue (Ambion) were
added. After vigorous mixing samples were incubated for 10min and centrifuged for
30min at 13,000 rpm and 4°C. The supernatant was discarded and the pellet washed
with 180 µl 70% EtOH. This was followed by a further centrifugation for 10min at
13,000 rpm and 4°C. Then, the supernatant was discarded and the pellet was air dried
for 5min at RT. The pellet was then dissolved in 35 µl H2O. In order to eliminate DNA
contamination from RNA preparations, a DNase digestion was performed. Therefore,
4 µl 10× TurboDNase buffer and 1 µl TurboDNase were added to RNA samples and
incubated for 15min at 37°C. The reaction was incubated for 15 min at RT. For RNA
precipitation, 4 µl 3M sodium acetate (pH=6.5) was added and incubated for 1 h at
-20°C. The RNA pellet was rinsed with 70% (v/v) ethanol once and then air dried for
5min at RT. After isolation, 500 ng of RNA was quality checked on a 1% agarose gel.
For mRNA analysis, 1 µg total RNA was reverse transcribed to cDNA using MuLV
reverse transcriptase (Thermo Fisher Scientific) using random hexamer oligonucleotides.
Therefore, 1 µg total RNA was diluted in 10µl H2O and mixed with 30 µl reaction mix-
ture. The reaction mixture and the PCR program for the reverse transcription are
depicted in Tab. 4.5.
After reverse transcription, 160 µl H2O was added to the reaction, resulting in a final
cDNA concentration of 5 ng/µl.
For the detection of miRs reverse transcription with miR specific stem-loop oligonu-
cleotides was employed. Conventional PCR and qPCR methods require DNA matrices
with a length of ≥40 nt so that the specific forward and reverse oligonucleotides can
hybridize with the DNA matrices. In stem-loop PCR, reverse transcription is performed
with a special oligonucleotide (given in Suppl. Tab. 5.7) that artificially extends
the cDNA. The oligonucleotide consists of a stable stem-loop structure and the last
six complementary nucleotides from the 3’ end of the miR to be detected [140]. For
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Table 4.5: Reaction mix and PCR program for reverse transcription with MuLV and random hex-
amers
Reaction mix PCR program
8µl MgCl2 (25mM)
4µl 10 x transcription buffer
0,4µl dNTPs (100mM)
2µl random hexamers (0.2 ng/µl)
2µl RNase inhibitor Ribolock
2µl MuLV reverse Transcriptase
ad. 30 µl
Temperature Time
20°C 10min
42°C 15min
99°C 5min
4°C ∞
miR detection, 100 ng total RNA was transcribed into cDNA using Supersript II reverse
transcriptase. For normalization in subsequent qPCR experiments, the small nucleolar
RNA U48 was co-transcribed into cDNA. For the reaction, 4µl total RNA was mixed
with 6 µl of the reaction mix. The reaction mix and PCR program for stem-loop reverse
transcription is depicted in Tab. 4.6.
Table 4.6: Reaction mix and PCR program for reverse transcription with Superscript II and stem-
loop oligonucleotides
Reaction mix PCR program
1µl stem-loop oligonucleotide (mir-
X), 500 nM
1µl stem-loop oligonucleotide (U48),
500 nM
1µl DTT, 100mM
0.25µl dNTPs, 10 µM
0,25µl Superscript II reverse transcrip-
tase
2µl 5x First Strand PCR buffer
0.5µl H2O
6µl + 4µl RNA (25 ng/µl)
Temperature Time Cycle
60°C 30min
30°C 30 s
42°C 30 s 60x
50°C 60 s
70°C 15 s
8°C ∞
After the stem-loop PCR, 40µl H2O was added to the reaction resulting in a final
cDNA concentration of 2 ng/µl.
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4.2.9 Quantitative RT-PCR
All quantitative real-time PCR (qPCR) analysis were performed on a StepOnePlus™
Real-Time PCR System (Thermo Fischer Scientific). SYBR green intercalates into the
major grove of double-stranded DNA and fluoresces in the bound state. The increase
in amplification of the target cDNA was measured by the increase of fluorescence and
therefore allows to quantify the relative amount of a target RNA compared to a control.
For quantification of RNAs in HEK293, HeLa HF1-3 cells and HUVEC RPLP0 mRNA
was used for normalization. For C2C12 RNA GAPDH mRNA was used for normal-
ization. All oligonucleotides used in qPCR experiments are listed in Suppl. Tab.5.7.
First a master mix containing Fast SYBR green Master Mix (Thermo Fischer Scientific)
and a target specific oligonucleotide pair was prepared. 15µl of the master mix were
pipetted into a 96-well qPCR plate. After that cDNA was added. The plate was sealed
with an optical cover centrifuged shortly to mix cDNA and reaction mix. The reaction
mix and qPCR program used are depicted in Tab. 4.7. Each oligonucleotide pair was
tested to produce only the desired product by sequencing of the PCR product.
Table 4.7: qPCR reaction mix and PCR program for SYBR green based qPCR
Reaction mix PCR program
10µl SYBR Green Master Mix
5µl oligonucleotide mix (10µM each)
containg forward and
reverse oligonucletides
5µl cDNA (5 ng/µl)
Temperature Time Cycle
95°C 20 s
95°C 3 s
60°C 30 s 40x
95°C 15 s
60°C 1min
heat in 0.3°C steps to 95 °C
95°C 15 s
For the detection of miRs, TaqMan qPCR was performed. This method is based on a
probe, which carries a fluorescent dye and a quencher, that can bind specifically to the
target cDNA. Upon amplification the polymerase cleaves the probe and releases the dye
which results in a specific emission. The probe binding site was introduced via the stem
loop oligonucleotide in cDNA synthesis (see 4.6).The reaction mix and qPCR program
are depicted in Tab. 4.8. Oligonucleotides are given in Suppl. Tab.5.7.
4.2.10 mRNA Decay Assay
For mRNA decay experiments, 200,000 HF1-3 cells stably expressing either UCP3 wt
or UCP3 MUTI/II, were seeded in 12-well cell culture dishes. 24 h after seeding the
cells, the medium was changed to DMEM supplemented with 5µg/ml actinomycine D
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Table 4.8: Reaction mix and PCR program for TaqMan based qPCR of miRs
Reaction mix PCR program
1µl universal oligonucleotide (10µM)
1µl forward oligonucleotide (10µM)
1µl universal probe 21
10µl 2x TaqMan Fast Universal Master-
mix
2µl H2O
15µl + 5µl RNA (25 ng/µl)
Temperature Time Cycle
50°C 2min
95°C 10min
95°C 15 s
60°C 1min 40x
(Sigma) for 30min. After that medium as changed back to standard growth medium.
Cells were harvested after 0, 2, 4 and 6 h and total RNA was extracted using Trizol.
After reverse transcription, GFP mRNA levels were determined by SYBR green based
qPCR analysis (see 4.2.9 . For the determination of mRNA half-life, GFP mRNA
levels were normalized to RPL0 mRNA levels and plotted against time. mRNA half-
lives were calculated assuming a first order decay rate. MRNA half-live was calculated
by the equation:
Y = (Y0 − Plateau) ∗ e(−K+X)+Plateau (4.1)
4.2.11 Western Blot Analysis
For the preparation of whole cell protein lysates, cells were lysed in lysis buffer [137mM
NaCl, 10% glycerol, 20mM Tris-HCl pH 8.0, 2mM EDTA pH 8.0, 1% Igepal, 5µl pro-
tease inhibitor cocktail (Sigma) for 20min on ice. In order to separate soluble and
insoluble fraction, cell lysates were centrifuged for 15min with 17,000 g at 4°C. The
supernatant was transferred to a fresh 1.5mM reaction tube and protein content was
determined according to the Bradford method. For SDS-PAGE, the Mini-PROTEAN®
TGX Stain-Free™ anyKd gels (Bio-Rad) were used. 10µg of protein sample were mixed
with protein loading buffer (PAP) (12.5% glycerol, 1% SDS, 3.75% 2-Mercaptoethanol,
Bromophenol blue) and incubated for 10min at 95°C. SDS-PAGE was run at 180V in
1x Laemmli buffer. Prior to blotting, total lane protein was visualized as loading control
with the ChemiDoc Imaging System (Bio-Rad). Proteins were transferred onto PVDF
membranes (Bio-Rad) using the Trans-Blot® Turbo™ transfer system (Bio-Rad). West-
ernblot membranes were blocked with TBST containing 5% BSA (Applichem) overnight
at 4°C. On the next day westernblot membranes were incubated with the primary an-
tibody Roquin-1/-2 (Millipore 3F12) with agitation for 1 h at RT. Anti-Roquin was
diluted 1:1000 in TBST. Afterward membranes were washed 3x with TBST with agita-
tion for 5min. The secondary antibody Horseradish peroxidase-conjugated anti-rat IgG
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(Jackson Immunoresearch) was applied at a dillution of 1:10,000 in TBST for 1 h with
agitation. Blots were washed 3x as described above. Blots were developed with the ECL
select (Life technologies) reagent. Imaging was performed with the ChemiDoc Imaging
System.
4.2.12 In Vitro Transcription
For RNA affinity purification the UCP3 wt, MUTI, MUTII, MUTI/II and R1 RNAs were
synthesized by in vitro transcription. Likewise CDEImut, CDEIImut and CDEI/IImut
used in EMSA experiments were synthesized by in vitro transcription. To generate linear
DNA templates the corresponding pHDV constructs were digested with HindIII which
cleaves the pHDV plasmid directly 3’ to the HDV ribozyme. Linearized plasmid DNA
was purified by phenol extraction prior to in vitro transcription. Transcription was per-
formed overnight at 37°C. The reaction mix is depicted in Tab. 4.9. After transcription
1/2 V 0.5M EDTA pH 8.0 was added to the reaction. Then the RNA was precipitated
with ethanol. After precipitation, the RNA pellet was dissolved in formamide loading
buffer (Formamide, 0.25mM EDTA, Bromphenol Blue) and the reaction products were
separated on a 6% PAA gel. Bands were visualized by UV-shadowing. The band of inter-
est was was excised and the gel pieces transferred into a 50ml reaction tube. The RNA
was eluted with 10ml 300mM NaAc pH 6.5 at 4°C overnight wit continuous agitation.
On the next day, gel debris were separated by filtration, the RNA ethanol precipitated
and the pellet dissolved in an appropriate amount of H2O. The RNA concentration was
determined by Nanodrop.
Table 4.9: In vitro transcription reaction mix using T7 RNA ploymerase
Amount Component
200µg DNA template
80µl 25mM Mg(Ac)2
200µl 1M Tris-HCl pH8.0
20µl 1M DTT
10µl 200mM Spermidine
40µl each 100mM ATP, UTP, GTP,
CTP
5µl T7 RNA polymerase
ad. 1ml H2O
4.2.13 RNA Affinity Purification
For purification of UCP3 binding proteins, the purified RNA was biotinylated at the
5’-end in a three step reaction. First 600 pmol RNA were dephosphorylated using calf
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intestine phosphatase (CIP, Roche). The reaction mix is depicted in Tab. 4.10. The
reaction was incubated for 30min at 37°C.
Table 4.10: Reaction mix for the dephosphorylation of RNA using CIP
Amount Component
600 pmol RNA
1µl 10x CIP buffer
1µl CIP
ad. 10 µl H2O
In the second step γ-S-ATP (Biomol) was used to transfer an sulfhydroxyl group
to the dephosphorylated 5’ end of the RNA using T4 polynucleotid kinase (T4 PNK,
NEB). Necessary reaction compounds were added directly to the CIP reaction. The
phosphorylation was incubated for 30min at 37°C. The reaction mix is depicted in Tab.
4.11.
Table 4.11: Reaction mix for γ-S-ATP phosphorylation of RNA using PNK
Amount Component
10µl CIP RNA
0.2mM γ-S-ATP
2µl 10x T4 PNK buffer
2µl T4 PNK
ad. 20 µl H2O
In the last step 10µl Biotin-long-arm maleimide (Vector Laboratories) was added and
incubated for 30 min at 65°C. Unincorporated label was depleted by LiCl precipitation.
Therefore, 70µl H2O was added to the reaction mixture. Then, 12.5 µl 4M LiCl and
375 µl ethanol were added. After vigorous mixing samples were incubated for 1 h at
-80°C. Subsequently the precipitation mixture was centrifuged for 10min at 4°C. The
supernatant was discarded and the RNA pellet was rinsed with 500 µl 70% (v/v) ethanol
once. After subsequent centrifugation the pellet was air dried and dissolved in 20µl H2O.
The RNA concentration was determined by Nanodrop.
For affinity purification 100 µl Dynabeads M-280 (Invitrogen) were washed 5x with
1ml incubation buffer (10mM Tris-HCl pH 7.4, 150mM KCl, 0.5mM DTT, 0.05%
Igepal, 100U/ml Ribolock). HEK293 cell lysates were prepared as follows: Cells were
rinsed once with PBS before Trypsin-EDTA digestion at 37°C for 3min. The Reaction
was stopped by the addition of DMEM medium. Then, cells were transferred to a 50 and
centrifuged. The supernatant was discarded and the cells were resuspended in 150 µl
(per T75 culture flask) lysis buffer (10mM Tris-HCl pH 7.4, 150mM KCl, 0.5mM DTT,
81
4.2 Methods
0.5% Igepal, 100U/ml Ribolock). Subsequently, the cells were snap freezed in liquide
nitrogen and then incubated on ice for 20min. Then, the lysates were centrifuged for
10min at 13,000 rpm. The supernatant was transferred to a fresh reaction tube and the
protein concentration was determined according to the Bradford method. For biotin-
avidin based RNA affinity purification 200 pmol RNA was then conjugated to Dynabeads
M-280 (Invitrogen) in 500 µl incubation buffer for 2 h at 4°C with continuous rotation.
Then 1mg whole cell protein of HEK293 cells together with 200 µg yeast tRNA (Sigma
Aldrich) and 5mg Heparin (Sigma Aldrich) was added to the beads and incubated for
1 h at 4°C followed by 15min at room temperature with continuous rotation. Afterward
beads were washed 5x with 1ml incubation buffer, resuspended in 30µl PAP (see section
4.2.11), and boiled at 95°C for 10min. Eluted proteins were separated by SDS-PAGE
(BioRad).
4.2.14 Mass Spectrometry
Proteins from RNA affinity purification were analyzed by mass spectrometry as previ-
ously described in [37]. Analysis was performed by Hennig Urlaub and Uwe Plessman
(MPI für Biophysik, Göttingen). In contrast to the procedure described in [37] the pro-
tein samples were separated on a NuPAGE SDS-PAGE gel. After gel electrophoresis
the entire lanes were cut into 23 slices and further processed as described. The LC-MS
analyses were performed on a Q-Exactive Plus MS (Thermo Fisher Scientific) coupled to
an UltiMate 3000 HPLC (Thermo Fisher Scientific) under similar condition as described
except that LC separation time was 48min. The MS data was acquired by scanning the
precursors in mass range from 350 to 1600m/z at a resolution of 70,000 at m/z 200. The
top 20 precursor ions were chosen for MS2 by using data dependent acquisition (DDA)
mode at a resolution of 15,000 at m/z 200 with maximum IT of 50ms. The generated
data was then analyzed as previously described using Mascot (Version 2.3.02) as search
engine. Ions were searched against the against Uniprot database (Taxonomy human,
155190 entries, 20161124). The data was than evaluated with the Scaffold software
(Version 4.8.2). For further analysis a cut-off of at least five unique peptides detected
in at least one of the samples was used.
4.2.15 In-Line Probing Analysis
In-line probing was performed as previously described [205]. First,UCP3 wt RNA was
synthesized by in vitro transcription using T7 RNA polymerase (see section 4.2.12). In
the next step, UCP3 wt RNA was dephosphorylated using CIP (Roche). The reaction
mix is depicted in Tab. 4.12. The dephosphorylation reaction was incubated at 55°C
for 30min. After that, the reaction was incubated at 95°C for 10min to inactivate the
enzyme.
In the next step the RNA was 5’ radioactively labeled using PNK (Roche). The re-
action mix is depicted in Tab. 4.13. The phosphorylation reaction was incubated at
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Table 4.12: Reaction mix for the 5’ dephosphorylation using CIP
Amount Component
20 pmol RNA
15 µl H2O
2 µl 10 x CIP buffer (Roche)
1 µl CIP
37°C for 1 h. After that 20 µl 2x loading buffer (10M urea) was added to the sample
and the sample subjected to denaturing 6% PAA gel electrophoresis. Bands were visu-
alized by exposing the gel to X-ray film. Then, the RNA was excised and the gel slice
transferred to a fresh 1.5ml reaction tube. The 5’[γ-32P]-labeled RNA was recovered
by gel extraction with chrush/soak solution (200mM NaCl, 10mM Tris–HCl pH 7.5,
1mM EDTA) and subsequent ethanol precipitation. Radioactivity was quantified with
a liquid scintillation counter.
Table 4.13: Reaction mix for the [γ-32P]-ATP phosphorylation using PNK
Amount Component
10 µl dephosphorylated RNA
1 µl H2O
2 µl 10 x PNK Puffer
6 µl [γ-32P]-ATP
1 µl PNK
For in-line probing analysis of the 64 nt UCP3 wt RNA, 40 kcpm of the [γ-32P]-labeled
RNA were incubated at 22°C for 40 h in in-line reaction buffer (10mM Tris-HCl pH 8.3,
10mM MgCl2, 100mM KCl) in a 20µl reaction. To generate a size marker, the [γ-32P]-
labeled RNA was subjected to alkaline hydrolysis. Therefore the RNA was incubated in
50mM Na2CO3, pH 9.0 at 96°C for 3 min. To map guanines, the [γ-32P]-labeled RNA
was incubated for 3min at 55°C with 20U RNase T1 (Ambion). The reaction mixes for
the alkaline hydrolysis and RNase T1 treatment are depicted in Tab. 4.14. After in-line
reaction, alkaline hydrolysis or RNase T1 treatment, samples were precipitated with 60µl
acetone:ethanol (1:1), 2µl 3M sodium acetate and 1 µl Glycoblue (Life Technologies)
in liquid nitrogen. Pellets were rinsed with 70% ethanol once and dissolved in 55M
urea. The reaction products were then separated by denaturing 10% PAGE. After
electrophoresis, gels were dried on a vacuum slab gel drier at 80°C for at least 1 h.
Dried gels were exposed to a phosphor imaging screen over night and analyzed using
Phosphoimager FL-5000 (Fuji).
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Table 4.14: Reaction mix for alkaline hydrolysis and RNase T1 treatment
alkaline hydrolysis RNase T1 treatment
17µl H2O
40 kcpm [γ-32P]-RNA
2µl Na2CO3 (500mM,pH9.0,
10mM EDTA)
add. 20 µl H2O
2µl Na-Citrat 250mM (pH9.0)
40 kcpm [γ-32P]-RNA
2µl RNase T1 (10U/µl)
add. 15 µl 8M urea
4.2.16 Electrophoretic Mobility Shift Assay (EMSA)
Mouse Roquin-1 core ROQ domain and N-terminus protein fragments as well as the
corresponding K220A, K239A, R260A (AAA) mutants [59] were provided Dr. Adreas
Schlundt (Johann Wolfgang Goethe-Universität, Frankfurt). EMSAs were performed
as described in ([59]. UCP3 wt, CDEImut, CDEIImut and CDEI/IImut RNAs were
prepared by 5’ end labeling of 10 pmol in vitro transcribed RNA with [γ-32P]-ATP using
CIP (Roche) as described in section 4.2.15. Labeled RNA was purified from unincor-
porated nucleotides by ammonium acetate (Roth) precipitation. Therefore, 10 µl 7.5M
ammonium acetate and 80µl ethanol were added to the reaction mix. After vortexing
the reaction was incubated on ice for 10min and then cetrifuged at RT and 17,000 g
for 10min. The supernatant was discarded and the pellet rinsed twice with 70% (v/v)
ethanol. The RNA pellet was air dried for 5min and resolved in 50 µl H2O. Radioac-
tivity was quantified with a liquid scintillation counter. Prior to binding reactions a
mastermix containing RNA (40 kcpm per 20 µl reaction), 2.5 µg/µl yeast tRNA (Sigma
Aldrich), 20mM HEPES pH 7.4, 50mM NaCl, 1mM MgCl2, 1mM DTT and 1 µg/µl
BSA was prepared. A dilution series of 10x protein stocks was prepared with the same
buffer components. For each binding reaction, 5 µl of the 10x protein stock was added
to 15µl of the mastermix. The binding reactions were incubated for 20min at RT. After
addition of 4µl 30% (v/v) glycerol as loading buffer, the RNP complexes were resolved
by non-denaturating PAGE (6% polyacrylamide, 5% glycerol, and 0.5x TBE) at 120V
for 40min at RT. Subsequently gels were dried at 80°C for 30min on a vacuum gel
drier and then exposed to a phosphor imager screen. For data analysis the fraction of
Roquin-bound RNA was plotted against the corresponding Roquin concentration. Using
Graphpad Prism software, a curve with the following equation
y = Bmax × X
h
KhD +Xh
(4.2)
was fitted to the data points, where Bmax is the maximum specific binding, KD the
dissociation constant, and h the Hill coefficient.
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4.2.17 siRNA-mediated Depletion of Roquin Proteins
100,000 HEK293 or 200,000 HF1-3 cells were reverse transfected in a 12-well cell cul-
ture dish with either siCTRL or siROQ1/2 mix at a final concentration of 100 nM using
Lipofectamine RNAiMAX (Thermo Fischer Scientific) and OptiMEM (Sigma Aldrich)
according to the manufacturer’s instructions. RNA and protein samples were prepared
48 h post transfection. To investigate the influence of Roquin knockdown on luciferase
activity, a transient transfection of the reporter plasmid was performed 24 h after re-
verse transfection of siRNAs. For knockdown of Roquin proteins in HUVEC 350,000
HUVECs were seeded in 60mm cell culture dishes. 24 h after seeding, cells were forward
transfected with either siCTRL or siROQ1/2 mix at a final concentration of 100 nM
using Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to the manufac-
turers instructions. RNA and protein samples were prepared 48 h post transfection. For
knockdown of Roquin proteins in C2C12 cells, 50,000 cells were reverse transfected in
a 12-well cell culture dish with 100 nM siCTRL or mmsiROQ1/2 mix. 48 h post trans-
fection cells had reached 90-100% confluency. To induce differentiation the medium was
switched to a culture medium containing 2% horse serum. After 24 h of differentiation
RNA and protein samples were prepared. All siRNAs used in this study were synthe-
sized by Sigma-Aldrich and correspond to the sequences (sense strand) given in Tab.
4.15.
Table 4.15: siRNAs used in this study
Name Target Sequence
siCRTL control 5’-UUCUCCGAACGUGUCACGU[dT][dT]-3’
siROQ1 human Roquin-1 5’-CCAAGAAAUGUGUAGAAGA[dT][dT]-3’
siROQ2 human Roquin-2 5’-UCUUCUACACAUUUCUUGG[dT][dT]-3’
mmsiROQ1 mouse Roquin-1 5’-CGCACAGTTACAGAGCTCA[dT][dT]-3’
mmsiROQ2 mouse Roquin-2 5’-GGACTTGGCTCATAAATCA[dT][dT]-3’
4.2.18 Computational Methods
All bioinformatic analyses were carried out by Dave Mathews (Rochester University,
New York, USA) and coworkers. The methods are as described in [113].
Search for conserved structures using Dynalign
For the bioinformatic prediction of structurally conserved RNA elements human UTR se-
quences (hg18) were downloaded from the UCSC genome browser (http://hgdownload.
soe.ucsc.edu/downloads.html#human). Next the acquired UTRs were fragmented into
overlapping windows of 100 nt with a step size of 50 nt. Then, the corresponding mouse
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sequences were identified using the human-mouse pairwise genomic alignment obtained
from UCSC genome browser (http://hgdownload.soe.ucsc.edu/goldenPath/hg18/
vsMm9/). Each pair of 100 nt long human and mouse sequences was input to the Dy-
nalign algorithm for RNA structure prediction [206]. To evaluate the results by their
probability of being a conserved structure Dynalign/SVMz was used [135].
"First, a measurement of the significance of the calculated free energy changes, z-
score, was calculated as compared to shuﬄed sequences [122]. The z-score, the number
of standard deviations from the mean, is calculated as:
z = m− µ
σ
(4.3)
where m is the predicted minimum free energy change of the input, µ and σ is the mean
and the standard deviation of free energy changes of the shuﬄed sequences. Second, the
Structure Conservation Index (SCI) was calculated (4):
SCI =
∆G0dynalign
∆G0seq1 −∆G0seq2
(4.4)
where ∆G°dynalign is the Dynalign predicted total minimum free energy change of the
two sequences and ∆G°seq1 and ∆G°seq2 are the predicted minimum free energy change
for each sequence alone [116]. The SCI is an indicator of structural conservation. The
larger the SCI, the more conserved the secondary structures are. Using the stability z-
score and the SCI, with the nucleotide composition of the two input sequences a support
vector machine, called SVMz, was trained to classify the probability that a window is a
conserved structure. The windows of sequence pairs were ranked by their probability of
being a conserved structure and the windows with a probability greater than 0.9 were
further analyzed." [113]
Prediction of human CDEs and their folding probability
"The whole human genome sequence (hg19) was downloaded from UCSC and the se-
quence was processed to 3’UTRs using bam2x (https://github.com/nimezhu/bam2x).
RNAmotif, which takes an RNA descriptor, an RNA sequence file and outputs the posi-
tions where the RNA motif is found [207], was run to find genes that contain the desired
motif. The motif is an RNA stem-loop, which has a stem length of 6-8 bp and a triloop
with sequence 5’-YRN-3’. Then, rm2ct from the RNAmotif program was used to con-
vert an output file to a ct file, which indicates the sequence and base pairing. The efn2
program from RNAstructure [208], which takes a ct file and calculates the folding free
energy change , was run and the equilibrium constant for the interior part of the desired
motif is calculated using the following equation:
K interior = e−
∆G037
RT (4.5)
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here, R is the gas constant and T is the absolute temperature in K.
The probability of a certain motif occurring in a given RNA sequence is as follows:
Pmotif = K interior ∗Qexterior/Q (4.6)
here, Q_exterior is the partition function over configurations outside the motif and Q
is the total partition function [151].
In order to calculate the exterior probability, a C++ program called ProbStemloop,
was written using RNAstructure. ProbStemloop takes three input parameters: the se-
quence file, the starting position of a stem-loop, the length of the stem-loop and outputs
the exterior probability for the motif. The sequences processed by the ProbStemloop
were truncated to 400 nt up- and downstream. Prior work demonstrated this much se-
quence is a sufficient representation of the local folding in mRNA [150]. Finally, the prob-
ability of motif is calculated with equation 4.6. All the code, written in python and C++,
is available at https://github.com/hongyingsun1101/Motif-Probability. Similarly,
stem-loops containing a hexaloop were searched across the human genome and the prob-
ability of this hexaloop containing stem-loops was also calculated. The motif is an RNA
stem-loop which has a stem with a length of 6-8 bp and a hexaloop with the sequence
5’-GUUYUA-3’." [113]
Evolutionary conservation of putative CDEs and ADEs
"The RefSeq genomic coordinates and sequences for mRNA 3’UTRs containing predicted
CDEs were obtained from UCSC Table browser [209] using the hg19/GRCh37 reference
genome. Because of occasional inconsistencies in UCSC and NCBI RefSeq genomic coor-
dinates for 3’UTRs, UCSC nucleotide sequences were scanned to identify the respective
CDE and genomic coordinates of the CDEs were adjusted as needed. Multiz 46-way
[210] multiple species alignments across each chromosome were obtained from UCSC
golden path database (updated 30-Oct-2009). For each instance of the CDE motif, we
determined conservation using multiple sequence alignments that fully span the length
of the motif. We checked for exact sequence conservation of each hg19 CDE across Mus
musculus (mm9, July 2007), Pan troglodytes (panTro2, Mar 2006), Bos taurus (bosTau4,
Aug 2006), and Canis familiaris (canFam2, May 2005). In the cases where there are
gaps at the 5’ or 3’ end of a CDE in any of the species, the nucleotides 5’ or 3’ to the
gap, respectively, were used to fill in the gap. In addition, we checked for conservation
across the five species allowing tolerated changes. Tolerated changes were defined as
any of the following: (a) changes in the triloop that still fit the definition of the motif
(5’-stem-YRN-stem-3’), (b) changes to the length of the stem such that only 6 base pairs
are required to be conserved, and changes to the stem that can still form canonical base
pairs. These could be (c) compensating base pair changes, or (d) G◦U wobble base
pairs."[113]
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The following abbreviations were used in this thesis:
Table 4.16
Abbreviation Full word
A adenine
actD actinomycin D
ADP Adenosindiphosphate
ARE AU-rich elemet
ARE-BP AU-rich element binding protein
AS aternative splicing
ATP adenosintriphosphate
AUF1 AU-rich binding factor
BP branch point
bp base pair(s)
C Cytosine
CBC cap binding complex
CDE constitutive decay element
CDS coding sequence
cDNA complementary/copy DNA
cpm counts per minute
CPSF6 cleavge and plolyadenylation specific factor 6
DANN desoxy ribonucleic acid
DHX DEAD bos helicase domain
DHX DED box helicase
DMEM Dulbecco modified eagle medium
dNTP desoxy-nucleotidtriphosphate
dsRNA double stranded RNA
EIF4E translation initiation factor 4E
Exp5 Exportin
FMRP fragile X mental retardation protein 1
G Guanine
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GFP green fluorescent protein
hnRNP heterogenous ribonucleoprotein
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Abbreviation Full word
HuR human antigen R
ICOS inducible T cell co-stimulator
IDD intrinsically disordered domain
IRE Iron-responsive elemet
IRES internal ribosomal entry site
IRP IRE binding protein
kDa kilo Dalton
KH K-homology domain
KSRP K-homology splicing regulatory protein
miR micro RNA
mRNA messenger RNA
mRNP messenger ribonucleoprotein particle
nc non coding
ncRNA non coding RNA
NGD no-go decay
NMD nonsense-mediated decay
NMR nuclear megnetic resonance
NSD non-stop decay
nt nucleotide(s)
OH Hydroxyl
PABP poly(A) binding protein
PAGE Polyacrylamide gel electrophoresis
PAN poly(A)-specific ribonuclease subunit
PARN poly(A)-specific ribonuclease
P-body processing body
PCR polymerase chain reaction
piRNA Piwi -imteracting RNA
pri primary
PTC pre-mature stop codon
PTR post transcriptional regulation
qPCR quantitative PCR
R Purine
RBD RNA binding domain
RBP RNA binding protein
RING really interesting new gene
RISC RNA induced silencing complex
RLU relative light units
RNA ribonucleic acid
RNase ribonuclease
RPLP0 ribosomal protein lateral stalk subunit P0
RRM RBA recognition motif
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Abbreviation Full word
RT reverse transcription
RT-qPCR reverse transcriptase qPCR
SECIS seleno cycsteine insertion element
SELEX systematic evolution of ligands by exponential enrich-
ment
siRNA small interfering RNA
SMD Staufen-mediated decay
snRNP small nucleolar ribonucleoprotein
SR serin/arginie
SS splice site
TIA-1 T cell intracellular antigen-1
TIAR TIA-realted
TNF tumor necrosis factor a
TTP tristetraprolin
U Uracil
UCP3 uncoupling protein 3
uORF upstream open reading frame
UTR untranslated region
UV ultra violet
wt wilde type
Xrn1 5’-3’ Exoribonuclease 1
Y Pyrimidine
ZnF zinc finger domain
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5 Supplemental Data
5.1 Supplementary Figures
Figure 5.1: Schematic map of the pDLP plasmid. The plasmid contains the CDS of the β-
lactamase (AmpR), firefly luciferase (luc2) and Renilla luciferase (hRluc) expressed
from a CMV promoter (Minimal CMV Promoter 1/2) and a shared enhancer element
(Enhancer). Additional features:, origin of replication (pUC origin), destabilization
sequence from the mouse ornithine decarboxylase (hPEST). Recognition sites for the
restriction endonuleases NotI and HindIII are indicated.
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Figure 5.2: Schematic map of the pCMV-MS plasmid. The plasmid contains the CDS of the
β-lactamase (AmpR) for ampillicin resistance and a CMV promoter for expression of
downstream sequences. Recognition sites for the restriction endonuleases XhoI and
XbaI are indicated.
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Figure 5.3: Schematic map of the pDF_FRT plasmid. The plasmid contains the CDS of the
β-lactamase (AmpR), hygromycin resistance gene (Hygro(R)), enhanced GFP (eGFP)
and mCHerry expressed from a CMV promoter (Minimal CMV Promoter 1/2) and a
shared enhancer element (Enhancer). Additional features: origin of replication (pUC
origin). Recognition sites for the restriction endonuleases NotI and HindIII are indi-
cated.
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Figure 5.4: Schematic map of the pHDV plasmid. The plasmid contains the CDS of the β-
lactamase (AmpR) for ampillicin resistance and the sequence of the HDV ribozym.
Additional features: origin of replication (pUC origin). Recognition sites for the re-
striction endonuleases EcoRI, NcoI and HindIII are indicated.
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Figure 5.5: Conservation of the CDEs in UCP3 across mammals. CDEI and CDEII are high-
lighted in blue and red, respectively. Mutations within CDEs relative to the human
sequence are indicated in black/bold. Adopted and modified from [113].
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Figure 5.6: In-line probing of the predicted structurally conserved UCP3 element. In-line
probing analysis of the 100 nt stucurally conserved elements in the UCP3 3’UTR. The
RNA was subjected to cleavage by RNase T1 or alkaline hydrolysis, or incubated for the
indicated time points at room temperature and pH8.3 (in-line) prior to Urea PAGE.
Red bars indicate CDEI.
Figure 5.7: Gene regulation is independent of the high AU content of the UCP3 wt ele-
ment. Luciferase activity of randomized sequences with the same nucleotide compo-
sition (R1-R5) as the UCP3 wt element and one randomized sequence with uniform
nucleotide content (64 nt). Firefly luciferase activity was normalized to Renilla lu-
ciferase as internal transfection control. Values are normalized to an empty vector
control. n = 3. (**) P-value <0.01. Adopted from [113].
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Figure 5.8: Identification of proteins associated with the UCP3 wt element. Analysis of
protein binding to the UCP3 RNAs shown in (Tab. 2.1) and a randomized control
with the same nucleotide composition (R1). For RNA affinity purification HEK293
whole cell lysates were incubated with the different UCP3 RNAs. Associated proteins
were visualized by SDS-PAGE. M = protein size marker. Adopted and modified from
[113].
Figure 5.9: Roquin mediates repression by the UCP3 wt element. (A) Western Blot of
Roquin-1 and Roquin-2 after siRNA-mediated knockdown in HeLa cells stably ex-
pressing a GFP mRNA containing the UCP3 wt element. Anti-Roquin was used to
verify the respective knockdown. Total lane protein is shown as loading control. n =
3. (B) GFP fluorescence of UCP3 wt with and without siRNA-mediated knockdown
of Roquin-1 and Roquin-2. GFP fluorescence was measured by flow cytometry. n =
3. Adopted and modified from [113].
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Figure 5.10: Secondary structure prediction of UCP3 RNAs used for Roquin binding ex-
periments. Secondary structure of UCP3 constructs used for EMSAs with recom-
binant Roquin-1 protein predicted by RNAstructure v6.0.1 (https://rna.urmc.
rochester.edu/RNAstructureWeb). Adopted and modified from [113].
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Figure 5.11: Non-canonical closing pairs reduce luciferase expression. (A) Overview of UCP3
mutants. (B) Luciferase activity of UCP3 mutants. Firefly luciferase activity was
normalized to Renilla luciferase as internal transfection control. Values are normalized
to an empty vector control, without UCP3 3’UTR sequences. n = 3. (**) P-value
< 0.01. (*) P-value < 0.05. Adopted and modified from [113].
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5.2 Supplementary Tables
Table 5.1: Conserved 3’UTR structures predicted by Dynalign and tested for functionality in vivo.
Adopted and modified from [113].
Gene symbol Chromosome loca-
tion
Sequence 5’→3’
ADM chr11:10306992-
10307091
GTGTCACCCCACCAGGGCGCAAGCCTCACTATTACTT
GAACTTTCCAAAACCTAAAGAGGAAAAGTGCAATGC
GTGTTGTACATACAGAGGTAACTATCA
BCL2L1 chr20:31665060-
31665159
CCCCAGAGCTGTTTATGGCCTCAGCTGCCTCACTTCC
TACAAGAGCAGCCTGTGGCATCTTTGCCTTGGGCTG
CTCCTCATGGTGGGTTCAGGGGACTCA
CTBP1 chr4:1211900-1211999 CATGAACGTTCTTGTCTGTGTACAGTTTTTAGAACAT
TACAAAGGATCTGTTTGCTTAGCTGTCAACAAAAAG
AAAACCTGAAGGAGCATTTGGAAGTCA
EGLN3 chr14:33925414-
33925513
AAATGGAGGTGGTAGATGCCACAGAGAGGCATCACG
GAAGCCTTAACAGCAGGAAACAGAGAAATTTGTGTC
ATCTGAACAATTTCCAGATGTTCTTAAT
ELK3 chr12:96267231-
96267330
CCCACGGGCTAGTTTACCTGTGTCGTGAGAAGGACA
TTGTGAAACTCTTGTTAATTTGGTTTGCACTTTTCAT
AACATGGATAGTCTAGATTTATGTTAG
EMX1 chr2:72934005-72934104 GGCCCCTGCGTGGGCCCAAGCTGGACTCTGGCCACT
CCCTGGCCAGGCTTTGGGGAGGCCTGGAGTCATGGC
CCCACAGGGCTTGAAGCCCGGGGCCGCC
HIRA chr22:19330849-
19330948
ATTGAATTTCCTTTGGCCGATAATCAGGATTTCCCTA
TAAGTCACTTGGACATTGGTCACTTGTAGGAAATTT
AAACTCTAATTATGACAGCTACACTGA
HMOX1 chr22:35393699-
35393798
GAAGGCTTTCAGGGCCTCCAGCCCTCTCACTGTGTC
CCTCTCTCTGGAAAGGAGGAAGGAGCCTATGGCATC
TTCCCCAACGAAAAGCACATCCAGGCAA
HOXC9 chr12:54002875-
54002974
TTTAGAGTTAGTTCTACCCAGCGAGGAGGAGGCGGG
GAGAGAAACTGCGTTCTCTTTCCCCAGCGCAACCGA
AATAAATGACACATACAAATGTGATTTT
MYF6 chr12:80709011-
80709110
CCTTCCTGGCCTAATCCTTTAGATTAGGTCACATTAC
ATTAACATTTAGGAACCCAGACCGAAAAGTTGCTGA
AAGGGAAGGAGACACATTCACAAAGAA
NR4A2 chr2:156325469-
156325568
TTTATACCACTGTATTGTGTGTAGTCCATGTTCTAAA
TCCAGGATGCCCCGGAGCCAAAATGCCCTTTCAGGT
TCTGCCTGCAGGTTAGGAAATAGCAAC
PDE5A chr4:119498128-
119498227
GAATGTTTGGAATCTTTCCTTTTTCAAAAGTAGGTT
AGGAGCAAATTATCATACATTCTGTGACATTTAAAG
CCTTTATAGGATAGTGAAAAATGCTGGC
RBPJ chr4:26431008-26431107 CTACCGTCTTTTTGCTAGGACTTAAACTGACTTGAGT
GTGGCAAAAAGTTAACAAAAAAGGAGAAAAAATGAA
CAATCGTTTGTGGTTTCTTGGGAAAAC
SIX2 chr2:45005909-45006008 GTTCTTGTTTGGGATTTATTTTCAACAAGTTACTTTT
AGGATCCTTTTGGGGCTGGAGACTGAGTCTTGAACC
ACAGAAGGGAATAAATTATACACCACT
TFDP1 chr13:113641068-
113641167
TGTTTACATACTTATAAGTCTATCATTTAAAGACATG
TACTGAAACAAATGTATTTGTTTCATAAGCATCTTCC
TGTAATCTATTATAAAATTGAAATTA
TGFBR1 chr9:99153356-99153455 TATTGTATTTGTGCAGGATTCTTTAGGCTTTATCAGT
GTAATCTCTGCCTTTTAAGATATGTACAGAAAATGT
CCATATAAATTTCCATTGAAGTCGAAT
THBS1 chr15:39595970-
39596069
ATGTAAATAGGCACTTAAATAGAAGCAGGAAAGGGA
GACAAAGACTGGCTTCTGGACTTCCTCCCTGATCCCC
ACCCTTACTCATCACCTGCAGTGGCCA
TLX3 chr5:171311950-
171312049
TTTTTTCTTTAGAAACCGGCCACCTGCTTCCCCCGCG
GGGGCCGCTGGAGGAAGGGCAGCCGACCCGGCCGCT
GGGGGAAGTGCCAGGGGCCCGGGGCAC
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Gene symbol Chromosome loca-
tion
Sequence 5’→3’
UBE2B chr5:134390754-
134390853
TGTTAAAATACATAACTTCAGTGCAAGAGACTTTGT
CACTTATTTCCTTATGTGTGTAGGAGGGGTTAATAA
GTCTCTAGCTCTCCATCTATTGATAGTT
UCP3 chr11:74001139-
74001238
CTGCCATGCCTCAAGAACACCTTTGTTTTGCACTGAC
AAGATGGAAAATAAATTATATTAATTTTTGAAACCC
ATTAGGCATGCCTAATATTTAGGCAAG
Table 5.2: UCP3 tandem CDE sequences and corresponding RLUs. Adopted and modified from
[113].
Construct Sequence 5’→3’ RLU
window CTGCCATGCCTCAAGAACACCTTTGTTTTGCACTGACAAGATGGAAAATAAATT
ATATTAATTTTTGAAACCCATTAGGCATGCCTAATATTTAGGCAAG
33.2
miRmut CTGCCATGCCTCAAGAACACCTTTGTTT--------CAAGATGGAAAATAAATTATATT
AATTTTTGAAACCCATTAGGCATGCCTAATATTTAGGCAAG
36.5
del1 ---------------------TTTGTTTTGCACTGACAAGATGGAAAATAAATTATATTAATTTTT
GAAACCCATTAGGCATGCCTAATATTTAGGCAAG
32.9
1-7 ACCTCGTGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
34.2
8-14 TCCCCGCAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATATTTAGGC
AAG
55.3
15-21 CAAGATGGAAAATACCGGCGCTTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
60.0
22-28 CAAGATGGAAAATAAATTATAGGCCGGGTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
66.6
29-35 CAAGATGGAAAATAAATTATATTAATTTGGTCCCACCATTAGGCATGCCTAATA
TTTAGGCAAG
29.9
36-42 CAAGATGGAAAATAAATTATATTAATTTTTGAAACAACGGCTGCATGCCTAATA
TTTAGGCAAG
40.8
43-49 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGTACGTAATAATA
TTTAGGCAAG
75.1
50-56 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCGCCGC
GGTAGGCAAG
78.8
57-64 GAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTGCTTACCT
80.0
MUTI CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
GGGAGGCAAG
60.1
MUTII CAAGATGGAAAATACCGGCGCTTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
73.3
MUTI/II CAAGATGGAAAATACCGGCGCTTAATTTTTGAAACCCATTAGGCATGCCTAATA
GGGAGGCAAG
98.6
CDEImut CAAGATGGAAAATAAATTATATAAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
66.9
CDEIImut CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTACTA
TTTAGGCAAG
72.8
CDEI/IImut CAAGATGGAAAATAAATTATATAAATTTTTGAAACCCATTAGGCATGCCTACTA
TTTAGGCAAG
88.5
M1 CAAGATGGAAAATAAATTTTATAAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
37.4
M2 CAAGATGGAAAATAAATTGTATCAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
33.4
M3 CAAGATGGAAAATAAATTCTATGAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
38.6
M4 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTATTA
TATAGGCAAG
40.9
M5 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTACTA
TGTAGGCAAG
35.2
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Construct Sequence 5’→3’ RLU
M6 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAGTA
TCTAGGCAAG
34.2
M7 CAAGATGGAAAATAAATTGTATCAATTTTTGAAACCCATTAGGCATGCCTAGTA
TCTAGGCAAG
36.6
M8 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAGTA
TUTAGGCAAG
57.3
M9 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAUTA
TGTAGGCAAG
55.8
M10 CAAGATGGAAAATAACTTATATTAAGTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
32.2
M11 CAAGATGGAAGATACATTGTATCAATGTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
34.4
M12 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCGTAATA
TTTACGCAAG
33.1
M13 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCTTAATA
TTTAAGCAAG
33.3
M14 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTTATA
TTAAGGCAAG
32.5
M15 CAAGATGGAAAATAAATTACATTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
41.2
M16 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAACA
TTTAGGCAAG
41.0
M17 CAAGATGGAAAATAAATTACATTAATTTTTGAAACCCATTAGGCATGCCTAACA
TTTAGGCAAG
46.3
M18 CAAGATGGAAAATAAATTATGTTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
46.8
M19 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATG
TTTAGGCAAG
51.4
M20 CAAGATGGAAAATAAATTATGTTAATTTTTGAAACCCATTAGGCATGCCTAATG
TTTAGGCAAG
61.5
M21 CAAGATGGAAAATAAATTATACTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
50.6
M22 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
CTTAGGCAAG
52.1
M23 CAAGATGGAAAATAAATTATACTAATTTTTGAAACCCATTAGGCATGCCTAATA
CTTAGGCAAG
73.7
M24 CAAGATGGAAAATAAATTATAATAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
54.0
M25 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
ATTAGGCAAG
45.6
M26 CAAGATGGAAAATAAATTATAATAATTTTTGAAACCCATTAGGCATGCCTAATA
ATTAGGCAAG
75.2
M27 CAAGATGGAAAATAAATTATAGTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
51.3
M28 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
GTTAGGCAAG
49.9
M29 CAAGATGGAAAATAAATTATAGTAATTTTTGAAACCCATTAGGCATGCCTAATA
GTTAGGCAAG
80.3
M30 CAAGATGGAAAATCAATTATATTAATTTTTGAAACCCATTAGGCATGCCTAATA
TTTAGGCAAG
50.2
M31 CAAGATGGAAAATAAATTATATTAATTTTTGAAACCCATTAGGCATCCCTAATA
TTTAGGCAAG
73.1
M32 CAAGATGGAAAATCAATTATATTAATTTTTGAAACCCATTAGGCATCCCTAATA
TTTAGGCAAG
90.4
R1 ATGAATGTACACTTATAGAAGAATTATGTAGGCTTACTGAACAATACATTAATC
TGATGATAAC
70.5
R2 TAAAGAAGACTATAAAAGCGTGAAATATAAGTAGTTTACTCTACCTCAGGAATT
ATTTCTTGAA
72.3
R3 TTCGCGATAAAAGAACAGAGAACTAATAGGCATCATAAATTTGATCATGATATA
ATTTTAGTTC
93.2
R4 GACGTCTAGACAGCTAAAAAGCGATATTAAAAATGTAGCTTTAAGCTAATTTTA
TATCAATGAT
91.3
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Construct Sequence 5’→3’ RLU
R5 GGTGATAATAAAGAATACTTTATCATAACACAGTTTTAGAAGTTTATCGCCGAT
TGACAAAAAT
85.0
64 nt GCAAGTGTCCTTCGGTTATCTACGATCTTGACGCAGGCCACTTATGTGTGGGTG
CCTACCCCCT
97.2
Table 5.3: Cycle thresholds of miRNAs predicted to bind to the UCP3 element. Adopted and
modified from [113].
hsa-miR- HEK293 Hela
148a 37.4 36.3
148b 36.8 35.9
152 36.9 35.8
130a n.d. n.d.
130b 36.6 36.4
301a n.d. n.d.
301b n.d. n.d.
Table 5.4: High confidence CDEs. Adopted and modified from [113].
Symbol RefSeqID chr start end
ABCC5 NM_005688 chr3 183638714 183638730
ABHD6 NM_020676 chr3 58280355 58280369
ADAMTS15 NM_139055 chr11 130346460 130346474
ADCY5 NM_001199642 chr3 123001187 123001203
ADGRL2 NM_012302 chr1 82457201 82457215
ADRB1 NM_000684 chr10 115806068 115806082
AGGF1 NM_018046 chr5 76359647 76359661
AKAP10 NM_007202 chr17 19808171 19808187
ANGPTL4 NM_001039667 chr19 8439095 8439111
ARID1B NM_017519 chr6 157530819 157530833
ARL8B NM_018184 chr3 5221752 5221766
ARRDC4 NM_183376 chr15 98517021 98517035
ASH1L NM_018489 chr1 155305857 155305873
ATXN1 NM_000332 chr6 16305397 16305413
ATXN3 NM_001127696 chr14 92527915 92527931
BCAN NM_198427 chr1 156623183 156623197
BMP2K NM_017593 chr4 79800482 79800496
BMPR1A NM_004329 chr10 88683813 88683827
BTAF1 NM_003972 chr10 93788736 93788750
CAMTA1 NM_015215 chr1 7827722 7827736
CASD1 NM_022900 chr7 94186130 94186144
CBL NM_005188 chr11 119170704 119170718
CCDC117 NM_173510 chr22 29184052 29184066
CCDC47 NM_020198 chr17 61823129 61823145
CCNB1 NM_031966 chr5 68473499 68473513
CD47 NM_198793 chr3 107764478 107764494
CHL1 NM_001253387 chr3 448291 448305
CLK3 NM_001130028 chr15 74922413 74922427
CNOT2 NM_001199302 chr12 70748435 70748449
CNTN3 NM_020872 chr3 74311829 74311845
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Symbol RefSeqID chr start end
CPEB4 NM_030627 chr5 173386101 173386115
CRISPLD2 NM_031476 chr16 84942917 84942931
CSF3 NM_000759 chr17 38173562 38173576
CTDSPL2 NM_016396 chr15 44816836 44816850
CTLA4 NM_005214 chr2 204738615 204738629
CYP1B1 NM_000104 chr2 38295065 38295081
CYR61 NM_001554 chr1 86049170 86049184
DCAF12 NM_015397 chr9 34087944 34087960
DCUN1D1 NM_020640 chr3 182660750 182660766
DDIT4 NM_019058 chr10 74035725 74035739
DDX42 NM_007372 chr17 61896655 61896669
DPY19L1 NM_015283 chr7 34970958 34970974
DSC1 NM_024421 chr18 28710394 28710410
DSCAML1 NM_020693 chr11 117298521 117298537
EFCAB14 NM_014774 chr1 47143920 47143936
EFNA4 NM_182689 chr1 155041915 155041929
EIF3J NM_003758 chr15 44854207 44854221
EPB41L1 NM_001258329 chr20 34818199 34818213
EPC1 NM_001272004 chr10 32556834 32556852
EPHB1 NM_004441 chr3 134978556 134978570
EPHB3 NM_004443 chr3 184299594 184299608
ESR1 NM_000125 chr6 152424378 152424392
ETAA1 NM_019002 chr2 67637244 67637258
FAM13B NM_001101800 chr5 137274014 137274030
FAM160B1 NM_020940 chr10 116624238 116624252
FAM43A NM_153690 chr3 194409617 194409631
FAM46A NM_017633 chr6 82455479 82455495
FAM8A1 NM_016255 chr6 17608952 17608966
FARSA NM_004461 chr19 13033456 13033472
FCHSD2 NM_014824 chr11 72549462 72549478
FGF18 NM_003862 chr5 170884516 170884530
FOS NM_005252 chr14 75748738 75748752
FYTTD1 NM_001011537 chr3 197510494 197510508
FZD8 NM_031866 chr10 35928121 35928137
GABRB3 NM_000814 chr15 26791941 26791957
GID4 NM_024052 chr17 17969423 17969437
GMFB NM_004124 chr14 54943484 54943500
GREM1 NM_001191322 chr15 33026142 33026156
GRM5 NM_000842 chr11 88238180 88238196
GTF3C2 NM_001035521 chr2 27549237 27549253
HDLBP NM_001243900 chr2 242166724 242166740
HMX2 NM_005519 chr10 124909746 124909760
HS3ST5 NM_153612 chr6 114378387 114378405
ID1 NM_181353 chr20 30194219 30194233
ID2 NM_002166 chr2 8824387 8824401
IFFO2 NM_001136265 chr1 19232348 19232364
IFFO2 NM_001136265 chr1 19234004 19234020
INSIG1 NM_198336 chr7 155100850 155100864
INSIG2 NM_016133 chr2 118866065 118866079
JADE1 NM_199320 chr4 129795977 129795991
KLF9 NM_001206 chr9 73000093 73000109
KRAS NM_004985 chr12 25358540 25358556
LAMC1 NM_002293 chr1 183114689 183114703
LHX2 NM_004789 chr9 126795190 126795204
LRAT NM_004744 chr4 155670433 155670447
MAF NM_001031804 chr16 79630496 79630512
MAP3K4 NM_005922 chr6 161537948 161537962
MAT2A NM_005911 chr2 85771791 85771805
MAX NM_002382 chr14 65541916 65541932
MED1 NM_004774 chr17 37562430 37562446
MFN1 NM_033540 chr3 179110163 179110177
MPHOSPH6 NM_005792 chr16 82182157 82182173
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NCOA1 NM_003743 chr2 24992156 24992170
NFIA NM_005595 chr1 61923942 61923956
NFIA NM_005595 chr1 61921872 61921886
NFKBID NM_139239 chr19 36379227 36379243
NIP7 NM_001199434 chr16 69375861 69375875
NPAS4 NM_178864 chr11 66193461 66193475
NRARP NM_001004354 chr9 140194952 140194968
NRARP NM_001004354 chr9 140194260 140194276
NRCAM NM_001037132 chr7 107788857 107788873
NYAP2 NM_020864 chr2 226516625 226516639
PAIP2 NM_001033112 chr5 138705353 138705367
PARD3B NM_057177 chr2 206484850 206484864
PCLO NM_014510 chr7 82449801 82449817
PHACTR2 NM_001100164 chr6 144145245 144145259
PIP5K1A NM_001135636 chr1 151221686 151221700
PLAGL2 NM_002657 chr20 30783440 30783456
POLD3 NM_006591 chr11 74351877 74351891
PPAN NM_020230 chr19 10221911 10221925
PPTC7 NM_139283 chr12 110973221 110973237
PROK2 NM_001126128 chr3 71820859 71820875
PTPN4 NM_002830 chr2 120741603 120741617
PTPN4 NM_002830 chr2 120739805 120739819
PTPRT NM_007050 chr20 40701525 40701541
PWWP2A NM_001267035 chr5 159503050 159503066
PWWP2A NM_001130864 chr5 159518937 159518953
RAB5A NM_004162 chr3 20026498 20026512
RAPGEF2 NM_014247 chr4 160280743 160280757
RAPGEF6 NM_001164386 chr5 130760771 130760787
RET NM_020975 chr10 43624817 43624831
RFX4 NM_001206691 chr12 107156393 107156407
RIC1 NM_001206557 chr9 5775355 5775369
RSF1 NM_016578 chr11 77377522 77377538
SCMH1 NM_001031694 chr1 41493682 41493698
SEL1L NM_005065 chr14 81940891 81940907
SEMA6C NM_001178061 chr1 151104559 151104575
SETD1A NM_014712 chr16 30995602 30995616
SHC3 NM_016848 chr9 91628200 91628216
SLC25A12 NM_003705 chr2 172641480 172641496
SLC25A37 NM_016612 chr8 23429802 23429816
SLC35F3 NM_173508 chr1 234460006 234460020
SLC35F4 NM_001206920 chr14 58030803 58030819
SLC39A14 NM_001128431 chr8 22278593 22278607
SLC44A5 NM_001130058 chr1 75667928 75667944
SLC9A6 NM_001042537 chrX 135128539 135128553
SNAI1 NM_005985 chr20 48605383 48605397
SNTB2 NM_006750 chr16 69342851 69342865
SOCS2 NM_001270467 chr12 93969847 93969861
SSH1 NM_018984 chr12 109177171 109177187
STRN3 NM_001083893 chr14 31363715 31363731
STXBP5L NM_014980 chr3 121138907 121138921
TARDBP NM_007375 chr1 11084178 11084192
TCF7L1 NM_031283 chr2 85536666 85536680
TCF7L2 NM_001146274 chr10 114925879 114925893
TFRC NM_001128148 chr3 195777829 195777845
THSD7A NM_015204 chr7 11414601 11414617
TM2D3 NM_025141 chr15 102182566 102182582
TMEM161B NM_153354 chr5 87491497 87491513
TNFSF15 NM_001204344 chr9 117547098 117547114
TOP1 NM_003286 chr20 39752108 39752122
TRIB1 NM_025195 chr8 126450481 126450495
TRPM7 NM_017672 chr15 50852637 50852653
TSHZ3 NM_020856 chr19 31766076 31766092
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UBE2Q2 NM_001145335 chr15 76193346 76193360
UBR3 NM_172070 chr2 170940511 170940525
UCP3 NM_003356 chr11 73712183 73712199
UCP3 NM_003356 chr11 73712216 73712232
UHRF1BP1 NM_017754 chr6 34845242 34845256
VASH2 NM_001136474 chr1 213162951 213162965
VGLL4 NM_001128219 chr3 11598209 11598225
YAF2 NM_001190977 chr12 42553247 42553263
ZBTB43 NM_001135776 chr9 129600417 129600431
ZC3H12A NM_025079 chr1 37949442 37949457
ZFPM2 NM_012082 chr8 106816017 106816031
ZSWIM6 NM_020928 chr5 60841392 60841406
Table 5.5: Sequences of the CDEs tested in luciferase assays.
Symbol Sequence 5’→3’
CYR61 ACAAAAGTAAATGGGAGGGCATTCCATCCCTTCCTGAAGGGGGACACTCC
ATGAGTGTCTGTGAGAGGCAGCTATCTGCACTCTAAACTGCAAACAGAAA
CYR61_CDEmut ACAAAAGTAAATGGGAGGGCATTCCATCCCTTCCTGAAGGGGGACACTCC
ATCAGTGTCTGTGAGAGGCAGCTATCTGCACTCTAAACTGCAAACAGAAA
ZC3H12A TCTAGCTGTCTGCCTCAGTGGGTCAGAAGCGATCACCCTGTTGATACACA
TTGTATCTCTGTAGTTTAAGGAGACGCTGCCGGTAACGGCGTCGGTCCGT
ZC3H12A_CDEmut TCTAGCTGTCTGCCTCAGTGGGTCAGAAGCGATCACCCTGTTGATACACA
TAGTATCTCTGTAGTTTAAGGAGACGCTGCCGGTAACGGCGTCGGTCCGT
TM2D3 GGAGTTGATGTGGTGTGAGTGATATATTTCTATGTTTTTAATGTACAGCA
TCTGTACTTTGTTTGCCTTGATAAAGGTAAGATAAATGAAACGCTGAACT
ATGCTAATCTGGAATTTGTTTTTATTTGCCTGAAATATATTTTTTTCTGT
GAAAAAATTAAAACGTACTTAAGCCAGGAGAATGAATTATACAGTGATTG
TM2D3_CDEmut GGAGTTGATGTGGTGTGAGTGATATATTTCTATGTTTTTAATGTACAGCA
TGTGTACTTTGTTTGCCTTGATAAAGGTAAGATAAATGAAACGCTGAACT
ATGCTAATCTGGAATTTGTTTTTATTTGCCTGAAATATATTTTTTTCTGT
CAAAAAATTAAAACGTACTTAAGCCAGGAGAATGAATTATACAGTGATTG
CSF3 TTGAGAGTATCAGGTCTCCCACGTGGGAGACAAGAAATCCCTGTTTAATA
TATAAACAGCAGTGTTCCCCATCTGGGTCCTTGCACCCCTCACTCTGGCC
CSF3_CDEmut TTGAGAGTATCAGGTCTCCCACGTGGGAGACAAGAAATCCCTGTTTAATA
TATAAACAGCAGTGTTCCCCATCTGGGTCCTTGCACCCCTCACTCTGGCC
TNF AGTTCAGACAGACATGTTTTCTGTGAAAACGGAGCTGAGCT
TNF_CDEmut AGTTCAGACAGACATGTTTTCTGTCAAAACGGAGCTGAGCT
Table 5.6: High confidence ADEs. Adopted and modified from [113].
symbol RefSeqID chr start end
NM_018429 BDP1 chr5 70863581 70863598
NM_014856 DENND4B chr1 153902430 153902447
NM_004338 LDLRAD4 chr18 13646121 13646138
NM_002317 LOX chr5 121399402 121399419
NM_007013 WWP1 chr8 87479410 87479427
NM_031483 ITCH chr20 33097856 33097873
NM_000899 KITLG chr12 88886588 88886605
NM_019008 MIEF1 chr22 39913359 39913376
NM_005923 MAP3K5 chr6 136878232 136878249
NM_020834 HOMEZ chr14 23743546 23743563
NM_014170 GTPBP8 chr3 112719847 112719864
NM_006843 SDS chr12 113830675 113830692
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NM_173801 OOSP2 chr11 59814873 59814890
NM_000964 RARA chr17 38513875 38513892
NM_012431 SEMA3E chr7 82996514 82996531
NM_018027 FRMD4A chr10 13686433 13686450
NM_016467 ORMDL1 chr2 190635779 190635796
NM_017787 WBP1L chr10 104575010 104575027
NM_001243812 CACNA1B chr9 141016502 141016529
Table 5.7: Oligonucleotide sequences used for PCR, reverse transcription and qPCR analysis.
Adopted and modified from [113].
Specificity Sequence 5’→3’
UCP3-fwd ATAGACCTCGAGTGAACAAGACAAGAAGGCCACTGGTAGCTAAC
UCP3-rev ATAGACGCGGCCGCGGCATGTGGGGCTGGATCTGGCCCTG
UCP3-del-fwd GAGGAGGGATTCTGGTCTTCAAGAAAATAAACCAAGATAGATCCATTTG
UCP3-del-ev CAAATGGATCATCTTGGTTTATTTTCTTGAAGACCAGAATCCCTCCTC
miR152-fwd GATCTACTCGAGCAGACTCGGCTCCCATCAC
miR152-rev GATCTACTCGAGCAGACTCGGCTCCCATCAC
pDF-fwd GATCTAGCTAGCGCACATTTCCCCGAAAAGTGC
pDF-rev GATCTAGGAGATATCGTCGACAAGCTTATC
pFRT-fwd GATCTACGATAAGCTTGTCGACGATATCTCCACACACCCGGGAATAAAATATC
pFRT-rev GATCTAGCTAGCCACTTTTCGGGGAAATGTGC
Luc2_3UTR_seq_fwd GAGGTGCCTAAAGGACTG
luc2_seq_rev2 AGTGAGCGAGGAAGCTCG
CMV_prom_fwd TAAGCAGAGCTCGTTTAGTG
SV40_polyA_rev CACTGCATTCTAGTTGTGG
pHDV_seq_fwd CACTTTATGCTTCCGGCTCG
AP1_pSP64 TTTAGGTGACACTATAGAATACA
miR130_SL GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAAATGCCC
miR148_SL GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACAAAG
miR152_SL GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCACCAAGT
miR301_SL GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAGCTTTG
U48_SL GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACGGTCAG
130a_fwd CGGCGGCAGTGCAATGTTAAAA
130b_fwd GGCGGCAGTGCAATGATGAAA
148a_fwd GCGGTCAGTGCACTACAGAA
148b_fwd AGCGGTCAGTGCATCACAGAA
152_fwd GGCGGTCAGTGCATGACAGA
301a_fwd GGCGGCAGTGCAATAGTATTGT
301b_fwd GGCGGCAGTGCAATGATATTGT
U48_fwd GAGTGATGATGACCCCAGGTAA
universal rev-primer GTGCAGGGTCCGAGGT
GFP_qPCR_fwd1 CGTAAACGGCCACAAGTTCA
GFP_qPCR_rev1 CGCTACCCCGACCACATGAAG
RPLP0_fwd TCGACAATGGCAGCATCTAC
RPLP0_rev ATCCGTCTCCACAGACAAGG
DDIT4_F1 GTTTGACCGCTCCACGAG
DDIT4_R1 CATCAGGTTGGCACACAAGT
CYR61_F2 CGAGGTGGAGTTGACGAGA
CYR61_R2 GAGCACTGGGACCATGAAGT
PLAGL2_F1 GCAACCAGAGCAGAGACCAT
PLAGL2_R1 GTCCTTGCGGTGAAACATCT
SNAI1_F1 CTCTTTCCTCGTCAGGAAGC
SNAI2_R1 CGGTGGGGTTGAGGATCT
NRARP_F2 ATGACCAACTGCGAGTTCAA
NRARP_R2 GAACTTGACCAGCAGCTTCA
CSF3_F2 GTCCCACCTTGGACACACTG
CSF3_R2 GACACCTCCAGGAAGCTCTG
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PLOD2_F1 GGGGCCAGAAAGTGAGATTA
PLOD2_R1 CCACTTTGTGGTTTGCCTTT
TNFSF15_F2 GCAGACGGAGATAAGCCAAG
TNFSF15_R2 GCCAGGCCTAGTTCATGTTC
ZC3H12A_F1 TCCACTCCCAGAAGAGGAAA
ZC3H12A_R1 GGATGGCACAAACACTGTGA
TM2D3_F1 GGGAAGCCTGTCACTTTTGA
TM2D3_R1 CCAGCAAAATCTGCAAGTCA
CASD1_F1 CATCACCTCCATAGCACCACT
CASD1_R1 TGCAGCTTCATTGTAAGCATCT
ITCH_fwd1 GAAGACGTTTGTGGGTGATT
ITCH_rev1 TAAGAAGCGGGGTTTATCTG
WWP1_fwd1 GACATGGAGATTTTGGGAAA
WWP1_rev1 CAAGGAAAGCTTTGGTCTGT
MAP3K5_fwd2 CAGGAAAACCCCCATTTTAT
MAP3K5_rev2 GCTCTCTTGTCAGGATCTGG
GTPBP8_fwd1 TGCAAATTCTTCACACATTTCT
GTPBP8_rev1 ATGGCTTTAGAGCACCTGAA
hsRC3H1_fwd TGGACAACCAGAACCACAAA
hsRC3H1_rev GCTGATCCATTTGGTACATCAC
hsRC3H2_fwd AAGGTTGGCGCTAATGGTC
hsRC3H2_rev CAGGAGTCTTGGGTGGAGAA
mmRC3H1_fwd TTGTACCTGAAGCCACTCAGCAGT
mmRC3H1_rev TCCACTAGCTGGCAATGAACCAGA
mmRC3H2_fwd TGCCCATTCTCAGGAAGAGCTTGA
mmRC3H2rev GCTGTGGTTGTGACAGTGCTGTTT
mmUCP3_fwd GATGTGGTGAAGGTCCGATT
mmUCP3_rev GGCATTTCTTGTGATGTTGGG
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6.1 Materials Used in this Study
6.1.1 Disposable Material and Kits
Table 6.1: Disposable material and kits used in this study.
Disposable/Kit Company
T75 culture flask Greiner Bio-One
Cell culture plates (6-well, 12-well, 24-well) Greiner Bio-One
Amersham ECL Select Western Blotting Detection
Reagent
GE Healthcare
cell culture dishes 60mm Greiner Bio-One
Dual Glo Luciferase Assay System Promega
Dual-Glo® Luciferase Assay System Promega
Flp-In™ System Life Technologies
Maxtract tubes (1.5ml; 2ml) QIAgen
MicroAmp® Fast 96-Well reaction plate Applied Biosystems
MicroAmp™ optical adhesive film Applied Biosystems
Mini-PROTEAN® TGX Stain-Free™ anyKd gels Bio-Rad
Nunc™ MicroWell™ white 96-well plates, polystyrene Thermo Fisher Scientific
PVDF membranes Bio-Rad
QIAprep® Spin Miniprep Kit QIAgen
QIAquick Gel Extraction Kit QIAgen
QIAquick PCR Purification Kit QIAgen
Reaction tubes (1.5ml; 2 ml) Greiner Bio-One
Reaction tubes (15ml; 50 ml) Greiner Bio-One
Trans-Blot® Turbo™ Transfer Pack Mini, 0.2µm
PVDF
Bio-Rad
Trypane blue staining kit Bio-Rad
QIAprep®Spin Miniprep kit QIAgen
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6.1.2 Chemicals and Enzymes
Table 6.2: Chemicals and enzymes used in this study.
Chemical/Enzyme Company
γ-S-ATP Biomol
γ-32P-ATP Hartmann
Acetone Roth
actinomycine D Sigma
Agarose peqLab
Ammonium sulfate Roth
Ampicillin Roth
anti Roquin-1/-2 ( 3F12) Millipore
anti-rat IgG Jackson Immunoresearch
ATP Roth
Biotin-long-arm maleimide Vector Laboratories
Bovine serum albumin (BSA) Applichem
Bradford Bio-Rad
Bromophenol blue Roth
Calf intestine phosphatase (CIP) Roche
CIP buffer 10x Roche
Clorophorm Roth
Cytidine triphosphate (CTP) peqLab
Deoxynucleotide triphosphate (dNTP) peqLab
Dithiothreitol (DTT) Roth
Dulbecco’s Modified Eagle Medium (DMEM) Sigma Aldrich
Dulbecco’s Phosphate buffered Saline (PBS) Life Technologies
Dynabeads M-280 Invitrogen
EBM-plus Lonza
ECL select GE Healthcare
EGM-Plus Singlequots Lonza
Ethanol VWR
Ethylenediaminetetraacetic acid (EDTA) Roth
Fetal Bovine Serum (FBS) Biochrom
First strand PCR buffer (5x) Thermo Fisher Scientific
Glycerol, p.a. Roth
GlycoBlue™ Invitrogen
Guanosine triphosphate (GTP) peqLab
Heparin Sigma Aldrich
HindIII-HF New England Biolabs
Horse serum (HS) Sigma Aldrich
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Chemical/Enzyme Company
hydrochloric acid (HCl) Roth
Hygromycin B Invivogen
IGEPAL CA-630 Sigma Aldrich
Isoamyl alcohol Roth
Isopropylic alcohol, p.a. VWR
Lipofectamine® 2000 Life Technologies
Magnesiumacetat (Mg(Ac)2) Roth
MulV reverse transcriptase Thermo Fischer Scientific
NcoI-HF New England Biolabs
NheI-HF New England Biolabs
NotI-HF New England Biolabs
Opti-MEM® Life Technologies
Penicillin/ Streptomycin Thermo Fischer Scientific
Potassium chloride (KCl) Roth
Proteinase-inhibitor-cocktail (PIC) Sigma Aldrich
Q5 High-Fidelity DNA Polymerase New England Biolabs
Q5 reaction buffer (5x) New England Biolabs
random hexamers Sigma Aldrich
RiboLock RNase inhibitor Molox
RNAimax Life Technologies
RNase T1 Ambion
Roti-Phenol Roth
Rotiphorese Acrylamide Solution Roth
Sodium acetate Roth
Sodium carbonate (Na2CO3) Roth
Sodium chloride (NaCl) Roth
Sodium dodecyl sulfate (SDS) Roth
Sodium pyruvate Thermo Fischer Scientific
Spermidine Sigma Aldrich
Supersript II reverse transcriptase Life Technologies
SYBR Green Master Mix (2x) Thermo Fischer Scientific
SYBR Green PCR Master Mix Thermo Fischer Scientific
T4 DNA Ligase New England Biolabs
T4 DNA Ligase Roche
T4 polynucleotid kinase New England Biolabs
T4 polynucleotid kinase Roche
T7 RNA Polymerase homemade
Taq polymerase New England Biolabs
TaqMan Fast Universal Master Mix (2x) Thermo Fischer Scientific
TaqMan® Universal PCR Master Mix Applied Biosystems
Tetramethylethylendiamin (TEMED) Roth
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Chemical/Enzyme Company
Thermo Pol buffer New England Biolabs
Transcription buffer (10x) Applied Biosystems
Tris Roth
TRIzol® reagent Thermo Fischer Scientific
Trypan blue Bio-Rad
Trypsin/ EDTA Invitrogen
Turbo Dnase Life Technologies
TurboDNase buffer (10x) Life Technologies
Tween® 20 Roth
Universal ProbeLibrary #21 Roche
Urea Roth
Uridine triphosphate (UTP) peqLab
XbaI New England Biolabs
XhoI New England Biolabs
yeast tRNA Sigma Aldrich
Zeocine Invivogen
6.1.3 Technical Equipment
Table 6.3: Technical equipment used in this study.
Technical equipment Company
Cytoflex S Beckman Coulter
Centrifuges Heraeus Christ
ChemiDoc Imaging System Bio-Rad
Gel documentation with UV screen INTAS
Infinite® M200 plate reader Tecan Trading AG
Liquid Scintillation Counter 1409 Wallac
Milli-Q® water purification system with RNase filter EMD Millipore
Mini-PROTEAN Tetra Cell electophoresis chamber Bio-Rad
NanoDrop® ND-1000 Spectrophotometer peqLab
Phosphoimager FL-5000 Fuji
Q-Exactive Plus MS Thermo Fisher Scientific
StepOnePlus™ Real-Time PCR System Thermo Fischer Scien-
tific
Storage phosphor Screen BAS_IP MS 2040 Fuji
T100™ Thermal Cycler Bio-Rad
TC-10™ Automated Cell Counter Bio-Rad
Thermomixer comfort Eppendorf AG
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Technical equipment Company
Trans-Blot® Turbo™ Bio-Rad
UltiMate 3000 HPLC Thermo Fisher Scientific
vacuum slab gel drier Bio-Rad
6.1.4 Plasmids
Table 6.4: Plasmids generated in this study.
Designator Plasmid Section Description
ADM pDLP_ADM 2.1.1
BCL2L1 pLDP_BCL2L1 2.1.1
CTBP1 pDLP_CTBP1 2.1.1
EGLN3 pDLP_EGLN3 2.1.1
ELK3 pDLP_ELK3 2.1.1
EMX1 pDLP_EMX1 2.1.1
HIRA pDLP_HIRA 2.1.1
HMOX1 pDLP_HMOX1 2.1.1 structually
HOXC1 pDLP_HOXC1 2.1.1 conserved
MYF6 pDLP_MYF6 2.1.1 RNA elements
MR4A2 pDLP_MR4A2 2.1.1 predicted by
PDE5A pDLP_PDE5A 2.1.1 Dynalign
RBPJ pDLP_RBPJ 2.1.1
SIX2 pDLP_SIX2 2.1.1
TFDP1 pDLP_TFDP1 2.1.1
TGFBR1 pDLP_TGFBR1 2.1.1
THBS1 pDLP_THBS1 2.1.1
TLX3 pDLP_TLX3 2.1.1
UBE2B pDLP_UBE2B 2.1.1
UCP3 pDLP_UCP3delseq 2.1.1
full 3UTR pDLP_UCP3 2.1.1 full length UCP3 UUTR
deletion pDLP_UCP3_DEL 2.1.1 UCP3 3’UTR without pre-
dicted element
2x window pDLP_UCP3_2x 2.1.1 2x UCP3 regulatory element
random ctrl pDLP_UCP3_RAND 2.1.1 Randomization of the 100 nt el-
ement
∆miR pDLP_UCP3mut2 2.1.2 UCP3 element without miR
binding sites
miR-152 pCMV_miR152 2.1.2 miR-152 overexpression plas-
mid
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del1 pDLP_UCP3mut3 2.1.3
del2 pDLP_UCP3mut5 2.1.3 truncation mutants
del3 pDLP_UCP3mut12 2.1.3 of the 100 nt
del4 pDLP_UCP3mut13 2.1.3 UCP3 element
del5 pDLP_UCP3mut4 2.1.3
1-7 pDLP_UCP3mut16_1 2.1.4
8-14 pDLP_UCP3mut16_2 2.1.4
15-21 pDLP_UCP3mut16_3 2.1.4 1-7 – 57-64
22-28 pDLP_UCP3mut16_4 2.1.4 heptamer mutants
29-36 pDLP_UCP3mut16_5 2.1.4 based on the 64 nt
36-42 pDLP_UCP3mut16_6 2.1.4 del2 construct
43-49 pDLP_UCP3mut16_7 2.1.4
50-56 pDLP_UCP3mut16_8 2.1.4
57-64 pDLP_UCP3mut16_9 2.1.4
MUTII pDLP_UCP3mut16_3 2.2.1 mutation of CDEI
MUTI pDLP_UCP3mut7_3 2.2.1 mutation of CDEII
MUTI/II pDLP_UCP3mut716 2.2.1 mutation of CDEI/II
CDEImut pDLP_UCP3mut31 2.3.1 mutation of closing bp in CDEI
CDEIImut pDLP_UCP3mut24 2.3.1 mutation of closing bp in
CDEII
CDEI/IImut pDLP_UCP3mut37 2.3.1 mutation of closing bp in
CDEI/II
M1 pDLP_UCP3mut32 2.3.2
M2 pDLP_UCP3mut46 2.3.2
M3 pDLP_UCP3mut34 2.3.2
M4 pDLP_UCP3mut22 2.3.2
M5 pDLP_UCP3mut25 2.3.2
M6 pDLP_UCP3mut47 2.3.2
M7 pDLP_UCP3mut48 2.3.2
M8 pDLP_UCP3mut55 2.3.2
M9 pDLP_UCP3mut46 2.3.2
CDEII2x pDLP_UCP3mut40 2.3.2
M10 pDLP_UCP3mut59 2.3.2
M11 pDLP_UCP3mut15 2.3.2
M12 pDLP_UCP3mut57 2.3.2
M13 pDLP_UCP3mut58 2.3.2 M1-M32
M14 pDLP_UCP3mut23 2.3.2 constructs used
M15 pDLP_UCP3mut50 2.3.2 for the mutation
M16 pDLP_UCP3mut51 2.3.2 analysis of the
M17 pDLP_UCP3mut52 2.3.2 del2 construct
M18 pDLP_UCP3mut42 2.3.2
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M19 pDLP_UCP3mut43 2.3.2
M20 pDLP_UCP3mut431 2.3.2
M21 pDLP_UCP3mut35 2.3.2
M22 pDLP_UCP3mut26 2.3.2
M23 pDLP_UCP3mut49 2.3.2
M24 pDLP_UCP3mut62 2.3.2
M25 pDLP_UCP3mut53 2.3.2
M26 pDLP_UCP3mut60 2.3.2
M27 pDLP_UCP3mut63 2.3.2
M28 pDLP_UCP3mut54 2.3.2
M29 pDLP_UCP3mut61 2.3.2
M30 pDLP_CDEI_5bp 2.3.2
M31 pDLP_CDEII_5bp 2.3.2
M32 pDLP_CDEI/II_5bp 2.3.2
R1 pDLP_UCP3R2 2.1.3 R1-R5
R2 pDLP_UCP3R3 2.1.3 randomizations
R3 pDLP_UCP3R4 2.1.3 of del2
R4 pDLP_UCP3R5 2.1.3
R5 pDLP_UCP3R6 2.1.3
64 nt pDLP_64 nt 2.1.3 artifitial sequence with 50%
GC content
pDF_FRT 2.1.5
UCP3 wt pDF_FRT_mut5 2.1.5 integration of GFP-UCP3 wt
and MUTI/II fusions
MUTI/II pDF_FRT_716 2.1.5
TM2D3 pDLP_TM2D3 2.4.2
TM2D3mut pDLP_TM2D3mut 2.4.2
CSF3 pDLP_CSF3 2.4.2 new CDEs and
CSF3mut pDLP_CSF3mut 2.4.2 corresponding
CYR61 pDLP_CYR61 2.4.2 closing pair mutants
CYR61mut pDLP_CYr61mut 2.4.2
ZC3H12A pDLP_ZC3H12A 2.4.2
ZC3H12Amut pDLP_ZC3H12Amut 2.4.2
TNF pDLP_TNF 2.4.2
TNFmut pDLP_TNFmut 2.4.2
UCP3 HDV_UCP3pe_N 2.1.4 UCP3 window with T7 pro-
moter and HDV ribozym
wt pHDV_mut5 2.1.4 de2 with T7 promoter and
HDV ribozym
MUTI pHDV_mut7_3 2.2.1 MUTI with T7 promoter and
HDV ribozym
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6.1 Materials Used in this Study
Designator Plasmid Section Description
MUTII pHDV_mut16_3 2.2.1 MUTII with T7 promoter and
HDV ribozym
MUTI/II pHDV_mut716 2.2.1 MUTI/II with T7 promoter
and HDV ribozym
R1 pHDV_R2 2.2.1 R1 with T7 promoter and
HDV ribozym
CDEImut pHDV_mut31 2.3.1 CDEI with T7 promoter and
HDV ribozym
CDEIImut pHDV_mut24 2.3.1 CDEII with T7 promoter and
HDV ribozym
CDEI/IImut pHDV_mut37 2.3.1 CDEI/II with T7 promoter
and HDV ribozym
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